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ABSTRACT

USING THE FROG EPIDERMIS TO UNCOVER DESMOSOME FUNCTION AND
REGULATION IN THE DEVELOPING EMBRYO
By Navaneetha Krishnan Bharathan, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2018
Major Director: Dr. Amanda J. Dickinson
Assistant Professor, Department of Human and Molecular Genetics

The desmosome is one of the major cell adhesion junctions found in the epithelia, heart,
and hair follicle. Described as a “rivet” that hold cells together, it provides these tissues with the
integrity to withstand the tremendous forces they face in everyday life. Defects in this junction can
lead to devastating diseases where patients are susceptible to skin infections and cardiovascular
defects. Limited treatments exist for diseases of the desmosome, and strategies do not target all
symptoms. Therefore, delineating the function and regulation of desmosomes is of paramount
importance for the development of prevention and treatment strategies. The Xenopus laevis has
been utilized for the study of embryonic development and tissue movements. This study takes
advantage of the frog model to study a key desmosomal protein, desmoplakin (Dsp), in the

xv
epidermal development of the embryo. First, Xenopus embryonic epidermis has junctio na l
desmosomes as early as the blastula stages. Desmosomes numbers per junction increase as the
embryo develops. Dsp is present in many epidermally-derived structures in the embryo at varying
levels. Xenopus embryos deficient in desmoplakin have phenotypic defects in epidermal structures
and the heart, mimicking mammalian models. Embryos with reduced Dsp exhibit an increased
susceptibility to epidermal damage under applied mechanical forces. Assays also reveal a potential
role for desmosomes in radial intercalation, a process through which cells move from the inner to
the outer epidermal layers. Embryos with reduced Dsp exhibit a slight reduction in intercala tio n
and defects in intercalating cell types, including multiciliated cells and small secretory cells.
Finally, c-Jun N-terminal kinase (JNK) may have a potential role in the regulation of desmosome
assembly and adhesion. Embryos with deficient Dsp display a partial recovery of mechanica l
integrity when treated with a JNK inhibitor.

CHAPTER 1: THE ROLE AND REGULATION OF DESMOSOMES IN THE XENOPUS
LAEVIS EMBRYONIC EPIDERMIS

INTRODUCTION

Desmosomes or macula adherens are junctional complexes that mediate cell-cell adhesion,
along with tight junctions and adherens junctions. Their strong adhesion confers the mechanica l
integrity to withstand stresses experienced by the skin and heart (Collins and Garrod, 1994;
Garrod, 1993). Desmosome function has largely been investigated in the context of cell adhesion
and disease. As a consequence, little is known regarding the regulation of desmosomes during
development in vivo and their function in morphogenesis. The current study makes use of the
vertebrate frog model, Xenopus laevis, to investigate desmosome function and regulation during
embryonic development.
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XENOPUS LAEVIS AS A MODEL ORGANISM
The African clawed frog, Xenopus laevis, is an allotetraploid aquatic amphibian species of
the order Anura. Over the last 100 years, this species along with the related diploid species,
Xenopus tropicalis¸ have been extensively utilized

for biological research and medical

applications. For example, these organisms have been used to study various aspects of cellular and
developmental biology including gastrulation, cell movements, and signaling pathways (Tandon
et al., 2017).
Xenopus laevis possesses many characteristics that have led to its emergence as a model
organism. First, many embryos (500-2000+) can be obtained in a single clutch, providing statistica l
power to experiments. Second, the egg size is relatively larger (1-1.3mm) than other aquatic
vertebrates including X. tropicalis (0.7-0.8mm) and the zebrafish, Danio rerio (0.7mm) (Hirsch et
al., 2002; Kimmel et al., 1995). The large egg size allows one to easily manipulate the embryo by
microinjection of morpholinos, mRNA, plasmid constructs, or protein. Over the last decade, the
genetic manipulation toolkit has expanded to include I-SceI meganuclease, Transcriptio n
Activator-Like Effector Nucleases (TALENs), and CRISPR/ Cas, thus making it possible to create
genetically manipulated organisms (Ishibashi et al., 2012; Joung and Sander, 2013; Lei et al., 2012;
Sater and Moody, 2017; Tandon et al., 2017). Third, fate maps for the embryonic blastomeres are
well-characterized in X. laevis, allowing one to study tissue-specific functions of a gene or protein
(Dale and Slack, 1987; Moody, 1987; Moody and Kline, 1990). Additionally, external fertiliza tio n
and detailed staging of early embryonic development make this organism well-suited for the study
of organogenesis and use in chemical drug screening (Dickinson, 2016; Harland and Grainger,
2011; Nieuwkoop and Faber, 1967; Schmitt et al., 2014).
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X. tropicalis is a diploid organism with 2n=20 chromosomes, while X. laevis is an
allotetraploid organism with 2n=36 chromosomes. Based on protein-coding gene phylogeny, the
ancestors of X. laevis and X. tropicalis are believed to have diverged around 48-65 Mya (Evans et
al., 2004; Hellsten et al., 2007; Matsuda et al., 2015; Session et al., 2016). The ancestor of X. laevis,
now thought to be extinct, had 18 chromosomes (2n) (Evans, 2008), and a whole genome
duplication (allotetraploidization) event around 17 Mya led to the emergence of X. laevis (Chain
and Evans, 2006; Evans et al., 2004; Hellsten et al., 2007; Hughes and Hughes, 1993; Session et
al., 2016).
The allotetraploidization of X. laevis resulted from the convergence of two 18-chromosome
species. The genetic contribution of both ancestral species appears to be cytologically distinct from
each other, forming bivalents instead of quadrivalents during meiosis (Tymowska and Kobel,
1972; Uno et al., 2013). Recently, these two “subgenomes” were designated “L” (Long) and “S”
(Short) for their relative differences in chromosome length(Matsuda et al., 2015). Each of the 9
pairs of chromosomes in the L subgenome are found to be homologous to those in the S subgenome
based on similarities in chromosome morphology and banding patterns as well as comparative
phylogenetic mapping (Krylov et al., 2010; Matsuda et al., 2015; Tymowska and Kobel, 1972;
Uno et al., 2013). Further genetic analysis revealed large deletions in the S subgenome. Genes
already present in multiple copies are more likely to be retained, such as Hox clusters. However,
genes involved in DNA repair and metabolic enzymes, for example, are lost, suggesting deletion
due to selection pressure (Session et al., 2016).
Despite the allotetraploidy of X. laevis, development and sequencing of the inbred J strain
has made it a more tractable model (Gantress et al., 2003; Pearl et al., 2012; Session et al., 2016).

3

DEVELOPMENT OF THE EMBRYONIC EPIDERMIS
The epidermis or skin plays pivotal roles in regulating body temperature as well as
protection from dehydration and infection. The human epidermis arises as a bi-layer from the
embryonic surface ectoderm sometime after neurulation (4 weeks) (Breathnach and Wyllie, 1965;
Holbrook and Odland, 1975). The outer protective layer of cells is called the periderm, and
functions as the embryonic epidermis in utero until about 5 months (Haslam et al., 2014). The
periderm is marked by expression of simple epithelial keratins K8/ K18 (Jackson et al., 1981; Moll
et al., 1982). The inner or basal layer is considered the epidermis proper, expressing K5/ K14
(Lourenco et al., 2008). This basal layer eventually gives rise to the remaining layers.
At around 8 weeks, adherens junction proteins including E-cadherin, P-cadherin, α catenin,
and α actinin are expressed in the bi-layer (Fujita et al., 1992; Hentula et al., 2001; Lourenco et
al., 2008). Tight junctions are also visible between peridermal cells and ZO-1 and occludin
expression have been demonstrated (Pummi et al., 2001). During this time, the basal layer
undergoes mitosis and gives rise to the intermediate cell layer which matures into the spinous layer
expressing K1/ K10 (Dale et al., 1985). This layer arises from asymmetric cell divisions and a
spindle shift in the basal layer from lateral to perpendicular (Lechler and Fuchs, 2005).
Between 9-20 weeks, the number of desmosomes in the spinous layer increases as it
proliferates (Dale et al., 1985; Holbrook and Odland, 1975). By 21-24 weeks post-coitus, the
spinous cells proliferate and migrate outward, giving rise to the granular and cornified layers
(Holbrook, 1983). The granular layer expresses transglutaminase and involucrin, while the
cornified layer is marked by filaggrin and loricrin expression (Koster and Roop, 2007). Finally,
keratinization proceeds as the cornified layer becomes flattened and the periderm is shed into the
amniotic fluid (Holbrook and Odland, 1980). This process leads to the formation of the stratum
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corneum that functions as a barrier (Liu et al., 2013). This final configuration of the stratified
epidermis is maintained through adulthood.
The Xenopus epidermis also develops from a bi-layered ectoderm (Chalmers et al., 2003;
Itoh et al., 1988). The single- layered 32-cell stage embryo develops an inner layer through
asymmetrical division (Chalmers et al., 2003). As the embryo progresses into the 1024-cell stage,
the number of layers increases and eventually thins out to two layers at the animal cap, forming
the prospective epidermis (Haslam et al., 2014).
As the embryos progresses through gastrulation (st. 12-15), specialized cell types are
specified in both layers. The outer layer eventually forms mucus-secreting goblet cells. During
neurulation (st. 19), the specified cell types of the inner layer integrate into the goblet cells of the
outer layer (Deblandre et al., 1999). The inner basal layer is maintained in a proliferative state,
similar to the mammalian embryonic epidermis. The Xenopus epidermis remains as a bi-layer until
metamorphosis.
During metamorphosis, the basal layer proliferates further and gives rise to the five-layered
adult skin (Duellman and Trueb, 1994; Itoh et al., 1988). Xenopus epidermis can also become
keratinized (stratum corneum) like that of mammals, although to a lesser extent. However, this
corneal layer is not present in fish, marking the evolutionary transition from aquatic to terrestrial
life (Fox, 1986; Schempp et al., 2009). Together, these similarities make the Xenopus epidermis a
suitable model for the study of embryonic development in general.
The specialized cell types in the Xenopus embryonic epidermis include the multiciliated
cells, ionocytes, and small secretory cells. These cells move from the inner to the outer epidermal
layer through a process known as radial intercalation. While these cell types are not present in the
mammalian epidermis, they are found in other epithelia (Billett and Gould, 1971). For example,
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multiciliated cells are found lining the human airways (Hayes et al., 2007). Ionocyte-like cells are
found in transporting epithelia of the mammalian kidney (Oliver, 1944; Wall, 2005). These
features validate the use of Xenopus embryonic epidermis as a model for radial intercalation and
the development of specialized epithelia.

RADIAL INTERCALATION IN THE XENOPUS EPIDERMIS
Radial intercalation is a process by which cells in adjacent layers throughout a multilayered
tissue exchange places with each another (Walck-Shannon and Hardin, 2014). This process is
known to occur in Drosophila melanogaster mesoderm to facilitate spreading, eventually forming
a monolayer (Clark et al., 2011; McMahon et al., 2010; McMahon et al., 2008). Deep cells in the
zebrafish embryo undergo radial intercalation to drive epiboly (Kane et al., 2005). In the
gastrulating Xenopus embryo, these movements occur in the chordamesoderm (Wilson and Keller,
1991).
The Xenopus embryonic epidermis also undergoes radial intercalation. The outcome of
these movements is the incorporation of specialized cell types into the outer epidermal layer at two
separate timepoints. Development of these cell types in the bi-layered ectoderm occurs through
four major steps. First, precursors of ionocytes and multiciliated cells are specified in the inner
layer of the ectoderm during gastrulation. At the same time, the outer layer is specified into goblet
cells. Second, ionocytes and multiciliated cells intercalate into the outer layer beginning at
neurulation. Third, these cells fully differentiate once they have been apically “docked” into their
final position (Deblandre et al., 1999). Finally, small secretory cells intercalate into the outer layer
during a second wave of intercalation (Cibois et al., 2014; Dubaissi et al., 2014). Many factors are
involved in the specification, intercalation, and differentiation of each of the cell types.
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Lateral inhibition through the Notch pathway restricts the fate of precursors in the inner
layer (Deblandre et al., 1999; Drysdale and Elinson, 1992). Cells expressing the Notch ligand,
Delta-1, adopt the differentiated cell fate while repressing this fate in neighboring cells where it
activates the Notch receptor (Bray, 2006; Deblandre et al., 1999). This mechanism results in an
organized spacing pattern of these cells.
The specification of the different cell types is controlled by many factors. In multiciliated
cell specification, Notch pathway inhibition leads to activation of Multicilin, a transcriptio na l
regulator that is necessary and sufficient for the multiciliated cell fate (Stubbs et al., 2012). Gmnc
(geminin coiled-coil domain containing) has been identified as an upstream activator of multic ilin
(Zhou et al., 2015). Multicilin in turn activates FoxJ1, a master regulator of motile ciliogene s is
(Stubbs et al., 2008). Additionally, the transcription factor, Rfx2, targets genes involved in cilia
assembly, motility, and planar polarization of directional beating (Chung et al., 2014; Chung et al.,
2012). Other factors that are expressed in ciliated cell precursors, such as Sox7, may also play
roles in differentiation (Fawcett and Klymkowsky, 2004). The differentiated multiciliated cell
facilitates mucus-clearance from the epidermis and might also help in oxygen uptake through the
skin before hatching (Billett and Gould, 1971; Deblandre et al., 1999; Mueller and Seymour,
2011).
Ionocytes are also specified by Notch inhibitory signaling through another target, FoxI1e.
This transcription factor can activate genes encoding proton-pump subunits and anion antiporters
such as pendrin and ae1. Additionally, expression of grainyhead- like transcription factor ubp1 can
regulate the formation of alpha- and beta-subtypes (Quigley et al., 2011). Ionocytes are required
for ionic regulation of the embryo and also have non-autonomous roles in proper development of
cilia in multiciliated cells (Dubaissi and Papalopulu, 2011).
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Multiciliated cells and ionocytes are specified during gastrulation and intercalate during
neurulation (st. 15-19). However, small secretory cells intercalate sometime after embryonic
hatching (st. 32). Development of these cells is controlled by Foxa1. The Lectin Peanut Agglutinin
(Lectin PNA) binds the carbohydrate sequence Gal-β(1-3)-GalNAc present in vesicular secretions
and can be used to identify these cells. Mass spectrometry analysis of this material revealed
glycosylated Otoglein- like protein which may contribute to the protective mucus layer on the
epidermis (Dubaissi et al., 2014). Together, all these specialized cell types are thought to work in
concert to provide resistance to bacterial infections (Stubbs et al., 2006).

ADHERENS AND TIGHT JUNCTIONS
The intercellular junctions in epithelial and endothelial tissues comprise the tight junctions
(zonula occludens), adherens junctions (zonula adherens), the desmosomes (macula adherens),
and gap junctions. The first three junctions help maintain an adhesive tissue. In the skin, adherens
junctions play a vital role in intercellular adhesion. However, they also mediate intracellular
signaling, cell polarity, and cell sorting (Gottardi et al., 2001; Niessen and Gottardi, 2008; Perrais
et al., 2007; Wang and Margolis, 2007; Wei et al., 2005). Tight junctions serve as a semi-permeab le
barrier in the skin where they protect against trans-epidermal water loss (Furuse et al., 2002; HadjRabia et al., 2004; Niessen, 2007). Tight junctions also function as a paracellular barrier, restricting
flow based on size and charge (Larre et al., 2014). Also similar to adherens junctions, tight
junctions can participate in signaling pathways (Gonzalez-Mariscal et al., 2014; Zihni et al., 2014).
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THE DESMOSOME AND ITS COMPONENTS
The desmosome appears as an electron dense structure in an electron micrograph and
consists of 3 main families of proteins - cadherins, armadillo proteins, and the plakins (Fig. 1.1).
The desmosomal cadherins, desmogleins (Dsg) and desmocollins (Dsc), form the transmembra ne
components of the desmosome. In humans and mice, four desmoglein genes (Dsg 1-4) and three
desmocollin genes (Dsc 1-3) have been identified. Furthermore, all three desmocollins are
alternatively spliced into two distinct isoforms (a and b) (Collins et al., 1991; Parker et al., 1991).
Depending on tissue type and availability, the desmosomal cadherins can form homo- or heterodimers in a cis- fashion and bind to apposing cadherins in a trans- fashion (Delva et al., 2009;
Green and Simpson, 2007).
The desmosomal cadherins are made up of several functional domains. At the N-terminus,
there are extracellular subdomains including four extracellular cadherin domains (EC1-4) which
are required for dimerization (Pokutta and Weis, 2007). The presence of a cell adhesion recognitio n
(CAR) site contributes to adhesion. At the C-terminal region of desmogleins and the “a” isoform
of desmocollins, there is an intracellular cadherin-like sequence (ICS) domain. In the desmocollin
“b” isoform, this domain is truncated and has additional unique amino acids. The ICS domain
enables binding to the armadillo protein, plakoglobin (Pg) (Mathur et al., 1994; Roh and Stanley,
1995; Troyanovsky et al., 1994).
The armadillo family of proteins, among others, include β-catenin, α-catenin, p-120
catenin, plakoglobin (γ-catenin), and the plakophilins. They are named for the presence of
distinctive armadillo repeats of a ~42 amino acid motif (Peifer et al., 1994; Peifer et al., 1992). In
the desmosome, plakoglobin (Pg) and plakophilin (Pkp) are present and attach to the cytopla smic
tail of the desmogleins and desmocollins (Kowalczyk et al., 1994; Mathur et al., 1994).
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Plakoglobin is analogous to β-catenin in the adherens junction (Butz et al., 1992; McCrea
et al., 1991). It has also been found to associate with both desmosomes and adherens junctions
(Cowin et al., 1986). Additionally, plakoglobin has some overlapping roles with β-catenin, and
can bind to TCF/ LEF factors (Simcha et al., 1998; Zhurinsky et al., 2000). In humans, there are
three plakophilin genes (Pkp 1-3) which have differential expression in epithelial and cardiac
tissues. For example, Pkp1 is expressed in the suprabasal layers of the multi-layered epidermis,
whereas Pkp2 is expressed more ubiquitously in simple, stratified, and complex epithelia, as well
as cardiomyocytes (Hatzfeld, 2007; Hatzfeld et al., 1994; Kapprell et al., 1988; Mertens et al.,
1996; Mertens et al., 1999; Schmidt et al., 1997). Plakophilin 3 is expressed in most simple and
stratified epithelia and is expressed in all epidermal layers (Bonne et al., 1999). All three
plakophilins have two alternatively spliced isoforms (a and b) (Mertens et al., 1996; Muhmer et
al., 2014; Schmidt et al., 1997). Plakophilins are found to associate with desmosomal cadherins,
plakoglobin, desmoplakin, and even the intermediate filaments, indicating that they are important
desmosomal proteins (Hatzfeld, 2007)
The plakin family of desmosomal proteins include desmoplakin (Dsp), epiplakin (Epi),
periplakin (Ppl), envoplakin (Evpl), plectin, and BPAG (bullous pemphigoid antigen) to name a
few. Proteins in this family bind to the underlying cytoskeleton mainly to intermediate filame nts
(IF). Through this interaction, they tether the IF to cell-cell or cell-matrix junctions (Green et al.,
1992; Stappenbeck et al., 1993). Some plakins have also been found to interact with actin and
microtubules (Roper et al., 2002). Plakins have characteristic domains which enable them to
dimerize (such as the alpha-helical coiled-coil domain) and to attach to intermediate filame nts
(such as the plakin repeat domains (PRD)) (Jefferson et al., 2004; Leung et al., 2002). At the N-
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terminal region, Dsp, for example, has a plakin domain comprising spectrin repeats (Virata et al.,
1992).
The intermediate filaments comprise several cytoskeletal proteins including epithelia l
keratins, mesenchymal vimentin, muscle desmin, and the nuclear lamins (Conway and Parry,
1988; Herrmann and Aebi, 1998). They are so named because their average diameter (10nm) lies
between the diameters of the other two major cytoskeletal proteins, actin microfilaments (7nm)
and microtubules (25nm). Most IFs have a 45nm central α-helical rod domain flanked by non-αhelical domains. The epithelial keratins are made up of Type I (acidic) and Type II (basic) keratins
that form heterodimers. The first step is the formation of a coiled-coil dimer of the Type I and
Type II keratins stabilized by a cysteine cross-link (Hatzfeld and Weber, 1990). This step is
followed by anti-parallel association of dimers forming a tetramer, called a protofilament (Steinert
et al., 1993). These units further dimerize and tetramerize to form the keratin filament (Aebi et al.,
1988; Goldie et al., 2007; Herrmann et al., 2009). Humans have over 60 epithelial keratins which
are expressed in a cell-type specific manner. For example, K5/ K14 are expressed in the
proliferating basal layer of the epidermis, while K1/K10 are expressed in the differentiated
suprabasal layers (Fuchs and Green, 1980; Roop et al., 1987). Each keratin is vital to normal
embryonic development, with little compensation by the remaining keratins. For example, K14
knockout mice have postnatal lethality with extensive blistering (Chan et al., 1994). K1/ K10
double knockout mice also have postnatal lethality probably due to loss of nuclear integrity during
differentiation (Wallace et al., 2012). Together, these proteins provide integrity to the cell and
mechano-transduction, i.e., generation of molecular signals in response to a mechanical stimulus
(Brooke et al., 2012; Green and Simpson, 2007).
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In an electron micrograph, the desmosome appears as a highly organized electron-dense
structure. The electron-dense nature of the plaque is indicative of negatively-charged polar groups.
The desmosome consists of 3 main families of proteins: cadherins, armadillo proteins, and plakins .
The desmosomal cadherins, desmogleins (Dsg) and desmocollins (Dsc), form the transmembra ne
components of the desmosome. In humans and mice, four desmoglein genes (Dsg 1-4) and three
desmocollin genes (Dsc 1-3) have been identified (Green and Simpson, 2007). These cadherins
can form homo- or hetero-dimers in a cis- fashion and bind to opposing cadherins in a calciumdependent trans- arrangement (Chitaev and Troyanovsky, 1997; Marcozzi et al., 1998; Syed et al.,
2002). Intracellularly, the cadherin tails interact with armadillo proteins, plakoglobin and
plakophilin (Kowalczyk et al., 1994; Mathur et al., 1994). The armadillo proteins in turn interact
with plakin family proteins, most notably, desmoplakin (Hatzfeld, 2007; Hatzfeld et al., 2000).
The plakin proteins tether the desmosome to the underlying cytoskeletal intermediate filame nts
such as keratin (Green et al., 1992; Stappenbeck et al., 1993) (Fig. 1.1). Desmoplakin is a protein
that is unique to and present in all desmosomes. Studies have revealed a reduction of desmosome
number and size in desmoplakin knockout models (Gallicano et al., 1998). Therefore, in the current
study, desmoplakin is used as a proxy to determine the role of desmosomes.
HUMAN DISEASES OF THE DESMOSOME
In mammals, desmosomes are predominantly found in various epithelia, the heart, and hair
follicle. They have been described as rivet-like structures facilitating cell-cell adhesion (Alberts,
1994). Along with underlying intermediate filaments, this complex also provides mechanica l
integrity to the skin and heart which are regularly subjected to physical forces (Green et al., 1998;
Russell et al., 2004). Perturbations of the desmosome and its components have been implicated in
human disease. Not surprisingly, these diseases have manifestations in the epithelia, the heart, and
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hair, either separately or in combination (Brooke et al., 2012). Some of the most devastating
desmosomal diseases are auto-immune. Pemphigus Foliaceus and Pemphigus Vulgaris present
with acantholysis and blistering of the skin and mucosal membranes, respectively (Payne et al.,
2004). Auto-antibodies are directed against DSG1 in Pemphigus Foliaceus and both DSG1 and
DSG3 in Pemphigus Vulgaris leading to disease symptoms (Amagai et al., 1991; Ding et al., 1997;
Ishii et al., 1997). Studies in mice suggest that Pemphigus vulgaris sera may cause endocytosis of
Dsg3, possibly through steric hindrance, which might contribute to morphological symptoms such
as the acantholysis observed in Pemphigus vulgaris patients (Amagai et al., 1995b; Calkins et al.,
2006; Jolly et al., 2010; Tsunoda et al., 2003).
Desmosomal proteins can also be targeted by infectious pathogens. Infectious diseases
such as Bullous impetigo and its generalized form, Staphylococcal Scalded Skin generally affect
children under 5 years of age and immunocompromised individuals (Hanakawa et al., 2002;
Hanakawa et al., 2003; Melish and Glasgow, 1970; Nishifuji et al., 2008). In these diseases, DSG1
is targeted by the causative Exfoliative toxins (ET), which are glutamate-specific serine proteases
that cleave DSG1 (Hanakawa et al., 2002; Hanakawa et al., 2003).
Desmosomal diseases can also be inherited in an autosomal dominant or recessive manner
(Celentano and Cirillo, 2017; McGrath, 2005). Plakophilin 1 (PKP1) was the first desmosomal
protein to be linked to hereditary skin disease. Complete loss of PKP1, which is normally found
in the suprabasal layer, is found to result in ectodermal dysplasia/ skin fragility syndrome
(McGrath et al., 1997). Autosomal dominant mutations in DSG1 can lead to striate palmoplantar
keratoderma in the palms of the hand and soles of the feet due to haploinsufficiency (Hunt et al.,
2001; Kljuic et al., 2003b). On the other hand, DSG4 mutations lead to defects in hair follic le
differentiation with hypotrichosis restricted to scalp, chest, arms, and legs (Kljuic et al., 2003a).
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The severity of inherited desmosomal diseases is emphasized by the propensity for ventricular
arrhythmias and sudden cardiac death (Delmar and McKenna, 2010). For instance, plakophilin 2
mutations are implicated in arrhythmogenic right ventricular cardiomyopathy, a disease which
accounts for 10% of cardiac-related deaths in teens (Gerull et al., 2004; Thomason et al., 2010;
van Tintelen et al., 2006).
Inherited mutations in desmoplakin (DSP) are also diverse, resulting in diseases with
varying degrees of severity. Autosomal dominant mutations in DSP leading to haploinsufficie nc y
result in SPPK, like patients with DSG1 mutations (Armstrong et al., 1999; Whittock et al., 1999).
These mutations are found in the plakin (N-terminal) domain of DSP. A recessive mutation in
desmoplakin causes a frameshift in the tail region, perturbing interactio n with intermed iate
filaments (IFs). Patients display dilated cardiomyopathy, woolly hair, and keratoderma – known
as Carvajal syndrome - and affected individuals experience heart failure within the teens (CarvajalHuerta, 1998). Another desmoplakin recessive disease with compound heterozygous mutatio ns
termed skin fragility ⁄ woolly hair syndrome is reported with similar findings but without the
dilated cardiomyopathy (Whittock et al., 2002). These cases reveal that desmosomal diseases are
often associated with symptoms in the epithelia, heart and hair. Additionally, these examples
highlight the variability in phenotypes when different regions of the same protein are mutated. To
design effective therapies, it is important to understand how desmosomal components, includ ing
the various functional domains, contribute to proper development and functioning.

USING ANIMAL MODELS TO STUDY DESMOSOME FUNCTION
The prevalence of desmosomal diseases and birth defects has prompted the need for animal
models to understand disease pathology. Currently, the mouse model, Mus musculus, is the most
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popular in vivo model used to study desmosome function. Desmosomes are first detected in the
blastocyst stage (32- to 64-cell) in the mouse embryo (Ducibella et al., 1975; Fleming et al., 1991;
Magnuson et al., 1977). These proteins are expressed after adherens junctions are formed, alluding
to desmosomes being dispensable during the initial cleavage stages. In the embryos of the teleost
fishes, Fundulus heteroclitus and zebrafish (Danio rerio), desmosomes begin to appear during
mid-gastrula stages (~st. 12.5) (Slanchev et al., 2009; Trinkaus and Lentz, 1967). It is possible that
the relatively late appearance of desmosomes in these fishes might be because of the presence of
the protective vitelline membrane which may provide structural integrity to the embryo.
Several mouse models illustrate the important roles of desmosomal proteins during the
early stages of life (Green and Simpson, 2007). For example, Desmoglein 2 ablation is lethal in
the mouse embryo, dying shortly after implantation (Eshkind et al., 2002). Similarly, Desmocollin
3 knockout mice die within the first 2 days of development (Den et al., 2006). Some desmosomal
components appear to be dispensable in the early embryo (younger than E10) but reveal important
roles after this stage. For example, plakoglobin knockout mice die by E11 due to cardiac
abnormalities. Of those that survive until birth, skin fragility is observed (Bierkamp et al., 1996).
Targeted ablation of Desmoglein 3 in mice leads to runting, hair loss, and suprabasilar acantholys is
(loss of cohesion) in the epidermis (Koch et al., 1997). Skin defects are also observed in
Desmocollin 1 knockout mice but acantholysis is instead present in the granular layer in
conjunction with hyperproliferation (Chidgey et al., 2001). These studies indicate that desmosomal
proteins have a significant role in the early embryo.
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DESMOPLAKIN STRUCTURE AND FUNCTION
In humans and mice, desmoplakin has a tripartite domain structure. The N-terminal plakin
domain associates with plakoglobin and plakophilin, linking desmoplakin to the desmoso mal
complex (Al-Jassar et al., 2011; Kowalczyk et al., 1997; Kowalczyk et al., 1999). This domain
consists of six spectrin repeats and a Src homology domain (SH3) with unrestricted flexibility
which is believed to impart adaptability to mechanical forces (Al-Jassar et al., 2013; Al-Jassar et
al., 2011). The rod domain facilitates dimerization of desmoplakin (Green et al., 1990). This
domain contains a heptad repeat and is thought to form a coiled-coil dimer which interacts with
intermediate filaments (Garrod and Chidgey, 2008; Green et al., 1990; Green et al., 1992). Finally,
the C-terminal plakin repeat domain associates with, and is essential for intermediate fila me nt
attachment (Choi et al., 2002; Green et al., 1990). This C-terminal tail domain contains three
globular subdomains in H. sapiens desmoplakin, designated A, B and C, each consisting of 4.6
repeats of a 38-amino acid motif (Green et al., 1990). The periodicity of amino acids in this domain
allow interaction with intermediate filaments (Bornslaeger et al., 1996; Choi et al., 2002; Fontao
et al., 2003). Together, these domains are critical to proper functioning of desmoplakin, but they
have not been analyzed in the X. laevis homologs.
Several studies in mice have attempted to determine the role of desmoplakin during
embryonic development. Embryos homozygous for a desmoplakin deletion mutation do not
survive beyond E6.5 (Gallicano et al., 1998). Most notably, Dsp-/- embryos are significa ntly
smaller, although E-cadherin labelling remain unaffected in the developing endoderm and
ectoderm. Keratin 8 (K8) also appear disorganized within the cell, with a collapse of keratin
networks to the cell periphery. There is also a >10X reduction in desmosome number and >2X
reduction in desmosome size. Since the early lethality was suspected to be due to defects in extra-
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embryonic tissues such as the visceral endoderm and the trophectoderm, a tetraploid rescue model
was developed (Gallicano et al., 2001). Here, the embryo proper that is homozygous for the dsp
mutation is cultured along with wild-type tetraploid cells, the latter of which eventually develops
into extra-embryonic tissues (Dragatsis et al., 1998; Kupriyanov and Baribault, 1998). These
embryos are still significantly smaller with fewer desmosomes. They also have an increased
lifespan and survive until E12.5. However, the heart is severely deformed with collapsed epicardial
and myocardial layers. The neuroepithelial folds are also greatly reduced usually preceded by
defective neural tube closure. Most importantly, the embryonic epidermis displays intercellular
separation and detachment from the underlying mesoderm. Interestingly, vasculature development
is also perturbed despite no desmosomes being present normally within these tissues. However,
desmoplakin is expressed in another junction, the complexus adherents, present in endothelia l
cells, possibly accounting for this phenotype (Schmelz and Franke, 1993; Schmelz et al., 1994).
In an effort to understand epidermis-specific roles of desmoplakin, conditional knockout mice
under the Keratin 14 promoter were also examined. There is no defect in the differentiation of the
epidermal layers. However ,the epidermis is fragile in these embryos, experiencing intercellular
separation under an applied mechanical stress (Vasioukhin et al., 2001).
Desmoplakin has also been implicated in other cellular processes and signaling pathways.
For instance, desmoplakin can function as a microtubule organizing center in mouse epidermis.
Ninein, a centrosomal protein required for microtubule anchoring is recruited to the desmosomes
by Dsp (Delgehyr et al., 2005; Lechler and Fuchs, 2007; Mogensen et al., 2000). There is some
evidence for the desmoplakin-intermediate filament connection as a regulator of cellular response
to mechanotransductive signals (Broussard et al., 2017). Although no inherited mutations of
desmosomal proteins have been found to be oncogenic, downregulation of Dsp can influe nce
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tumorigenesis and invasion. Decreased invasion and increased adhesion are observed when
desmosomal components are introduced into normally non-adhesive fibroblasts (Tselepis et al.,
1998). Dsp-knockdown keratinocytes exhibit increased proliferation associated with increased
phosphor-ERK1/2 and phosphor-Akt levels (Wan et al., 2007). Furthermore, increased tumor
invasion is observed in a desmoplakin-deficient mouse model of pancreatic neuroendocrine tumors
(Chun and Hanahan, 2010).

REGULATION OF THE DESMOSOMAL COMPLEX AND HYPERADHESION
Embryonic development occurs through the coordination of various processes includ ing
cell division, migration, intercalation, and cell death. Maintaining tissue adhesion and integr ity
during morphogenesis would require precise regulation of desmosome dynamics, for example,
through control of transcription and post-translational modifications. Transcription factors
associated with regulation of desmosomal gene expression include AP-2, Oct-2, NF-kB, Lef-1,
HoxC, and C/EBP (Adams et al., 1998; Bazzi et al., 2009; Johnson et al., 2014; Marsden et al.,
1997; Potter et al., 2001). Protein Kinase C alpha (PKCα), EGFR, lipid raft clusters, and
plakophilins are documented as regulators of desmosomal assembly and adhesive strength (BassZubek et al., 2008; Garrod et al., 2005; Kimura et al., 2007; Klessner et al., 2009; Miravet et al.,
2003; Stahley et al., 2014; Tucker et al., 2014; Wallis et al., 2000; Yin et al., 2005). Furthermore,
desmosomal components can regulate signaling pathways. For example, plakoglobin can regulate
Wnt/ β-catenin (Chidgey and Dawson, 2007; Conacci-Sorrell et al., 2002; Miravet et al., 2002),
p38MAPK (Spindler et al., 2014), and Hippo signaling (Chen et al., 2014). Recent studies also
suggest regulation of biochemical and mechanotransductive signaling by desmoplakin (Broussard
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et al., 2017; Yang et al., 2012). However, not much is known about the downstream effectors of
these signaling pathways.
Cadherins in both adherens junctions and desmosomes require calcium for homophilic
binding and maintenance of adhesion at cell contacts. However, desmosomes have a unique
property of achieving insensitivity to calcium chelators (such as EGTA) when they mature and are
termed “hyperadhesive” (Garrod and Kimura, 2008). Cells with calcium-insensitive desmosomes
are in a stronger adhesive state (Kimura et al., 2007). Molecular modeling of the crystal structure
of the EC domains of desmosomal cadherins suggests that the Ca 2+ ion is trapped, making it
isolated from calcium chelators (Garrod et al., 2005). Hyperadhesive desmosomes are thought to
identified by the presence of an electron-dense midline between apposing desmosome halves under
electron microscopy, although direct evidence is yet to be demonstrated.
Hyperadhesive desmosomes were first detected in the stratified epithelia of the Rana
pipiens (frog) adult skin and cat and rat esophagi as being resistant to EDTA-mediated dissociatio n
(Borysenko and Revel, 1973). In keratinocyte and simple epithelial cell culture, desmosomes begin
to assemble when calcium (1.8 - 2mM) is added to the growth medium in as soon as 15 min.
(Mattey and Garrod, 1986; Watt et al., 1984). The addition of calcium is also followed by
stratification of the monolayer within 24h. Only when confluency is reached are desmosomes
demonstrated to achieve hyperadhesion (Wallis et al., 2000). Hyperadhesive desmosomes are also
found in the developing mouse embryo. For instance, the first epidermal desmosomes that
assemble are sensitive to disruption by calcium chelation but switch to a hyperadhesive nature
between E12.0-14.0 (Kimura et al., 2012).
There are many mechanisms found to regulate the adhesive state of the desmosome. Since
wound healing is a dynamic process requiring some cell movements, it is not surprising that
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desmosomes need to switch from their hyperadhesive state upon wounding. Wallis and colleagues
observed the switch to a calcium-sensitive state upon scratch wounding of monolayers (Wallis et
al., 2000). Importantly, Protein Kinase C α (PKCα) activation is increased after wounding and is
thought to be responsible for the switch from a resistant to calcium-sensitive state. Plakophilin 1
overexpression in keratinocytes transforms desmosomes to a hyperadhesive state (Tucker et al.,
2014). Since it is known that Dsp-IF interaction is crucial for maintaining adhesive strength in
epithelial sheets, the function of Dsp in hyperadhesion was also explored (Huen et al., 2002). A
phosphorylation-deficient mutant of Dsp (S2849G) with increased IF binding leads to increased
cohesiveness of cell sheets (Hobbs and Green, 2012). Importantly, being able to modulate the
adhesive state of the desmosome might be an effective therapeutic strategy for some desmosomal
diseases. Overexpression

of Plakophilin

1 or PKC inhibition

in keratinocytes induces

hyperadhesion and abrogates Pemphigus vulgaris sera-induced loss of adhesion (Cirillo et al.,
2010; Tucker et al., 2014). Therefore, being able to identify regulators of desmosomes is benefic ia l
to alleviate the pathophysiology of certain desmosomal diseases.

C-JUN N-TERMINAL KINASE
The c-Jun N-terminal kinase or JNK, also known as stress-activated MAP kinase (SAPK)
is a member of MAPK signaling pathways through which cells respond to extracellular stimuli.
These stimuli can include UV radiation, pH fluctuations, and heat, as well as chemical stimula tio n
including cytokines, growth factors, and hormones (Davis, 2000; Weston and Davis, 2002).
The MAPK signaling cascade contains at least three MAP kinases in series. MAPKKKs
phosphorylate MAPKKs, which phosphorylate MAPKs such as JNK. JNK is activated by dual
phosphorylation on Threonine and Tyrosine residues by MKK4 and MKK7 (Davis, 2000; Derijard
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et al., 1995; Lin et al., 1995; Moriguchi et al., 1997; Tournier et al., 1997; Yan et al., 1994). MKK4
and MKK7 are known to be activated by ASK1, MLK2, and MEKK2-5 (Blank et al., 1996; Deacon
and Blank, 1997; Ellinger-Ziegelbauer et al., 1997; Gerwins et al., 1997; Hirai et al., 1997; Ichijo
et al., 1997). However, all these proteins can be differentially regulated. For example, treatment of
cells with tumor necrosis factor (TNF) leads to activation of MKK7 but not MKK4 (Takekawa et
al., 1997; Tournier et al., 2001; Wang et al., 1996). In contrast, both MKK4 and MKK7 can be
activated by environmental stresses. The JNK signaling cascade is thought to be coordinated, in
part, by JNK interacting proteins (JIP) that act as scaffolds for JNK cascade elements (Gupta et
al., 1996; Kukekov et al., 2006; Xu et al., 2005).
JNK regulates

activator

protein-1

(AP-1) transcriptional

activity

through

the

phosphorylation of various effectors. For example, JNK phosphorylates the transactivation domain
of c-Jun on Ser-63 and Ser-73 leading to its stabilization and increased transcriptional activity
(Pulverer et al., 1991; Smeal et al., 1991). JNK can also phosphorylate other transcription factors
including Junb, JunD, c-Fos, and ATF2 (Ip and Davis, 1998). Together, these proteins constitute
the AP-1 transcription factors that regulate stress-responsive genes.
Some of the major effects of the JNK pathway are inflammatory responses and regulatio n
of apoptosis and cell survival. JNK can mediate opposing responses through isoform- or cellspecific mechanisms. For example, JNK1 and JNK2 differentially affect fibroblast prolifera tio n
through either promoting or reducing c-Jun stability (Sabapathy et al., 2004). JNK can also have
opposite effects on apoptosis, either promoting it by phosphorylating Bim and Bmf, or suppressing
it through its effects on Bcl-2 and Bcl-xL (Donovan et al., 2002; Ferrer et al., 2005; Kharbanda et
al., 2000; Lei and Davis, 2003; Yamamoto et al., 1999).
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In mammals, there are three JNK genes, JNK1, JNK2, and JNK3, all of which can undergo
differential splicing, resulting in a total of 10 isoforms. JNK1 and JNK2 are expressed
ubiquitously, while JNK3 is largely restricted the brain, heart, and testis (Bogoyevitch and Kobe,
2006; Davis, 2000). Xenopus is also predicted to have all 3 JNK genes, but there is limited
expression data at the tissue level (Bagowski et al., 2001). In situ hybridization reveals expression
of JNK1 in head and dorsal regions of the Xenopus embryo after neurulation (Garriock et al., 2005;
Yamanaka et al., 2002). Several animal models reveal the importance of JNK in vivo during
embryogenesis. Single knockout Jnk1-/- and Jnk2-/- mice are viable, with defects in apoptotic and
immune responses (Constant et al., 2000; Dong et al., 2000; Dong et al., 1998; Tournier et al.,
2000). However, Jnk1-/-/Jnk2-/- double knockout mice exhibit embryonic lethality with decreased
apoptosis in the hindbrain, increased apoptosis in the forebrain, and exencephaly (Kuan et al.,
1999; Sabapathy et al., 1999).
JNK is also known to regulate embryonic morphogenesis in vivo. In D. melanogaster, JNK
activity positively regulates dorsal closure through DJun and expression of decapentaplegic
(related to mammalian BMP-4) in leading edge cells of the dorsal epidermis (Glise and Noselli,
1997; Hou et al., 1997; Kockel et al., 1997; Riesgo-Escovar and Hafen, 1997; Sluss and Davis,
1997). In Xenopus embryos, both activation and inhibition of JNK can lead to convergent
extension defects (Yamanaka et al., 2002). JNK isoforms are also important for proper
development of the epidermis in vivo. For example, JNK1-deficient mice exhibit reduced
epidermal proliferation and differentiation resulting in a thinner epidermis. However, mice
deficient in JNK2 have epidermal hyperplasia, suggesting opposite roles for JNK1 and JNK2 in
epidermal development (Weston et al., 2004).
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JNK activity is dysregulated in a variety of human diseases affecting many organs. Strong
JNK activity has been observed in neurons and the hippocampus in patients with Alzheime r’s
disease (Shoji et al., 2000; Thakur et al., 2007; Zhu et al., 2001). Furthermore, liver samples from
patients with nonalcoholic fatty liver disease are found to have elevated JNK activity (Ferreira et
al., 2011). Unsurprisingly, JNK activity is also elevated in diseases with abnormal inflammator y
responses including inflammatory bowel disease and rheumatoid arthritis (Mitsuyama et al., 2006;
Mun et al., 2009; Schett et al., 2000). Similarly, JNK is activated in psoriatic skin, probably leading
to abnormal epidermal proliferation and differentiation (Takahashi et al., 2002). Besides these
instances, many cancers including retinoblastoma, melanoma nevi, and colorectal, breast, and
ovarian cancers, exhibit altered JNK activity (Chen et al., 2011; Gulmann et al., 2009; Jorgensen
et al., 2006; Odegaard et al., 2007; Wang et al., 2010). Therefore, understanding the role of JNK
in mediating cellular processes will facilitate the development of therapeutic strategies.

SIGNIFICANCE
Work in the past decade has delineated novel functions of desmosomes in both adhesive
and nonadhesive contexts. However, in the context of the whole embryo, much is unknown
regarding regulation and function of the desmosomal complex during morphogenesis. The present
study reveals roles for desmosomes in epidermal homeostasis and morphogenesis. Furthermore cJun N-terminal kinase (JNK) may have a potential role in regulation of desmosome assembly and
stability. Notably, this study validates the frog as a tractable vertebrate model to study desmosome
regulation and function in the developing embryo.
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Figure 1.1: The desmosome and its components.
Schematic of a desmosome (adapted from (Garrod, 2010; Green and Simpson, 2007; Staehelin and
Hull, 1978; Stahley and Kowalczyk, 2015)). EC=Extracellular space; IC=Intracellular space;
Dsg=Desmoglein; Dsc=Desmocollin; Dsp=Desmoplakin; Pg=Plakoglobin; Pkp=Plakophilin;
IF=Intermediate Filament.
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MATERIALS AND METHODS

A. XENOPUS ADULTS AND EMBRYOS
Xenopus laevis embryos were obtained and cultured using standard methods (Sive et al.,
2000) approved by the VCU Institutional Animal Care and Use Committee (IACUC protocol
number 5AD20261). Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and
Faber, 1967).

B. BIOINFORMATICS ANALYSIS TO COMPARE DESMOPLAKIN EXONIC
SEQUENCES
The following full length desmoplakin exonic sequences of the longest isoforms were
retrieved from NCBI: Homo sapiens Desmoplakin isoform I (NM_004415.3) and Mus musculus
Desmoplakin (NM_023842.2). Xenopus laevis exonic sequences for dsp.L (XB-GENE-866134)
and dsp.S (XB-GENE-17346609) were both obtained from Xenbase (http://www.xenbase.org). To
estimate percent identity, pairwise sequence alignments were performed against X. laevis dsp.L
using the EMBOSS Water tool (Smith Waterman algorithm) (https://www.ebi.ac.uk/) and
DNAfull scoring matrix (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000).
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C. BIOINFORMATICS ANALYSIS TO COMPARE DESMOPLAKIN PROTEIN
SEQUENCES
The following full length Desmoplakin (Dsp) protein sequences of the longest isoforms
were retrieved from NCBI: Homo sapiens Desmoplakin I (NP_004406) and Mus musculus
Desmoplakin (NP_076331) were used for the analysis. To obtain Xenopus laevis Dsp.L (XBGENE-866134) and X. laevis Dsp.S (XB-GENE-17346609) protein sequences, coding DNA
sequences obtained from Xenbase Genome build Version 9.1 (X. laevis) (http://www.xenbase.or g)
were translated using the ExPASy Translate tool (Gasteiger et al., 2003). To obtain percent identity
and similarity, pairwise sequence alignments were performed against X. laevis Dsp.L using the
EMBOSS Water tool (Smith Waterman algorithm) (EMBL-EBI) with the BLOSUM62 scoring
matrix (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000).

D. DETERMINING DESMOPLAKIN DOMAINS IN XENOPUS LAEVIS
To determine coordinates of domains, previously characterized domain coordinates in
human DSPI protein was used as a reference (Al-Jassar et al., 2011; Green et al., 1990; Virata et
al., 1992). The LALIGN tool (EMBL-EBI) was used to align the amino acid sequence for each
human DSP domain with the full- length protein of M. musculus Dsp and X. laevis Dsp.L and Dsp.S
to locate the corresponding regions (Li et al., 2015; McWilliam et al., 2013). This was done using
the BLOSUM50 scoring matrix. To obtain percent identity and similarity for each domain,
pairwise sequence alignments were performed against corresponding domains in X. laevis Dsp.L.
The EMBOSS Water tool (Smith Waterman algorithm) (EMBL-EBI) was used with the
BLOSUM62 scoring matrix (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000).

26

E. MULTIPLE SEQUENCE ALIGNMENT OF DESMOPLAKIN PROTEIN
Multiple sequence alignment of desmoplakin protein sequences of X. laevis (Dsp.L and
Dsp.S), human, and mouse was performed with Clustal Omega (EMBL-EBI) using the HHalign
algorithm (Goujon et al., 2010; McWilliam et al., 2013; Sievers et al., 2011). The threshold for
shading (using the BOXSHADE tool) in the Clustal Omega generated sequence alignment was set
to 50% using the BLOSUM62 scoring matrix.

F. TEM TO EXAMINE DESMOSOME ULTRASTRUCTURE AND
LOCALIZATION IN THE EPIDERMIS
Embryos were fixed with 2% glutaraldehyde (MP Biomedicals, 198595) in 0.1M sodium
cacodylate buffer (Electron Microscopy Services, 12300) at 4°C overnight. They were then rinsed
in 0.1M cacodylate buffer three times (30 min. each). Embryos were incubated in 0.1M cacodylate
buffer for up to 3 days at 4°C and then fixed in 2% osmium tetroxide in 0.1M cacodylate buffer
for one hour. They were then rinsed in 0.1M cacodylate buffer three times (15 min. each). They
were dehydrated in graded ethanol series (50%, 70%, 80%, 95%) for 5-10 minutes each followed
by dehydration in 100% ethanol three times (10-15 min. each). Embryos were then incubated in
propylene oxide (EMS, 20401) three times (10–15 min. each). They were then infiltrated with a
50/50 mix of propylene oxide and Poly/Bed 812 resin mix (Polysciences, 08792-1) overnight. This
was followed by infiltration with pure EMbed 812 resin (EMS, 14120) mix overnight. Embryos
were then embedded in flat molds and placed in 60˚C oven for 2 days. Embryos were sectioned on
Leica EM UC6i Ultramicrotome (Leica Microsystems) into 700-900Å thick sections on grids and
stained with 5% Uranyl acetate (EMS, 22400) and Reynold’s Lead Citrate (Lead Nitrate (EMS,
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17900), Sodium Citrate (EMS, 21140)). Grids were imaged on JEOL JEM-1230 TEM (JEOL
USA, Inc.) with the Gatan Orius SC1000 digital camera (Gatan Inc., Pleasanton, CA).

G. MORPHOLINOS
Two

splice-site

blocking

desmoplakin

(Dsp)
and

ACAGTTACTACTTACTCTATGCTGC-3’)

morpholinos,

DspMO1

DspMO2

(5’(5’–

TTGATGCAGAGCAAAGTTCAAACCT-3’) with fluorescein tags were designed and purchased
from Genetools (Table 1.1). A standard control morpholino (CMO) provided by Genetools was
used as a control for all experiments. 34 ng of DspMO1 was injected per embryo and 17-25ng
DspMO2 was injected per embryo. Targeted injections were accomplished with 3-5 ng per
blastomere. Microinjections were carried out using a FemtoJet microinjector (Eppendorf) and a
SteREO Discovery.V8 (Zeiss) stereoscope.
To determine if the MOs caused splicing defects in embryos, RT-PCR was performed as
described previously (Dickinson and Sive, 2009). RNA from 10 embryos was extracted using
TRIzol (Invitrogen) followed by lithium chloride precipitation. cDNA was prepared using the
High-capacity cDNA Reverse Transcription kit and specific primers (Applied Biosystems) (Table
1.2). cDNA was then diluted 1:25 and the following PCR program was performed using Apex™
Hot Start Taq DNA Polymerase Master Mix: (1) 95°C for 5 min., (2) (95°C for 30s, 61°C for 30s,
72°C for 30s) X 40, (3) 72°C for 5 min. Samples were run on a 3% agarose gel to identify distinct
banding patterns.
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H. CRISPR
CRISPR gRNA sequences were designed against exons 8 (DspCRISPR1) and 19
(DspCRISPR2) in dsp.L (these correspond to exons 8 and 17 in dsp.S, respectively) using the
CHOPCHOP tool (http://chopchop.cbu.uib.no/). sgRNA adaptor sequences and scaffold (loopsequence oligo) were designed as previously described (Shah et al., 2016) (Table 1.3).
The PCR reaction to create a 120 bp product containing gene-specific sequence, T7 primer
sequence and loop-specific oligo was as follows: (1) 98°C for 30s, (2) (98°C for 10s, 61°C for 10s,
72°C for 15s) X 45, (3) 72°C for 5 min. The PCR product was then purified using the DNA Clean
& Concentrator Kit (Zymo Research, D4014). The Ambion MEGAscript T7 kit (Thermo Fisher
Scientific, AM1333) was used for in vitro transcription and RNA was preferentially precipitated
using the lithium chloride precipitation solution (Thermo Fisher Scientific, AM9480). To create
F0 mosaic mutants, embryos were co-injected with 1ng gRNA and 1.5ng Cas9 protein (PNA-Bio,
CP01) at the one-cell stage. Wild-type embryos were used as controls.
The T7 endonuclease I assay was used to detect mutations induced by CRISPR/ Cas9
(Mashal et al., 1995). Genomic DNA was extracted by incubating embryos in 35μl of alkaline lysis
buffer (25 mM NaOH (Fisher Scientific, BP359), 0.2 mM Na 2+-EDTA (OmniPur, 4050)) at 95°C
for 40 minutes. The samples were then cooled to 4°C and then 35μl of neutralization buffer (40
mM Tris-HCl (Sigma-Aldrich, T3253)) was added. The target region was then amplified with
specific primers (Table 1.4). The PCR reaction was: 1. 98°C for 30s, 2. (98°C for 5s, 61°C for
10s, 72°C for 20s) X 36, 3. 72°C for 2min. PCR products were purified with the DNA Clean and
Concentrator kit (Zymo Research, D4014), eluted into nuclease-free water, and quantified using
the NanoDrop Lite spectrophotometer (Thermo Fisher Scientific). Purified PCR product (200ng)
was used in the following protocol: 1. 95°C for 5 min., 2. 95°C-85°C @ -2°C/s, 3. 85°C-25°C @
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-0.1°C/s. Then, 1μl of T7 endonuclease I (NEB, M0302) was added and incubated at 37°C for 15
min. Samples were run on a 3% agarose gel to identify presence of mutations.

I. MECHANICAL STRESS ASSAYS
Impact Assay: Embryos were vertically dropped from a height of 15 cm using a transfer
pipette (Fisher Scientific, 13-711-7M) onto a 150 X 15mm petri dish lined on the bottom with
5mm of 2% agarose (Bioline, 41025). Images were taken on both left and right lateral sides of the
embryos before and after the assay was performed. This was replicated in a blind manner to avoid
any handling bias while pipetting embryos. Differences were compared statistically using a
Student’s t-test.
Rotational Assay: Embryos were placed in 50ml plastic polypropylene tubes (USA
Scientific, 1500-1811) with 15 ml 0.1 X MBS (Modified Barth’s Saline). The tubes were then
rotated using a RKVSD vertical rotating mixer (ATR Biotech) at 55 rpm for a total of 25 rotations.
Embryos were then scored as being intact or damaged based on whether the epidermis was intact
or not. Differences were compared statistically using a Student’s t-test.

J. CONSTITUTIVELY-ACTIVE JNK AND DOMINANT-NEGATIVE
DESMOPLAKIN
The previously

validated

constitutively-active

JNK1, MKK7-JNK1A1 (pcDNA3-

flagMKK7B2Jnk1a1) (referred here as CA-JNK) construct was obtained from Addgene (ID:
19726) (courtesy of Roger Davis) and cloned into pCS2+ for expression in X. laevis embryos
(Houssin et al., 2017). The dominant-negative desmoplakin (DP-NTP) construct fused with either
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EGFP or mCherry (in pCS2+) was generously provided by Dr. Daniel Conway (Bornslaeger et al.,
1996; Huen et al., 2002).

K. CHEMICAL TREATMENTS
To inhibit JNK, embryos were treated with 100µM SP600125 (Sigma-Aldrich, S5567)
(Bennett et al., 2001). DMSO was used as the control treatment at a final concentration of 1% in
0.1X MBS.

L. IMMUNOFLUORESCENCE, ANTIBODIES AND FLUORESCENT LABELING
Embryos were fixed in 4% Paraformaldehyde (PFA) or Dent’s fixative (80% methanol,
20% DMSO) and then labeled whole or after vibratome sectioning. For sectioning, embryos were
embedded in 5% low-melt agarose (SeaPlaque GTG Cambrex) and sectioned using a 5000 Series
Vibratome into 150-200µm sections. All antibodies were diluted in 1X PBT. Primary antibodies
used were mouse anti-desmoplakin I+II (abcam, ab16434, diluted 1:75), mouse anti α-tubulin
(Developmental Studies Hybridoma Bank (DSHB), AA4.3, 1:50), rabbit anti-phospho-Histone H3
(Ser10) (Millipore, 06-570, 1:1000), mouse anti-cytokeratin type II (DSHB, 1h5, 1:25), anti-βcatenin (Invitrogen, 71-2700, 1:500), and mouse anti-E-cadherin extracellular domain (DSHB,
5D3, 1:25). Secondary antibodies used were anti-mouse Alexa Fluor 568 (Molecular Probes,
A11004, 1:500), anti-rabbit Alexa Fluor 488 (Molecular Probes, A11008, 1:500), anti-mouse
Alexa Fluor 488 (Molecular Probes, A11029, 1:500), anti-rabbit Alexa Fluor 568 (Molecular
Probes, A11036, 1:500), anti-mouse Alexa Fluor Plus 647 (Molecular Probes, A32728, 1:500) and
anti-rabbit Alexa Fluor 405 (Molecular Probes, A31556, 1:500). To label small secretory cells, a
Lectin PNA-Alexa Fluor 488 conjugate (Molecular Probes, L21409, 1:1000) was utilized.
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Rhodamine phalloidin (Life Technologies, R415, 1:50) was used to label F-actin. Embryos fixed
in PFA were washed three times in 1X PBT (1h each). Embryos fixed in Dent’s fix were incubated
in 90% MeOH for 10 min., then in 100% MeOH for 10 min. They were then stored at -20°C
overnight in 100% MeOH. Embryos were then incubated in a MeOH: PBT (1X) dilution series
into 1X PBT. Embryos (fixed in either PFA or Dent’s fix) were then incubated in the primary
antibody or fluorescent label at 4°C overnight. They were then washed three times in 1X PBT (1h
each) and incubated in secondary antibody at 4°C overnight. This was repeated for multiple labels.
Embryos were then washed three times in 1X PBT (1h each) and were mounted in 90-100%
glycerol for confocal imaging.
For Cleaved Caspase-3 labeling (anti-rabbit, Cell Signaling, 9661, 1:1000), embryos were
fixed in 4% PFA (2-3h at RT), embryos and then were washed in PBT and blocked in 1% goat
serum/ 1% Triton PBT overnight (Kennedy and Dickinson, 2012). They were incubated in
antibody on a nutating mixer at 4°C for 2 days.

M. CONFOCAL MICROSCOPY
Imaging was performed with the Nikon Eclipse Ni-U/ C2 confocal microscope. Step size
was maintained at 0.5μm and size of stack was set between 6-12μm. Finally, maximum intens ity
projections of these stacks were obtained. The NIS-Elements AR 4.50.00 software was used for
imaging and processing, including increasing intensity of images where allowed. Additional image
processing was performed in Adobe Photoshop Creative Cloud. Brightness of images was
increased or decreased to the same level in all images in an experiment.
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N. ANALYSIS OF KERATIN RETRACTION IN DSP MORPHANTS
To determine the effect of morpholino- mediated loss of Dsp on keratin organizatio n,
additional image analysis was performed using the NIS-Elements AR 4.50.00 software. Maximum
intensity projections of confocal images on Keratin-labeled embryos was generated. Using
information from an Intensity Profile chart in a linear cross-section, intensity values were obtained
for membrane junctions on opposite sides of a cell. These Border Intensity values (BI) were
averaged (AvgBI). The coordinates of the 2 borders where intensity was recorded were also noted.
Three equidistant points between the two border coordinates above were placed within the cell on
the same linear cross-section. Intensity values were calculated at these three points also. These
Intracellular Intensity values (ICI) were averaged (AvgICI). A ratio of (AvgBI/AvgICI) was obtained
for eight random cells in an image (representative of one embryo). Statistical analysis of
differences between intensity ratios of Dsp morphants and control morphants was performed using
a Student’s t-test.

O. BIOTIN LABELING OF THE SUPERFICIAL LAYER
Embryos were incubated from st. 19 (21hpf) to st. 20 (22hpf) in a 2mg/ml solution of EZLink Sulfo-NHS-LC-Biotin for 1h (Thermo Fisher Scientific, 21335). Embryos were then
transferred to 0.1X MBS to develop for another 4-5h until st. 24 (26hpf). Embryos were then fixed
in 4% PFA overnight at 4°C. Embryos were then washed three times in 1X PBT for 1h each and
blocked with 1%BSA at RT for 1h. Embryos were labeled with Streptavidin, conjugated to Alexa
Fluor 568 (Life Technologies, S11226, 1:500) overnight followed by three washes in 1X PBT for
30 min. each. They were mounted in 90% glycerol and imaged using a confocal microscope.
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P. SURFACE AREA MEASUREMENT OF INTERCALATED CELLS
To measure the surface area of intercalated cells, confocal images were processed in Adobe
Photoshop CC 2017. Under Image Adjustments, threshold was set such that intercalated cells were
visible as distinct cells from the biotin- labeled cells. A scale bar was calibrated for each image.
Using the Magic Wand Tool, individual cells were automatically selected and areas were
calculated. These measurements were exported to Microsoft Excel and statistical analysis was
performed.

Q. EGTA-INDUCED CELL DISSOCIATION
Embryos were treated with either 100μM SP600125 (20μl of 10mM stock in DMSO) or
20μl DMSO in 0.1 X MBS at 15°C from st. 32–41. DMSO was used as the control treatment at a
final concentration of 1%. Whole embryos were washed for 1 hour in calcium- free 0.1 X MBS.
This was followed by a 4mM EGTA treatment for 30 min. Embryos were then fixed in Dent’s fix,
labeled for desmoplakin and imaged as described above.

R. STATISTICAL ANALYSIS
Chi-square (χ2 ) test for independence was used to determine statistically significa nt
differences in phenotype prevalence. Pooled data from replicates was used for length and
phenotype analysis. Mann-Whitney test (GraphPad Prism) was used to determine statistica lly
significant differences in surface areas of intercalating cells. Student’s t-test was used to determine
statistical significance in the remaining comparisons. All data is representative of at least two
independent experiments.
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Table 1.1: Morpholino sequences used for injections.
Morpholino

DspMO1

DspMO2

Sequence (5’ –> 3’)

Subgenome
Homolog

Exon/
Intron
junction

Match with
target site
(bp/ bp)

ACAGTTACTACTTACTCTAT
GCTGC

dsp.L

E4/ I4

25/ 25

dsp.S

E4/ I4

19/ 25

TTGATGCAGAGCAAAGTTC
AAACCT

dsp.L

E14/ I14

25/ 25

dsp.S

E12/ I12

22/ 25

Table 1.2: Primers used to genotype morphants.
Morpholino

Forward Primer (5’ –> 3’)

Reverse Primer (5’ –> 3’)

DspMO1

TAAATATGGAGATGCAAG
TCAGC

CAAGATCCCATCGATAG
TCAGC

422

DspMO2

CCTGGCACTACTGCATGAT
C

AACAGCCAGTTCTCTTGT
TTCTC

388
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Wild-type
fragment
size (bp)

Table 1.3: CRISPR gRNA sequences and mismatches.
gRNA

gRNA sequence +
PAM

Subgenome
Homolog

Exon

(5’ –> 3’)

Target site with mismatches (in
BOLD)
(5’ –> 3’)

dsp.L

8

GGTGCTGGTTCATGATAAGC

DspCRISPR1

GGTGCTGGTTC
ATGATAAGCTG
G

dsp.S

8

GGTGCTGGTTCATGATAAGC

dsp.L

19

GGTCGCATCTGACAGTTTGA

DspCRISPR2

GGTCGCATCTG
ACAGTTTGATG
G

dsp.S

17

GATCGCATCTGACAGTTTGA
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Table 1.4: Primers for CRISPR mutation analysis with T7 endonuclease I assay.
gRNA

DspCRISPR1

DspCRISPR2

Primers

Primer sequence (5’ –> 3’)

Wildtype
fragment
size (bp)

dsp.L
Forward

AAACTGATGAGTGAGCTGGAG

237

Approx.
fragment
sizes if
cleaved
(bp)
68, 169

dsp.L
Reverse

CTTGACAAGACCACTAAACCC

dsp.S
Forward

AAACTGATGAGTGAGCTGGAG

380

68, 312

dsp.S
Reverse

ATTTTCTTTCAGGTGGACATCG

dsp.L
Forward

GGGAATTAGAGAAACAAAGCAAGC

382

111, 271

dsp.L
Reverse

GCATTTTCTACCAGTGGCTG

dsp.S
Forward

GTGGGAATTAGAGAAGCAAAGC

325

113, 212

dsp.S
Reverse

ACCTTTGCTATGTGTGTAGGG

37

RESULTS
SECTION 1: DEVELOPMENT AND STRUCTURE OF THE EMBRYONIC
DESMOSOME IN XENOPUS LAEVIS

Although the desmosomal structure has been reported in Xenopus laevis adult and tadpoles
(Borysenko and Revel, 1973), it has not been examined at earlier developmental stages. Further,
studies of the desmosomal complex in Xenopus have widely focused on plakoglobin but not other
crucial desmosomal proteins (DeMarais and Moon, 1992; Karnovsky and Klymkowsky, 1995;
Kofron et al., 2002; Kofron et al., 1997). Therefore, the goal of this section is to determine if and
when desmosomes and desmoplakin, a critical desmosomal protein, are present in the X. laevis
embryo.

A. TEM ANALYSIS OF DESMOSOMES REVEALED CONSERVED
ULTRASTRUCTURE AND INCREASING NUMBERS DURING
DEVELOPMENT
While others have demonstrated that desmosomes exist in the adult and tadpole epidermis
of X. laevis (Borysenko and Revel, 1973), these structures have not been identified in the early
embryo. Therefore, to fill this gap in knowledge, desmosomes were imaged by Transmiss io n
Electron Microscopy (TEM) as the embryo develops through gastrulation and neural tube
formation. Ultrastructurally, the desmosome appeared as an electron-dense cytoplasmic plaque
that was present adjacent to the plasma membrane of opposing cells (Fig. 1.2A). In a subset of
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desmosomes, a midline in the extracellular space between plaques in opposing cells was present.
This structure is thought to signify stable trans-interactions between the desmosomal cadherins
(Fig. 1.2B). These results indicate that in the early embryo of X. laevis, desmosomes resembled
those observed in M. musculus, D. rerio, as well as adult amphibians, signifying a conserved
ultrastructure (Borysenko and Revel, 1973; Fleming et al., 1991; Garrod and Chidgey, 2008;
Goonesinghe et al., 2012).
The number of desmosomes per junction have been reported to increase during human
development (Dale et al., 1985; Holbrook and Odland, 1975). Therefore, to determine if Xenopus
embryos exhibited a similar increase, desmosomes were counted in the outer ectodermal layer in
various stages ranging from st. 10 to st. 22. These stages were chosen because they represent a
critical period of ectodermal development. During this time, the ectoderm forms, undergoes
migratory movements to envelop the whole embryo (Nieuwkoop and Faber, 1967), and begins to
express early epidermal differentiation markers (Jonas et al., 1985; Wilson and HemmatiBrivanlou, 1995). Therefore, desmosomes were counted at st. 10 (9-11 hpf), st. 14 (16-17 hpf), st.
19 (21-22 hpf) and st. 22 (24-25 hpf) (n=2 embryos/ stage). At st. 10 (9-11 hpf), tight junctions
and adherens junctions were observed at the apical-most region of all cell-cell junctions (green bar,
Fig. 1.2C). However, desmosomes were only observed in 28% of these junctions (yellow arrow,
Fig. 1.2C, D). Further, only one desmosome was observed at each of these junctions (Table 1.5).
At st. 14 (16-17 hpf), desmosomes were detected at 51% of junctions (yellow arrow, Fig. 1.2E, F;
Table 1.5). At st. 19 (21-22 hpf), desmosomes were detected in 76% of junctions (yellow arrows,
Fig. 1.2G, H). While 68% of these junctions had one desmosome, two desmosomes were observed
in 8% of junctions (Table 1.5). At st. 22 (24-25 hpf), desmosomes were observed in 93% of
intercellular junctions (yellow arrows, Fig. 1.2I, J). At this time, more than half of all junctions
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had more than one desmosome. Specifically, 47% of junctions had two desmosomes and 9% of
junctions had three or more desmosomes (Table 1.5). These results indicate that the number of
desmosomes increase during early development of the X. laevis embryo, consistent with
observations in the developing human embryo.
Thus far, the TEM analysis was only focused on desmosomes in the outer layer of the
ectoderm. The Xenopus embryonic ectoderm and epidermis are bi-layered (Itoh et al., 1988;
Nieuwkoop and Faber, 1967). Therefore, the next step was to determine whether desmosomes
could also be detected in the inner epidermal layer. At st. 31 (37-40 hpf), in a subset of images,
desmosomes were visible between cells of the inner epidermal layer (red arrow, Fig. 1.2L). At st.
44 (92-98 hpf), desmosomes were also present between the outer and inner epidermal layers (green
and red arrows, Fig. 1.2M). The inner epidermal layer was not examined before st. 31. These
results indicate that desmosomes are present between cells of both epidermal layers of the X. laevis
embryo.

B. COMPARATIVE SEQUENCE ANALYSIS OF X. LAEVIS DESMOPLAKIN
WITH OTHER VERTEBRATES REVEALED CONSERVED DOMAINS
A comparative sequence analysis of the intracellular desmosomal protein, desmoplakin
(Dsp), has not been performed between X. laevis and mammalian homologs.

Such an analysis

provides a measure of sequence identity and similarity between homologs in different species and
can be used to predict whether its function is shared. Therefore, a bioinformatics analysis was
performed to 1) determine overall gene and protein sequence similarity with homologs of other
vertebrate species, 2) identify the key functional domains of X. laevis Dsp, and 3) determine
sequence similarity between X. laevis Dsp.L and Dsp.S homologs.
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B.1. OVERALL SEQUENCE COMPARISON REVEALED CONSERVED GENE AND
PROTEIN SEQUENCE BETWEEN X. LAEVIS AND MAMMALIAN SPECIES
The first step was to determine the homology of X. laevis Dsp to homologs in mamma lia n
species, H. sapiens and M. musculus. Bioinformatic analysis revealed that the H. sapiens coding
region shared 65.7% identity with the X. laevis dsp.L homolog. M. musculus coding region shared
64.4% identity with X. laevis dsp.L. The H. sapiens and M. musculus desmoplakin proteins each
shared 66% identity with X. laevis Dsp.L (Table 1.6). Together, these results indicate that the X.
laevis Dsp.L shares a high degree of similarity with mammalian homologs, suggesting conserved
function.

B.2. COMPARISON OF DESMOPLAKIN FUNCTIONAL DOMAINS REVEALED
CONSERVATION BETWEEN X. LAEVIS AND MAMMALIAN SPECIES
A multiple sequence alignment of all three homologs revealed stretches of conserved
amino acid sequences (Appendix A.1). The next step was to determine the similarities of
individual domains in the X. laevis desmoplakin protein with those in mammalian Dsp homologs.
First, a comparative analysis of the plakin domain was performed. Comparative analysis revealed
that the plakin domains of both Homo sapiens and Mus musculus homologs shared 64% identity
and 80% similarity respectively with the same domain of X. laevis Dsp.L. (Fig. 1.3, Part I). A
bioinformatics analysis of the plakin subdomains also revealed similarity in sequences between X.
laevis and mammalian desmoplakin homologs (Appendix A.3). Next, the rod domain was
compared across species. Comparative analysis revealed that the rod domain of H. sapiens and M.
musculus homologs shared 61% identity and 82% similarity with the corresponding domain in X.
laevis Dsp.L. (Fig. 1.3, Part I). Finally, the similarities of the A, B, and C subdomains in the C-
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terminal domain were analyzed. The A, B, and C subdomains in both H. sapiens and M. musculus
shared 87%, 91%, and 93% similarity, respectively, with the corresponding regions in X. laevis
Dsp.L. (Table 1.7; Fig. 1.3, Part I). Together, these results indicate that the functional domains
of X. laevis Dsp.L share a high degree of similarity with those in the mammalian homologs,
suggesting that its overall function could also be shared.

B.3. COMPARING X. LAEVIS L AND S SUBGENOME HOMOLOGS REVEALED SIZE
DIFFERENCES
The desmoplakin allele is present in both the L (Long) and S (Short) subgenomes in X.
laevis. The S subgenome has experienced more deletions, thus it might be predicted that L and S
homologs differ in coding sequence length. Therefore, to determine whether there were
differences, pairwise alignments were performed between the gene coding DNA sequence and
protein sequences of these homologs. Results revealed that the X. laevis dsp.S gene coding DNA
sequence shared 91% identity with dsp.L (Table 1.6). At the protein level, Dsp.S had a length of
2767 a.a., which was 96.5% of the length of Dsp.L, and shared 93% similarity.
Next, the similarity of the functional domains between the homologs was analyzed. The
plakin domain of the Dsp.S homolog shared 86% similarity with the same domain in Dsp.L.
Analysis of the coding DNA sequence alignment revealed a gap in the S homolog which
corresponded to exons 11 and 12 in the L homolog (Appendix A.2). This encodes part of the SR56
plakin subdomain which only shared 60% similarity between the homologs (Table 1.7). The rod
domain of the Dsp.S homolog shared a 96% similarity with the corresponding domain in Dsp.L.
The C-terminal domain in the Dsp.S homolog was predicted to contain A, B, and C subdomains
and shared 98%, 97% and 99% similarity, respectively, with the same subdomains in Dsp.L (Fig.
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1.3, Part II). Together, these results suggest that Dsp.S shares a high degree of similarity with
Dsp.L but has deletions within the plakin domain, which might result in functional differences.

C. IMMUNOFLUORESCENCE REVEALED DIFFERENCE IN PATTERNS
BETWEEN EARLY AND LATE STAGES

C.1. IMMUNOFLUORESCENCE REVEALED VARIABLE LEVELS OF
DESMOPLAKIN WITHIN EPIDERMAL TISSUES AT EARLY STAGES
As mentioned above, the ubiquitous presence of desmoplakin in all desmosomes makes it
suitable to study the role of desmosomes during development. While the results above revealed
that desmosomes are detected in the X. laevis embryonic epidermis, it is unknown if desmoplakin
localizes to the membrane during this period. Therefore, the pattern of desmoplakin localiza tio n
when the epidermis undergoes morphogenesis was determined using Immunofluorescence (IF) at
st. 21-23 (23-25 hpf). Desmoplakin appeared to be adjacent to the membrane (marked by βcatenin) throughout the epidermis (n=15, 3 experiments, Fig. 1.4A-A’’). However, the levels of
both β-catenin and desmoplakin were not the same in all cells. At the vertex of 4 to 5 surrounding
cells, consistent with where cells are fated to intercalate, there appeared to be lower levels of both
β-catenin and desmoplakin (white arrow, Fig. 1.4A). Other cells with small apical surfaces,
consistent with newly intercalating cells, had enriched levels of desmoplakin but not β-catenin
(white arrowhead, Fig. 1.4A). In summary, the variable levels of desmoplakin within the epidermis
suggest that desmosome assembly might be dynamic during epidermal development.
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C.2. IMMUNOFLUORESCENCE REVEALED PRESENCE OF DESMOPLAKIN IN
EPIDERMALLY-DERIVED TISSUES AT LATE STAGES
As the Xenopus embryo approaches pre-metamorphic stages, many structures are derived
from the developing epidermis. These include the outer corneal layer of the eye, and the
operculum, which have desmosomes (Hu et al., 2013; Nieuwkoop and Faber, 1967). Therefore,
desmoplakin was imaged by IF in these epidermally-derived structures at st. 42-43 (80-92 hpf).
Results revealed ubiquitous levels of desmoplakin in the outer corneal layer (Fig. 1.4B-B’’).
Desmoplakin was also present throughout the epidermis including the tail fin (Fig. 1.4C-C’) and
was detected in the operculum and the external gills, which are derived from the visceral arches
(Fig. 1.4D-D’’). These results indicate that desmoplakin presence in many epidermally-der ived
tissues might suggest a requirement for proper development or functioning of these structures.
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Figure 1.2: Transmission Electron Microscopy (TEM) analysis of the X. laevis embryonic
desmosome during early development.
(A-B) TEM imaging revealing desmosomal ultrastructure in the Xenopus laevis embryo without
(A) and with (B) midline (white arrow) (Scale bar=100 nm). (C-J) Electron micrographs depicting
desmosomes in the X. laevis embryo at various developmental stages (electron-dense plaques,
yellow arrows) (Scale bar = 250 nm). Green bracket (C) indicates Tight junction and Adherens
junction. (K) Graph depicting the percentage of junctions with desmosomes at various stages. (L)
Electron micrograph of st. 31 epidermis revealing desmosomes in the inner epidermal layer (red
arrow) (Scale bar=0.5µm). Yellow arrows denote desmosomes in the outer epidermal layer. (M)
Electron micrograph of st. 44 epidermis revealing desmosomes in the inner epidermal layer (red
arrow) (Scale bar=1µm). Yellow arrows denote desmosomes in the outer epidermal layer and
green arrow denote desmosomes between outer and inner epidermal layer. EC=Extracellular
space; PM=Plasma membrane; ODP=Outer dense plaque; IDP=Inner dense plaque; DM=Dense
midline; OL=Outer Layer; IL=Inner Layer.
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Figure 1.3: Comparative bioinformatics analysis of the desmoplakin protein.
Part I. Comparative analysis of functional domains in desmoplakin protein between vertebrate
species and the X. laevis Dsp.L homolog. Part II. Comparative analysis of functional domains in
desmoplakin protein between the X. laevis Dsp.L and Dsp.S subgenome homologs. Percent
Similarity with X. laevis Dsp.L is denoted for each domain within boxes. Numbers below boxes
depict amino acid coordinates for each domain. A,B,C=C-terminal homologous plakin repeat
domains.
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Figure 1.4: Desmoplakin expression in the developing embryo.
(A-A’’) Immunofluorescence of desmoplakin (green) and β-catenin (red) at st. 22. Some cells have
relatively high desmoplakin intensity (white arrowheads) and other cells have lower levels (white
arrow) (Scale bar=25µm). (C-E’’) Immunofluorescence of desmoplakin (green) and nuclei
(purple) in Eye (B-B’’), Fin (C-C’’) and Gill (D-D’’) epidermis at st. 43 (Scale bar=50µm).
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Table 1.5: Percentage of junctions with desmosomes in various developmental stages in the
X. laevis embryo.
Stage

Embryo

No. of
junctions
analyzed

Percentage of junctions

0
1
2
N≥3
desmosomes/ desmosome/ desmosomes/ desmosomes/
junction
junction
junction
junction
st. 10

st. 14

st. 19

st. 22

1

12

66.67
(n=8)

33.33
(n=4)

0
(n=0)

0
(n=0)

2

27

74.07
(n=20)

25.93
(n=7)

0
(n=0)

0
(n=0)

1

12

41.67
(n=5)

58.33
(n=7)

0
(n=0)

0
(n=0)

2

39

51.28
(n=20)

46.15
(n=18)

2.56
(n=1)

0
(n=0)

1

16

25
(n=4)

62.5
(n=10)

12.5
(n=2)

0
(n=0)

2

44

22.73
(n=10)

70.45
(n=31)

6.82
(n=3)

0
(n=0)

1

17

0
(n=0)

41.18
(n=7)

52.94
(n=9)

5.88
(n=1)

2

51

9.8
(n=5)

35.29
(n=18)

45.1
(n=23)

9.8
(n=5)
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Table 1.6: Desmoplakin gene and protein comparative analysis against X. laevis Dsp.L.
Organism

Accession
number or
Database

X. laevis
(Dsp.L)

Whole Protein
(%Identity/
Similarity)

Xenbase
Genome build
9.1
NP_004406

H. sapiens
M. musculus

NP_076331

X. laevis (Dsp.S)

Xenbase
Genome build
9.1

Length (amino
acid)

Coding DNA
sequence
(%Identity)

100

2866

100

66.0/ 82.2

2871

65.7

65.6/ 82.1

2883

64.4

90.1/ 93.4

2767

90.7

Table 1.7: Desmoplakin protein domains comparative analysis against X. laevis Dsp.L.
Organism

X. laevis
(Dsp.L)
H. sapiens
M. musculus
X. laevis
(Dsp.S)

PLAKIN
(%Identity/
Similarity)

ROD
(%Identity/
Similarity)

A
(%Identity/
Similarity)

100

100

100

100

100

64.6/ 80.5

61.1/ 81.8

72.6/ 86.9

84.6/ 93.0

76.0/ 91.4

64.3/ 80.0

60.8/ 81.9

71.4/ 87.4

84.6/ 93.4

75.4/ 91.4

82.7/ 85.9

92.7/ 95.7

93.7/ 98.3

96.0/ 97.4

94.3/ 98.9
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B
(%Identity/
Similarity)

C
(%Identity/
Similarity)

SECTION 2: EMBRYOS WITH REDUCED OR IMPAIRED DESMOPLAKIN
FUNCTION HAVE EPIDERMAL DEFECTS, REDUCED MECHANICAL
RESISTANCE, AND IMPAIRED RADIAL INTERCALATION

Although the role and regulation of desmoplakin has been studied extensively in cell
culture, there are only a handful of studies examining its role in the developing embryo (Gallica no
et al., 2001; Gallicano et al., 1998). Therefore, the goal of this section is to determine the functio n
of desmoplakin in the early embryo by performing loss-of-function experiments using various
molecular techniques.

PART I
A. KNOCKDOWN WITH MORPHOLINOS RESULTS IN REDUCED
DESMOPLAKIN
To understand the role of a protein during development it is necessary to decrease or
deplete that protein and assess the effects on the embryo. To do this, first, antisense morpholinos
were used to knock down desmoplakin in embryos. Morpholino concentrations can be optimized
to examine the effects of decreasing the dosage of Dsp in the embryo. This is especially useful
when a complete knockout might be lethal (Gallicano et al., 1998). While morpholinos are an
effective method to test the role of gene function in Xenopus, effects due to toxicity, nonspecific
effects, or the creation of neomorphs can lead to misleading results (Blum et al., 2015; Eisen and
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Smith, 2008; Heasman, 2002). Thus, two splice-blocking morpholinos targeting different regions
of the dsp.L homolog were used in this study.
Two splice-blocking morpholinos against desmoplakin were designed to target either the
exon 4-intron 4 splice junction (DspMO1) (Fig. 1.5A) or the exon 14-intron 14 splice junction,
(DspMO2) (Fig. 1.5B) of Dsp.L mRNA. Additionally, DspMO2, but not DspMO1 is predicted to
bind efficiently to Dsp.S mRNA (Table 1.1). To assess their efficacy, fertilized eggs were injected
with DspMO1, DspMO2, control (CMO) or no morpholino (pools of n=10, 2 experiments each).
First, the efficacy of DspMO1 was assessed against RNA from tailbud stages (st. 30-31). RT-PCR
of the DspMO1 target region revealed a single 422 bp band in DspMO2-, CMO-injected and wildtype embryos (Fig. 1.5C). However, in DspMO1-injected embryos, an extra 253 bp band,
consistent with exon 4 splicing, was observed (Fig. 1.5C). These results indicate that the DspMO1
morpholino produced splicing defects within the target region and a reduction in normal Dsp
mRNA. The next step was to determine the efficacy of the DspMO2 morpholino. RT-PCR of the
DspMO2 target region revealed a single 388 bp band in CMO-injected and wild-type embryos
(Fig. 1.5D). However, an extra ~500 bp band, consistent with intron retention, was observed (Fig.
1.5D). These results indicate that the DspMO2 morpholino produced splicing defects within the
target region and a reduction in normal Dsp mRNA.
To determine whether the splicing defects resulting from the DspMO1 were effective in
reducing protein levels, embryos were imaged using immunofluorescence to detect desmoplakin
levels. Results revealed that CMO-injected embryos had a normal intensity and pattern of Dsp as
described above (Section 1C) (Fig. 1.5E). However, in both DspMO1- and DspMO2-injected
embryos, there was a reduction in desmoplakin (Fig. 1.5F,G). These results indicate that the
morpholinos effectively lead to reduction in desmoplakin in the epidermis.
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B. CRISPR/ CAS9-MEDIATED MUTAGENESIS OF DESMOPLAKIN HOMOLOGS
IN F0 MUTANTS RESULTS IN REDUCTION OF DESMOPLAKIN
While the results above confirm that morpholinos effectively target Dsp, using differe nt
approaches to study gene and protein function ensures the validity of phenotypes (Blum et al.,
2015; Kok et al., 2015). Additionally, morpholino efficacy starts to decrease after a few days
(Eisen and Smith, 2008). Therefore, the CRISPR/Cas9 (clustered regularly interspaced short
palindromic repeats/CRISPR-associated) system was utilized for targeted mutagenesis of the dsp
gene (Bhattacharya et al., 2015; Nakayama et al., 2013; Wang et al., 2015). This method creates
double stranded breaks in the genome which frequently lead to indels due to the error-prone nonhomologous end joining repair mechanism. To generate F0 dsp CRISPR mutants, gRNAs were
designed to target both the L and S homologs. To ensure that the technique was effective, a positive
control was performed by targeting the tyrosinase (tyra + tyrb) genes as previously described
(Chapter 2) (Wang et al., 2015). Two CRISPR gRNAs were designed to target sites in the eighth
(DspCRISPR1) and nineteenth (DspCRISPR2) exons of the dsp.L homolog (corresponding to the
eighth and seventeenth exons on the dsp.S homolog, respectively) (Fig. 1.6A). To determine
whether the gRNAs were effective, injected embryos were analyzed for mutations using a T7
endonuclease assay. If mutations are present, the target region is cleaved. First, the efficacy of
DspCRISPR1 was determined using DNA from tailbud stages (st. 30-31). Results revealed a 237
bp (dsp.L) and 380 bp (dsp.S) band in 100% of wild-type embryos (n=12, 3 experiments).
However, in 80% of DspCRISPR1-injected embryos, multiple bands, including the 237 bp and
380 bp bands, were detected in both dsp.L and dsp.S homologs (n=15, 3 experiments) (Fig. 1.6B).
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The sizes of these extra bands are consistent with mutations in the gRNA target region (Table 1.4).
This indicates that the gRNA was effective and that the embryos were mosaic.
Next, the efficacy of DspCRISPR2 was assessed using DNA from tailbud stages (st. 3031). Results revealed a 382 bp (dsp.L) and 325 bp (dsp.S) band in 100% of wild-type embryos
(n=12, 3 experiments). However, in 100% of DspCRISPR2-injected embryos, multiple bands,
including the 382 bp and 325 bp bands, were detected in both dsp.L and dsp.S homologs (n=16, 3
experiments) (Fig. 1.6B). The sizes of these extra bands are consistent with mutations in the gRNA
target region (Table 1.4). This indicates that the gRNA was effective and that DspCRISPR2injected embryos were also mosaic, similar to DspCRISPR1-injected embryos.
The next goal was to determine whether the mutations in the target region led to a reduction
in desmoplakin protein. To do this, embryos were imaged by immunofluorescence to detect
desmoplakin presence in F0 mutants. Results revealed that control embryos had a normal pattern
of Dsp labeling as described above (Section 1C) (Fig. 1.6C). However, in both DspCRISPR1 and
DspCRISPR2 F0 mutants, there was a reduction in desmoplakin. There was some variability in
the amount of desmoplakin loss between individual CRISPR-injected embryos. For example, in a
subset of embryos there were low levels of desmoplakin across a wide region of epidermis (Fig.
1.6D,F). On the other hand, other embryos displayed a reduction in desmoplakin in smaller patches
of epidermis (Fig. 1.6E,G). This suggests that the degree of mosaicism is different between
injected embryos (Wang et al., 2015). These results indicate that CRISPR-mediated mutagene s is
of desmoplakin L and S homologs is effective at reducing desmoplakin protein.
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PART II
A. DSP MORPHANTS AND F0 MUTANTS HAVE REDUCED SIZE

Morpholinos successfully resulted in reduction of desmoplakin protein in embryos. The
next step was to observe the effects on the morphology of embryos injected with morpholino and
CRISPR gRNA. First, DspMO1 morphants were assessed for defects. Embryos appeared normal
at cleavage, blastula, and gastrula stages (until 13 hpf). However, at stage 25-30, a large percentage
of DspMO1 morphants were shorter. DspMO1 morphants (n=98, 4 experiments) were, on average,
1.45-fold shorter than control morphants (n=77, 4 experiments) (t-test, p<0.0001) (Fig. 1.7A).
Next, DspMO2 morphants were observed to determine if the phenotypes mimicked those of the
DspMO1 morphants. Embryos were able to progress through cleavage, blastula, and gastrula
stages (until 13 hpf) normally. However, like DspMO1 morphants at stage 25-30, a large
percentage of DspMO2 morphants were also shorter. DspMO2 morphants (n=67, 3 experiments)
were, on average, 1.35-fold shorter than control morphants (n=76, 3 experiments) (t-test,
p<0.0001) (Fig. 1.7B).
To ensure the specificity of morphant phenotypes, CRISPR/ Cas9 mutants were examined
to determine whether they mimicked morphants. Embryos were able to progress through cleavage,
blastula, and gastrula stages (until 13 hpf) normally. F0 mutant embryos that were sequenced and
found to have mutations in both dsp homologs were imaged prior to genotyping. Like the Dsp
morphants at stage 25-30, these mutants were also shorter. D'Agostino & Pearson omnibus
normality testing revealed that the distribution of length measurements was not normal
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(DspCRISPR1=p<0.0001; DspCRISPR2= p<0.001). Non-parametric statistical analysis revealed
that DspCRISPR1 (n=109, 2 experiments) and DspCRISPR2 (n=90, 2 experiments) F0 mutants
had statistically significant reductions in length (Mann-Whitney test, p<0.0001) relative to wildtype embryos (Fig. 1.7C,D).

B. DSPMO1 AND DSPMO2 MORPHANTS EXHIBIT DEFECTS IN
EPIDERMALLY-DERIVED STRUCTURES AND THE HEART

B.1. DSPMO1 AND DSPMO2 MORPHANTS HAVE EPIDERMAL DEFECTS AT
EARLY STAGES

At early stages (st. 25-30), embryos also displayed epidermal tears, hyperpigmentatio n,
ventral abdominal blistering and neural tube defects in DspMO1 and DspMO2 morphants.
Analysis of DspMO1 and DspMO2 morphants were performed separately. While 39.8% of
DspMO1 morphants had skin defects (n=296, 6 experiments), this was present in only 3.62% of
controls (n=276, 6 experiments) (χ2 -test, p= 3.34E-25) (Fig. 1.8B). Skin defects occurred in
27.47% of DspMO2 morphants (n=233, 4 experiments) compared to only 3.41% of control
morphants (n=205, 4 experiments) (χ2 -test, p= 9.39E-12) (Fig. 1.8C). Ventral blisters were present
in 29.25% of DspMO1 morphants (n=294, 6 experiments) compared to only 6.16% of controls
(n=276, 6 experiments) (χ2 -test, p= 8.03E-13) (Fig. 1.8D). Ventral blisters were present in 17.17%
of DspMO2 morphants (n=233, 4 experiments) compared to only 2.93% of control morphants
(n=205, 4 experiments) (χ2 -test, p= 0.00039) (Fig. 1.8E). While 16.33% of DspMO1 morphants
had neural tube closure defects (n=294, 6 experiments), none of the control morphants presented
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with these defects (n=276, 6 experiments) (χ2 -test, p= 2.31E-12) (Fig. 1.8F). Finally, while 15.02%
of DspMO2 morphants had neural tube closure defects (n=233, 4 experiments), only 1.46% of the
controls presented with these defects (n=205, 4 experiments) (χ2 -test, p= 4.91E-07) (Fig. 1.8G).
These results suggest that DspMO1 and DspMO2 morpholinos are associated with defects in size,
epidermal development, and neural tube closure of embryos (Fig. 1.8O). These results also reveal
that defects in both morphants mimic each other, suggesting that these phenotypes are specific to
desmoplakin loss at early stages.

B.2. DSPMO1 AND DSPMO2 MORPHANTS HAVE EYE, FIN, AND HEART DEFECTS
AT LATE STAGES
Results revealed that desmoplakin is present in epidermally-derived structures such as the
lens, fin, and external gill buds in late tailbud stage embryos (>50 hpf). Desmoplakin is also known
to be expressed in the mammalian heart, which becomes functional during Xenopus late tailbud
stages (Lohr and Yost, 2000; Warkman and Krieg, 2007). Therefore, the next step was to determine
whether Dsp loss disrupted the development of these structures. Analysis of DspMO1 and
DspMO2 morphants were performed separately. Several defects were noticeable in DspMO1 and
DspMO2 morphants at stage 41-43. The reduction in anterio-posterior axis length is still retained
from mid-tailbud stages but this was not quantified. While control morphants appeared unaffected,
many DspMO1 and DspMO2 morphants did not develop proper eye structures, and displayed
ruffled fins and pericardial or cardiac edemas. Eye defects, including defects in RPE pigmenta tio n
occurred in 44.77% of DspMO1 morphants (n=62, 2 experiments) compared to only 5.45% of
control morphants (n=55, 2 experiments) (χ2 -test, p= 5.61E-07) (Fig. 1.8I). Similar eye defects
occurred in 63.16% of DspMO2 morphants (n=76, 2 experiments) compared to only 7.25% of
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control morphants (χ2 -test, p= 2.91E-12) (n=69, 2 experiments) (Fig. 1.8J). Fin defects were
present in 53.23% of DspMO1 morphants (n=62, 2 experiments) compared to only 1.82% of
control morphants (n=55, 2 experiments) (χ2 -test, p= 6.79E-120) (Fig. 1.8K). While fin defects
were present in 38.16% of DspMO2 morphants (n=76, 2 experiments), none of the controls
displayed these defects (n=69, 2 experiments) (χ2 -test, p= 9.65E-09) (Fig. 1.8L). Cardiac defects
were present in 17.74% of DspMO1 morphants (n=62, 2 experiments), while only 1.82% of control
morphants exhibited these defects (n=55, 2 experiments) (χ2 -test, p= 8.51E-89) (Fig. 1.8M). While
50% of DspMO2 morphants also exhibited cardiac defects (n=76, 2 experiments), only 2.9% of
controls displayed these defects (n=69, 2 experiments) (χ2 -test, p= 2.33E-10) (Fig. 1.8N). These
results suggest that the DspMO1 and DspMO2 morpholinos perturb the development of many
epidermally-derived structures as well as other desmosome-containing tissues such as the heart
(Fig. 1.8O; Table 1.8). These results also indicate that both morpholinos mimic each other at late
stages, suggesting that these defects are specific to Dsp knockdown.

C. DSP CRISPR MUTANTS MIMIC MORPHANT PHENOTYPES AT EARLY AND
LATE STAGES

C.1. DSP MUTANTS HAVE REDUCED SIZE AND EPIDERMAL DEFECTS AT
EARLY STAGES

At these early stages, defects appeared similar to morphants, including epidermal tears,
hyperpigmentation, ventral abdominal blistering and neural tube defects. Skin defects occurred in
7.3% of DspCRISPR1 (n=219, 4 experiments) and 8.18% of DspCRISPR2 F0 mutants (n=232, 4
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experiments) compared to only 0.78% of wild-type embryos (n=256, 4 experiments) (χ2 -test,
DspCRISPR1, p=0.00021; DspCRISPR2, p=5.64E-05) (Fig. 1.9A-C). Ventral blisters were
present in 10.95% of DspCRISPR1 (n=219, 4 experiments) and 12.06% of DspCRISPR2 F0
mutants (n=232, 4 experiments) compared to only 1.56% of wild-type embryos (n=256, 4
experiments) (χ2 -test, DspCRISPR1, p=1.46E-05; DspCRISPR2, p=2.83E-06) (Fig. 1.9D,E).
Finally, while 5.48% of DspCRISPR1 (n=219, 4 experiments) and 5.17% of DspCRISPR2 F0
mutants (n=232, 4 experiments) had neural tube defects, no wild-type embryos presented with
these defects (n=256, 4 experiments) (χ2 -test, DspCRISPR1, p=0.00015; DspCRISPR2,
p=0.00023) (Fig. 1.9F,G).
These results indicate that phenotypes of CRISPR-injected embryos mimic those observed
in morphants at early stages, suggesting that these phenotypes are specific to desmoplakin loss.
However, the lower prevalence relative to morphants, compounded with variability observed with
desmoplakin labeling suggest that these mutants are mosaic.

C.2. DSP MUTANTS HAVE EYE, FIN, AND HEART DEFECTS AT LATE STAGES
Next, CRISPR/ Cas9 F0 mutants were examined to determine whether they mimicked
morphants at late stages. The reduction in anterio-posterior axis length is still retained from mid tailbud stages but this was not quantified. While wild-type controls appeared unaffected, many
DspCRISPR1 and DspCRISPR2 F0 mutants did not develop proper eye structures including RPE
and displayed ruffled fins and cardiac edemas. Eye defects, including defects in RPE pigmenta tio n
and colobomas occurred in 13.33% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of
DspCRISPR2 F0 mutants (n=174, 3 experiments) compared to only 1.41% of wild-type embryos
(n=213, 3 experiments) (χ2 -test, DspCRISPR1, p=1.62E-08; DspCRISPR2, p=0.0015) (Fig. 1.9H-
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J). Fin defects were present in 9.09% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of
DspCRISPR2 F0 mutants (n=174, 3 experiments) while only 0.47% of wild-type embryos
displayed fin defects (n=213, 3 experiments) (χ2 -test, DspCRISPR1, p=7.61E-09; DspCRISPR2,
p=0.00012) (Fig. 1.9K,L). Finally, cardiac defects, including cardiac edemas were quantified in
morphants were present in 10.91% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of
DspCRISPR2 F0 mutants (n=174, 3 experiments) while only 0.47% of wild-type embryos
displayed

cardiac defects (n=213, 3 experiments)

(χ2 -test, DspCRISPR1,

p=4.08E-06;

DspCRISPR2, p=0.00012) (Fig. 1.9M,N). These results indicate that phenotypes of CRISPRinjected embryos mimic those observed in morphants at late stages also, suggesting that these
phenotypes are specific to Dsp loss. However, the lower prevalence relative to morphants,
compounded with variability observed in Dsp labeling, suggest that these mutants are mosaic (Fig.
1.9O; Table 1.9).
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PART III
A. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY
MECHANICAL STRESS
Epidermal tearing was observed in Dsp morphants and CRISPR F0 mutants. Patients with
mutations in desmoplakin and plakophilin 1 also have skin that is prone to tearing when exposed
to mechanical agitation (McGrath et al., 1997; Whittock et al., 2002). Therefore, the next step was
to determine whether a reduction of desmoplakin in Xenopus embryos also results in a reduced
resistance to mechanical stresses.

A.1. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY
SHEAR AND IMPACT FORCES
First, an “Impact Assay” was used where in st. 26 embryos were picked up using a pipette
and released from a height of 15 cm into a dish lined with 2% agarose (Fig. 1.10A). This assay
was predicted to cause shear and impact stresses. Results revealed that more DspMO1 morphants
(85%) exhibited damage to the epidermis compared to controls (15%) (n=20, 2 experiments) (χ2 test, p=9.54E-06) (Fig. 1.10B-D’). These results indicate that the epidermis of DspMO1 morphants
exhibits quantitatively decreased resistance to shear and impact forces.
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A.2. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY
ROTATIONAL FORCES
Next, a “Rotation Assay” was used where in st. 26 embryos were placed in a buffercontaining 50 ml conical tube that underwent rotations at 55rpm (t=30s) in a vertical rotating mixer
(Fig. 1.10E). The embryos were subject to various mechanical stresses as they contacted the
surface tension of the media as well as the side of the tube. Results revealed that significantly more
DspMO1 morphants (80%) exhibited damage to the epidermis compared to controls (25%) (n=20,
2 experiments) (χ2 -test, p=0.00048) (Fig. 1.10F-H’). These results indicate that the epidermis of
DspMO1 morphants exhibit reduced resistance to tension and shear forces.
Together, these mechanical assays demonstrate that the epidermis of DspMO1 morphants
have quantitatively decreased resistance to mechanical stress such as impact, shear and tensional
forces. This suggests that reduction in desmoplakin may contribute to decreased mechanica l
resistance of the epidermis.

B. DSP MORPHANTS EXHIBIT A LOSS OF JUNCTIONAL DESMOSOMES AND
WIDENED INTERCELLULAR GAP
Next, the desmosome structure was examined in Dsp morphants to determine whether Dsp
is required for desmosome formation or maintenance. Desmosomes were imaged by TEM to
observe and quantify the desmosomal junctions in the embryonic epidermis at st. 30-31 (72-76
hpf). There was an increase in the intercellular gap in DspMO1 morphants relative to controls.
This intercellular gap was increased basal to tight and adherens junctions (not quantified, arrows,
Fig. 1.11A-D). Results also revealed that 57% of junctions in DspMO1 morphants had
desmosomes compared to 97% of junctions in controls (n=44 (CMO) and n=56 (DspMO1) in 2

63

embryos, 2 experiments) (Fig. 1.11E). Additionally, while only 2% of junctions in DspMO1
morphants had three or more desmosomes, 27% of junctions in controls had three or more
desmosomes (Table 1.10). These results suggest that desmoplakin may be required for proper
formation or maintenance of the desmosome and maintaining intercellular adhesion.

C. DSP MORPHANTS HAVE DEFECTS IN THE FORMATION OF SPECIALIZED
EPIDERMAL CELL TYPES
The Xenopus embryonic epidermis has multiple specialized cell types. Since the epidermis
of Dsp morphants appeared abnormal, the development of these cells might also be affected in
Dsp morphants.

Therefore, the α-tubulin of multiciliated

cells (MCCs) was imaged by

immunofluorescence (Fig. 1.12A). At st. 31, cilia appeared shorter and fewer in number per cell
in DspMO1 morphants compared to controls (Fig. 1.12B). The number of cilia-positive cells
relative to the total number of cells was 2.77-fold less in the DspMO1 morphants (0.064; n=9)
relative to controls (0.178; n=9, 2 experiments) (t-test, p<0.00001) (Fig. 1.12B-D).
To determine whether the reduction in multiciliated cells in DspMO1 morphants was due
to desmoplakin loss, MCCs were also counted in DspMO2 morphants injected at the 1-cell stage.
At st. 31, cilia appeared shorter and fewer in number per cell in DspMO2 morphants compared to
controls, similar to DspMO1 morphants (Fig. 1.12E). The number of cilia-positive cells relative
to the total number of cells was 2.09-fold less in the DspMO2 morphants (0.087; n=8) relative to
controls (0.181; n=9, 2 experiments) (t-test, p<0.00001) (Fig. 1.12E-G). Together, these results
indicate that Dsp morphants display impaired development of multiciliated cells.
Next, the Lectin Peanut Agglutinin (Lectin PNA) was labeled to determine whether the
development of small secretory cells (SSCs) was affected in Dsp morphants (Fig. 1.13A). At st.
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34, the number of PNA-positive cells relative to the total number of cells was 5.79-fold less in the
DspMO1 morphants (0.023; n=11) relative to controls (0.139; n=10, 2 experiments) (t-test,
p<0.00001) (Fig. 1.13B-D).
To determine whether the reduction in small secretory cells in DspMO1 morphants was
due to desmoplakin loss, SSCs were also counted in DspMO2 morphants injected at the 1-cell
stage. At st. 34, the number of PNA-positive cells relative to the total number of cells was 3.74fold less in the DspMO2 morphants (0.031; n=10) relative to controls (0.115; n=10, 2 experiments)
(t-test, p<0.00001) (Fig. 1.13E-G). Together, these results indicate that Dsp morphants have
impaired development of small secretory cells.
In summary, these results suggest that a reduction in Dsp may reduce the prevalence and
perturb the development of specialized cell types that radially intercalate into the outer epidermis.

D. DSP MORPHANTS HAVE DEFECTS IN RADIAL INTERCALATION
Dsp morphants were demonstrated to have fewer and defective specialized cell types that
radially intercalate into the outer epidermal layer. More precisely, there is a reduction in ciliapositive multiciliated cells and Lectin PNA-positive small secretory cells in Dsp morphants.
Therefore, the next step was to determine whether the reduction in the number of these cell types
was a result of reduced radial intercalation. To track radial intercalation, the epidermis of control
and DspMO1 morphants were pulse labeled with biotin from st.19 (46 hpf) until st. 20 (47 hpf)
(Fig. 1.14A). Embryos fixed and labeled immediately after this treatment demonstrated complete
and relatively uniform labeling of the epidermis (not shown). Biotin incubation was followed by a
4-hour washout to allow unlabeled cells to emerge into the outer layer (Fig. 1.14A).
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Controls fixed after this washout had many biotin-negative regions that were consistently
interspersed among biotin positive cells (Fig. 1.14B-B’’). These unlabeled regions represented the
cells that radially intercalated during the washout period. Results revealed a significant, albeit
slight reduction in the average number of unlabeled cells in DspMO1 morphants (t-test, p=0.0475)
(n= 11, 3 experiments) (Fig. 1.14C-C’’). There was a large amount of variability, where a subset
of DspMO1 morphant embryos had the same or even more unlabeled cells than a subset of the
controls (Fig. 1.14D,D’’,E). There were also significantly fewer multiciliated cells in the same
images of DspMO1 morphants (t-test, p<0.0000001, n= 11, 3 experiments; Fig. 1.14F). In some
DspMO1 morphants, the size of the apical surfaces of many unlabeled cells appeared smaller
(arrows, Fig. 1.14D). Therefore, the relative surface area of the biotin-negative cells was quantified
in the same images. Results revealed that there was indeed a statistically significant reduction in
the average surface area of biotin-negative cells in the DspMO1 morphants (n=822 cells, 11
embryos) relative to controls (n=806 cells, 11 embryos) (Mann-Whitney test, p<0.0001, 3
experiments) (Fig. 1.14G, H). A histogram analysis revealed that these apically emerging cells
had surface areas that followed a binomial distribution with a substantial proportion of cells in
CMO morphants greater than 100µm2 . Together, these results indicate that radial intercalation and
formation of the multiciliated cells in the embryonic epidermis may require Dsp.

E. DSP MORPHANTS AND F0 MUTANTS HAVE ABNORMAL ORGANIZATION
OF KERATIN INTERMEDIATE FILAMENTS
Radial intercalation is partly orchestrated by the cytoskeleton through actin-generated
forces and is also regulated by the rigidity of neighboring cells (Sedzinski et al., 2016). Therefore,

66

keratin intermediate

filaments

were imaged to determine whether Dsp morphants have

perturbations in intermediate filament organization.
To assess this, control and Dsp morphants at st. 30-31 (72-76 hpf) were fixed and labeled
for keratin. Results revealed that keratin filaments appear as a contiguous network in controls
(n=21, 4 experiments) (Fig. 1.15A-B). In DspMO1 morphants, however, keratin appeared to be
retracted from the membrane and appeared to have gaps between networks in neighboring cells
(n=12/16, 3 experiments) (Fig. 1.15C-D). The same results were observed in DspMO2 morphants
(n=8/12, 2 experiments) (Fig.15E-F). CRISPR F0 mutants also displayed keratin retraction in a
subset of embryos (Fig. 1.15, Part II). These results indicate that a reduction in Dsp disrupts the
organization of keratin intermediate filaments, which may contribute to defects in morphogene s is.

F. DISRUPTION OF DESMOPLAKIN-KERATIN LINK REPRODUCES SOME
MORPHANT AND MUTANT PHENOTYPES
Dsp morphants and CRISPR F0 mutants displayed retraction of keratin filame nts.
Therefore, the next step was to determine whether disrupting the link between desmoplakin and
keratin while maintaining desmosome adhesion produced similar phenotypes. To test this, the
established dominant-negative DP-NTP (Desmoplakin – N-terminal peptide) construct was
injected into embryos (Huen et al., 2002) (Fig. 1.16A). This construct has a truncated human
desmoplakin which is demonstrated to uncouple intermediate filaments from the desmosome.
Membrane-GFP and wild-type embryos were used as controls.
First, endogenous desmoplakin and keratin were imaged by immunofluorescence to
determine the effect of DP-NTP on protein localization. Results revealed low endogenous
desmoplakin in cells expressing DP-NTP and keratin retraction while appearing normal in controls
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(Fig. 1.16B-E). These results indicate that DP-NTP replaces endogenous desmoplakin at the
membrane and is associated with keratin reorganization.
Next, DP-NTP-injected were examined to determine whether maintaining the desmosomal
connection but abolishing the attachment to keratin mimicked the effects of desmoplakin
reduction. Results revealed no defects during cleavage, blastula, or gastrula stages. When embryos
developed into mid-tailbud stages (st. 30-31), hyperpigmentation was present in DP-NTP
expressing regions (Fig. 1.16G, G’). The embryos also had a reduction in size, but no embryos
displayed epidermal tearing. At late tailbud stages (st. 40-42), embryos displayed cardiac edemas
and ruffled fins, although fin ruffling was less severe relative to morphants and mutants (Fig.
1.16H,I). These results indicate that the effects of abolishing desmosome-keratin link partially
overlap with those observed in Dsp knockdown or knockout techniques. This also suggests that
loss of desmosomal adhesion may have relatively severe effects in embryonic development.
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Figure 1.5: Desmoplakin depletion with antisense morpholinos.
(A) Schematic of binding of DspMO1 to exons within dsp.L mRNA and resulting splice products.
(B) RT-PCR of dsp.L reveals alternative splice products in DspMO1 morphants (black arrow) but
not in control morphants (CMO) or wild-type (WT). (C) Schematic of binding of DspMO2 to
exons within dsp.L mRNA and resulting splice products. (D) RT-PCR of dsp.L reveals alternative
splice products in DspMO2 morphants (black arrow) but not in control morphants (CMO) or wild type (WT). (E-G) IF of desmoplakin (white) CMO (E), DspMO1 (F), and DspMO2 (G) morphants
(Scale bar = 25 µm).
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Figure 1.6: Desmoplakin depletion with CRISPR/ Cas9 mutagenesis.
(A,B) Schematic of binding of DspCRISPR1 (A) and DspCRISPR2 (B) gRNA to exons within
dsp.L and dsp.S. Black arrowheads represent primer locations. (C,D) T7 endonuclease I assay
revealing mutations in DspCRISPR1 and DspCRISPR2 (Lanes 2,3 in C and D, respectively) F0
mutants but not corresponding wild-type (Lanes 4,5 in C and D). Mutations are identified as
presence of more than one band. HyperLadder 25 bp (Bioline) is in Lane 1. (E-I) IF of desmoplakin
(white) in wild-type and DspCRISPR F0 mutants. Variability in desmoplakin reduction in
DspCRISPR1 (F,G) and DspCRISPR2 (H,I) mutants (Scale bar = 50 µm).

70

Figure 1.7: Dsp morphants and mutants displayed reduction in size.
(A) Box plot of size ranges between CMO and DspMO1 morphants. (B) Box plot of size ranges
between CMO and DspMO2 morphants. (C) Box plot of size ranges between WT embryos and
DspCRISPR1 mutants. (D) Box plot of size ranges between WT embryos and DspCRISPR2
mutants. Boxes represent 25th (lower), 50th (median), and 75th (upper) percentiles. Whiskers
represent 5th (lower) and 95th (upper) percentiles. Dots above and below whiskers are individ ua l
embryos that have sizes outside the 5th and 95th percentile.

71

72

Figure 1.8: Desmoplakin knockdown with DspMO1 and DspMO2 results in size reduction,
epidermal, and heart defects.
(A-G) Phenotypes observed in CMO (A), DspMO1 (B,D,F), and DspMO2 (C,E,G) morphants at
st. 31. (B,C) Epidermal tearing; (D,E) Blister; (F,G) Neural tube defects (yellow arrow). (H-N)
Phenotypes observed in CMO (H), DspMO1 (I,K,M), and DspMO2 (J,L,N) morphants at st. 42.
(I,J) Eye defects including coloboma; (K,L) Ruffled fin and reduced fin size; (M,N) Cardiac
edema. (Scale bar; A-N = 1 mm). (O) Graph of relative prevalence of phenotypes in CMO,
DspMO1, and DspMO2 morphants expressed as a percentage.
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Figure 1.9: Desmoplakin knockdown with DspCRISPR1 and DspCRISPR2 results in size
reduction, epidermal, and heart defects.
(A-G) Phenotypes observed in WT (A), DspCRISPR1 (B,D,F), and DspCRISPR2 (C,E,G)
morphants at st. 31. (B,C) Epidermal tearing; (D,E) Blister; (F,G) Neural tube defects (yellow
arrow). (H-N) Phenotypes observed in WT (H), DspCRISPR1 (I,K,M), and DspCRISPR2 (J,L,N)
morphants at st. 42. (I,J) Eye defects including coloboma; (K,L) Ruffled fin and reduced fin size;
(M,N) Cardiac edema. (Scale bar; A-N = 1 mm). (O) Graph of relative prevalence of phenotypes
in WT, DspCRISPR1, and DspCRISPR2 morphants expressed as a percentage.
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Figure 1.10: Depleting desmoplakin reduces resistance of epidermis to impact and shear
stresses.
(A) Schematic of experimental design for the Impact Assay. (B) Bar graphs summarizing
quantification of proportion of CMO and DspMO1 morphants with a ruptured epidermis after
Impact Assay (mean±s.e.m.). (C-D’) Representative images of CMO (C.C’) and DspMO1 (D,D’)
morphants after Impact Assay. (E) Schematic of experimental design for the Rotation Assay. (F)
Bar graphs summarizing quantification of proportion of CMO and DspMO1 morphants with a
ruptured epidermis after Rotation Assay (mean±s.e.m.). (G-H’) Representative images of CMO
(G,G’)
and
DspMO1
(H,H’)
morphants
after
Rotation
Assay.
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Figure 1.11: Depleting desmoplakin is associated with a loss of junctional desmosomes.
(A-D) TEM micrograph of junctions in CMO (A,B) and DspMO1 (C,D) morphants (Scale bars =
250 nm). Intercellular gap in DspMO1 morphants (black arrows in C,D). (E) Graph depicting the
percentage of junctions with desmosomes in CMO and DspMO1 morphants.
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Figure 1.12: Desmoplakin morphants have a reduction in multiciliated cells.
(A) Schematic of morpholino injection and labeling for MCCs. (B-C’’) IF of α-tubulin (green) and
E-cadherin (purple) in CMO (B-B’’) and DspMO1 (C-C’’) morphants (Scale bar = 50μm). (D)
Graph depicting ratio of cilia+ cells/ Total cells in CMO and DspMO1 morphants. (E-F’’) IF of αtubulin (green) and E-cadherin (purple) in CMO (E-E’’) and DspMO2 (F-F’’) morphants (Scale
bar = 25μm). (G) Graph depicting ratio of cilia+ cells/ Total cells in CMO and DspMO2
morphants.
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Figure 1.13: Desmoplakin morphants have a reduction in small secretory cells.
(A) Schematic of morpholino injection and labeling for SSCs. (B-C’’) IF of Peanut Agglutinin or
PNA (green) and E-cadherin (purple) in CMO (B-B’’) and DspMO1 (C-C’’) morphants (Scale
bar = 50μm). (D) Graph depicting ratio of PNA+ cells/ Total cells in CMO and DspMO1
morphants. (E-F’’) IF of Peanut Agglutinin or PNA (green) and E-cadherin (purple) in CMO (EE’’) and DspMO2 (F-F’’) morphants (Scale bar = 50μm). (G) Graph depicting ratio of PNA+
cells/ Total cells in CMO and DspMO2 morphants.
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Figure 1.14: Desmoplakin morphants have a reduction in radial intercalation and surface
area of intercalating cells.
(A) Schematic of morpholino injection and biotin labeling to visualize apical emergence. (B-D’’)
IF of Biotin label (red) and Multiciliated cells (purple) in CMO (B-B’’) and DspMO1 (C-D’’)
morphants (Scale bar = 50μm). Some intercalated cells in DspMO1 morphants have small apical
surface (white arrows, D). (E) Box and whisker plot depicting ratio of Intercalated cells/ Total
cells in CMO and DspMO1 morphants. (F) Box and whisker plot depicting ratio of Multiciliated
cells/ Total cells in CMO and DspMO1 morphants. (G, H) Histograms depicting frequency and
cumulative percentage of Surface Area of intercalated cells in a range of bin sizes in CMO (G) and
DspMO1 (H) morphants.
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Figure 1.15: Desmoplakin morphants (Part I) and F0 mutants (Part II) display abnormal
organization of keratin intermediate filaments.
(A-A’’) Immunofluorescence of keratin Type II (red) and membrane marked by β-catenin (green)
in control embryos. (C-C’’) Immunofluorescence of keratin Type II with retraction from
membrane in DspMO1 (Part I) and DspCRISPR1 (Part II) embryos. (E-E’’) Immunofluoresce nce
of keratin Type II with retraction from membrane in DspMO2 (Part I) and DspCRISPR2 (Part II)
embryos. Scale bar = 25µm. Inset: Magnified view of cell-cell junction. (B, D, F) Intensity profile
for red and green channels along yellow arrow for control (B), DspMO1 and DspCRISPR1 (D),
and DspMO2 and DspCRISPR2 (F) embryos. Arrow points to right side of the graph. Vertical
blue line represents position of white marker on arrow.
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Figure 1.16: Dominant-negative desmoplakin disrupts keratin linkage and is associated with
hyperpigmentation, reduced size, and cardiac defects.
(A) Schematic of wild-type Dsp (top) and a C-terminal deletion construct of Dsp, DP-NTP, tagged
with EGFP (bottom). (B-B’’) IF of desmoplakin in mGFP-injected embryos. (C) IF of Keratin in
mGFP-injected embryos. (D-D’’) IF of desmoplakin in DP-NTP-EGFP-injected embryos. (E) IF
of Keratin in DP-NTP-EGFP-injected embryos. (Scale bar = 20 µm). (F-G’) mGFP-injected (F)
and DP-NTP-injected (G) embryos at st. 30-31 with an enlarged view of the epidermis (F’, G’)
(Scale bar = 1 mm). (H) mGFP-injected at st. 40-41. (I) DP-NTP-injected embryos at st. 40-41
with cardiac defects and mild fin ruffling (white arrows) (Scale bar = 1 mm).
84

Table 1.8: Prevalence of phenotypes in Dsp morphants with p-values.
Phenotype

Control morphant (%)

Dsp Morphant (%)

p-value

3.62

39.8 (DspMO1)

3.34E-25

3.41

27.47 (DspMO2)

9.39E-12

6.16

29.25 (DspMO1)

8.03E-13

2.93

17.17 (DspMO2)

0.00039

0

16.33 (DspMO1)

2.31E-12

1.46

15.02 (DspMO2)

4.91E-07

5.45

44.77 (DspMO1)

5.61E-07

7.25

63.16 (DspMO2)

2.91E-12

1.82

53.23 (DspMO1)

6.79E-120

0

38.16 (DspMO2)

9.65E-09

1.82

17.74 (DspMO1)

8.51E-89

2.9

50 (DspMO2)

2.33E-10

Skin defect

Blister

Neural tube
defect

Eye defect

Fin defect

Cardiac edema
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Table 1.9: Prevalence of phenotypes in Dsp mutants with p-values.
Phenotype

Skin defect

Blister

Wild-type (%)

Dsp Mutant (%)

p-value

7.3 (DspCRISPR1)

0.00021

8.18 (DspCRISPR2)

5.64E-05

10.95 (DspCRISPR1)

1.46E-05

12.06 (DspCRISPR2)

2.83E-06

5.48 (DspCRISPR1)

0.00015

5.17 (DspCRISPR2)

0.00023

13.33 (DspCRISPR1)

1.62E-08

8.05 (DspCRISPR2)

0.0015

9.09 (DspCRISPR1)

7.61E-09

8.05 (DspCRISPR2)

0.00012

10.91 (DspCRISPR1)

4.08E-06

8.05 (DspCRISPR2)

0.00012

0.78

1.56

Neural tube
0
defect

Eye defect

Fin defect

Cardiac edema

1.41

0.47

0.47
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Table 1.10: Percentage of junctions with desmosomes in CMO and DspMO1 morphants.
Stage

Embryo

No. of
junctions
analyzed

Percentage of junctions

0
1
2
N≥3
desmosomes/ desmosome/ desmosomes/ desmosomes/
junction
junction
junction
junction
CMO

1

2

DspMO1

1

2

26

18

24

32

3.85

26.92

34.62

34.62

(n=1)

(n=7)

(n=9)

(n=9)

0

50

33.33

16.67

(n=0)

(n=9)

(n=6)

(n=3)

33.33

20.83

45.83

0

(n=8)

(n=5)

(n=11)

(n=0)

50

43.75

3.13

3.13

(n=16)

(n=14)

(n=1)

(n=1)
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SECTION 3: REGULATION OF CELL JUNCTION LOCALIZATION BY C-JUN NTERMINAL KINASE

Previous studies have demonstrated that JNK signals regulate adherens junction assembly
in cultured intestinal epithelial cells (Naydenov et al., 2009). JNK inhibition also protects against
E-cadherin internalization by EGTA-mediated calcium depletion in Xenopus epidermis (Houssin
et al., 2017). Therefore, the next step was to determine whether JNK also regulated desmosomal
junctions.

A. INCREASED JNK ACTIVITY IS ASSOCIATED WITH LOSS OF DESMOPLAKIN
First, the previously established constitutively-active JNK1 construct was injected into
embryos to determine whether JNK signals regulate junctional disassembly in the Xenopus
epidermis (Fig. 1.17A). This construct consists of a Mus musculus Map2k7β2 upstream of human
JNK1α1. Map2k7 (MKK7) activates JNK1 in a constitutive manner (Lei et al., 2002; Liao et al.,
2006). Wild-type embryos at st. 30-31 (35-38 hpf) were used as controls. Results revealed that
while controls had Dsp expression at the cell membrane, CA-JNK-expressing embryos had
decreased desmoplakin at the cell edges (70%, n=17, 3 experiments, Fig. 1.17B,C). Furthermore,
desmoplakin appeared to be present in cytoplasmically- localized globules in a subset of cells in
these embryos (Fig. 1.17C, arrows). These results suggest the possibility that increased JNK
activity reduces desmoplakin levels.
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B. DECREASED JNK ACTIVITY DURING GASTRULA STAGES IS ASSOCIATED
WITH INCREASED DESMOPLAKIN AT THE MEMBRANE
Increased JNK activity was associated with reduced desmoplakin. Therefore, a plausib le
hypothesis is that decreased JNK activity would have the opposite effect, i.e., an increase in
junctional desmoplakin.
To test this, embryos were treated with a JNK inhibitor, SP600125, at a concentration of
100µM from st. 14 (26 hpf) until st. 19 (31 hpf) (Fig. 1.17D). Normally at st. 19, desmoplakin is
punctate at the membrane. Results revealed that desmoplakin was increased in 72% of embryos
treated with SP600125 relative to controls (n=25, 3 experiments) (Fig. 1.17E, F). These results
suggest that decreased JNK activity might increase desmoplakin at the membrane.

C. DECREASED JNK FUNCTION IS ASSOCIATED WITH RESISTANCE TO EGTAMEDIATED DISPLACEMENT OF JUNCTIONAL PROTEINS
JNK inhibition was associated with increased desmoplakin at the junction. Also, inhibiting
JNK in cell culture and Xenopus embryos alleviated ethylene glycol-bis(β-aminoethyl ether)N,N,N',N'-tetraacetic acid (EGTA)-mediated internalization of E-cadherin (Houssin et al., 2017;
Naydenov et al., 2009). EGTA chelates available calcium in the medium causing internaliza tio n
of calcium-dependent junctions (Kartenbeck et al., 1991; Wallis et al., 2000). Therefore, the next
step was to determine whether JNK inhibition could also alter EGTA-mediated displacement of
desmoplakin in the Xenopus larval epidermis.
To test this hypothesis, st. 32 embryos were treated with a JNK inhibitor (SP600125) until
st.41 followed by a short EGTA (4mM) treatment (Fig. 1.18A). Results revealed that the epidermis
of control embryos (treated with EGTA) began to dissociate from the rest of the body after an
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average of 27 min. (Fig. 1.18D). On the other hand, embryos exposed to both the JNK inhib itor
and EGTA took on average 63 min longer to begin to dissociate (n=16, 2 experiments; Fig. 1.18E;
average time to begin dissociation=90 min.).
Next, desmoplakin was imaged by immunofluorescence in treated embryos to determine
whether there were changes in localization. Results revealed that in embryos treated with DMSO
or SP600125 alone, desmoplakin was maintained at the membrane (Fig. 1.18F,G). In the embryos
that only received EGTA, the desmoplakin appeared to be re-localized to the cytoplasm (n=16, 2
experiments; Fig. 1.18H). However, in embryos treated with both the JNK inhib itor and EGTA,
the desmoplakin was maintained at the membrane similar to controls that were treated with DMSO
or treated with SP600125 alone (n=16, 2 experiments; Fig. 1.18I). These results indicate that JNK
inhibition can protect the cells from the anti-adhesive effects of EGTA. Furthermore, JNK
inhibition appears to protect against the EGTA-mediated loss of adherens junction and desmosome
components from the membrane.

D. JNK INHIBITION ENHANCES THE MECHANICAL RESISTANCE OF
DESMOPLAKIN MORPHANTS
JNK inhibition prevented EGTA-induced displacement of desmoplakin and E-cadherin.
Additionally, overexpression of E-cadherin can compensate for Pemphigus vulgaris IgG-mediated
loss of desmosomal adhesion in cells (Rotzer et al., 2015), suggesting a role for E-cadherin in
mechanical resistance. Therefore, the next step was to determine whether JNK inhibition of Dsp
morphants improves the mechanical stress response. To test this, DspMO1 and control morphants
were treated with the JNK inhibitor (100μM SP600125) or control (DMSO) for 5 hours (st. 2226). The mechanical resistance of the SP600125- and DMSO-treated DspMO1 and control
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morphants was evaluated using the “Impact Assay” (as described in section 2, Part III, A.1) (Fig.
1.19A). Results revealed that 77% of the DMSO-treated DspMO1 morphants had epidermal tears
(n=24, 3 experiments) (Fig. 1.19D,F). On the other hand, only 33% of JNK inhibitor treated
DspMO1 morphants had epidermal tears or disruptions (n= 21, 3 replicates, t-test, p= 0.005; Fig.
1.19E,F). These results present the possibility that blocking JNK function can increase mechanica l
resistance in the epidermis of desmoplakin-deficient embryos.
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Figure 1.17: Differences in JNK activity is associated with changes in desmoplakin pattern
at cell membranes.
(A) Schematic of experimental design for injection of constitutively-active JNK1 (CA-JNK). (BC) IF of Dsp (red) in WT (B) and CA-JNK-injected embryos (C). Apparent cytoplasmicallylocalized globules of Dsp in (C) (white arrows) (Scale bar = 25µm). (D) Schematic of experimenta l
design for treatment of embryos with JNK inhibitor SP600125. DMSO is used as control treatment.
(E-F) IF of Dsp (green) in DMSO- (E) and SP600125-treated embryos (F) (Scale bar = 25µm).
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Figure 1.18: Decreased JNK activity is associated with resistance to EGTA-mediate d
internalization of junctional proteins.
(A) Schematic of experimental design for treatment of embryos with JNK inhibitor SP600125 and
EGTA. (B-E) Images of embryos after treatment with DMSO (B), SP600125 (C), DMSO+EGTA
(D), and SP600125+EGTA (E). (F-I) IF of desmoplakin after treatment with DMSO (F), SP600125
(H’), DMSO+EGTA (H), and SP600125+EGTA (I) (Scale bar = 50μm).
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Figure 1.19: JNK inhibition enhances the mechanical resistance of desmoplakin morphants .
(A) Schematic of treatment of embryos with JNK inhibitor SP600125 followed by mechanica l
assay. (B-E) Images of embryos after mechanical assay of CMO+DMSO (B) CMO+SP600125
(C), DspMO1+DMSO (D), and DspMO1+SP600125 (E) (Scale bar = 1 mm). (F) Graph depicting
proportion of embryos with damaged epidermis after mechanical assay.
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DISCUSSION

Diseases of the desmosome often result in abnormalities in the skin, heart, and hair follic le.
This causes increased susceptibility to skin infections and cardiac disorders, the latter of which can
be fatal during teenage years. One way to help affected individuals is by targeting signaling
pathways that contribute to the pathophysiology of the disease. Hence, creating animal models of
desmosomal disease can facilitate the study and development of therapeutic strategies. This study
here uses antisense morpholinos and the CRISPR/ Cas9 system to reduce the levels of the
desmosomal protein, desmoplakin, in Xenopus embryos. Abnormalities are present in the
epidermis and desmosome ultrastructure already described in previous literature (Gallicano et al.,
2001). Furthermore, there are anomalies in the development of other embryonic structures such as
the orofacial region. Perturbations in morphogenesis, including radial intercalation of distinct cell
types into the outer layer of the developing epidermis also occur. Additionally, this study
demonstrates a potential role for c-Jun N-terminal kinase (JNK) in regulating desmosome
assembly in vivo.

Desmosome structure and development is highly similar in the frog embryonic epidermis
The

desmosome

structure

in

the

Xenopus

embryo

is

similar

to

other

vertebrates. Ultrastructurally, the desmosome appears as a distinct electron-dense cytoplasmic
plaque adjacent to the plasma membrane (Berika and Garrod, 2014; Farquhar and Palade, 1963,
1965). This structure is similar to desmosomes observed in the adult skin and tadpole of X. laevis
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(Borysenko and Revel, 1973). Importantly, it also resembles those observed in humans, mice and
zebrafish (Fleming et al., 1991; Garrod and Chidgey, 2008; Goonesinghe et al., 2012; Holbrook
and Odland, 1975). Desmosomes in Xenopus embryos were infrequently observed to possess a
“midline”. Midline-containing desmosomes are also observed as early as blastocyst stages in the
mouse (Fleming et al., 1991). Such a midline is thought to indicate a mature desmosome. Evidence
in mouse epidermis and tissue culture also suggests that such desmosomes might also be
“hyperadhesive” (Garrod and Kimura, 2008; Garrod et al., 2005; Hobbs and Green, 2012).
Hyperadhesive desmosomes are insensitive to calcium depletion, which is normally required for
desmosomal cadherin dimerization. Tissue remodeling, which occurs frequently in a developing
embryo, would require that some desmosomes be more dynamic and therefore, not hyperadhesive.
This is indeed the case in the early mouse embryo which initially has calcium-depende nt
desmosomes that lack a midline. Desmosomes then develop a midline and become hyperadhesive
between E12-E14. Hyperadhesive desmosomes can also revert to calcium-dependence in the
mouse trophectoderm, which might be required to facilitate cell migration (Kimura et al., 2012).
Thus, the presence of a hyperadhesive or mature desmosome in an early embryo might indicate
the need for tissue stability at certain times during development.
Consistent with the structural observations of Xenopus embryonic desmosomes, molecular
studies indicate the presence of desmosomal cadherins in the epidermis of the X. laevis adult (Ohga
et al., 2004). RNAseq analysis of the X. laevis transcriptome also reveals the expression of
Desmoglein 2, Desmocollin 3, and Desmoplakin, in the embryo beginning in cleavage stages
(Session et al., 2016).
Not only does the Xenopus desmosome share structural similarities, it may also increase in
numbers as the embryo develops across vertebrates. There was a quantitative increase in the
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number of epidermal desmosomes per junction in the outer epidermal layers in the Xenopus
embryo between gastrulation and neurulation. Similarly, in the mouse embryo, desmosome
numbers per junction increase between the cleavage and blastocyst stages (Fleming et al., 1991).
In the developing human epidermis, desmosome numbers increase between the 9th and 20th weeks
of gestation (Dale et al., 1985; Holbrook and Odland, 1975). Although the observations in
Xenopus, mouse, and human are recorded at different timepoints, this data indicates that there is
an increase in desmosomal numbers per junction as the vertebrate embryo develops. This trend
coincides with epidermal development in the Xenopus embryo. During this time, the ectoderm
undergoes migratory movements such as convergent extension and radial intercalation and begins
to express epidermal differentiation markers (Jonas et al., 1985; Nieuwkoop and Faber, 1967;
Wilson and Hemmati-Brivanlou, 1995). Maintaining an adhesive outer layer while these dynamic
processes occur is crucial. The vitelline membrane, which normally protects the embryo from
external forces, is also gradually lost after neurulation as the embryo becomes increasingly motile.
Thus, the increase in desmosomes might facilitate stronger intercellular binding to form an
epidermis that has greater adhesion and protective capabilities.
At later stages in the Xenopus embryo, desmosome numbers continued to increase and
began to appear between inner and outer cell layers. During tadpole stages, desmosomes are
present between cells within the inner layer. Similarly, such findings are reported in the developing
human fetal epidermis (Dale et al., 1985; Holbrook and Odland, 1975). Specifically, desmosomes
are observed between the periderm and basal layers of the developing epidermis. As the huma n
epidermis undergoes stratification beginning at the 9th gestational week, desmosomes begin to
appear between the new layers as well (Dale et al., 1985). Thus, the appearance of these
desmosomes may serve to further strengthen the epidermal tissue.
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Together, the similarity in desmosome structure and development between Xenopus and
mammalian models indicate that the frog is a practical model for the study of desmosomes in the
embryo.

The Xenopus desmoplakin gene and protein are highly similar to mammalian homologs
Our analysis revealed that desmoplakin, a component that is unique to and present in all
desmosomes, is highly similar between Xenopus and mammalian homologs. The Xenopus dsp.L
coding region contains 24 exons similar to the human and mouse homologs (Green et al., 1999).
The Xenopus Dsp.L protein also shares a high degree of similarity with mouse and human
homologs. Furthermore, the three functional domains of Dsp, the plakin, rod, and C-terminal were
predicted to be present and shared a high degree of similarity with the corresponding domains in
mammalian Dsp. Thus, the high degree of similarity between Xenopus and mamma lia n
desmoplakin at the whole protein and domain level suggests that function might also be conserved
across species. This further validates the frog model as an ideal model for the study of
desmoplakin.

The Xenopus desmoplakin L and S homologs are highly similar except in the plakin domain
Genome annotation in X. laevis reveals the presence of Dsp on each subgenome, Dsp.L
and Dsp.S. Comparative analysis revealed a high degree of similarity between the domains of
Dsp.L and Dsp.S homologs. However, while the dsp.L and dsp.S gene coding regions share 91%
identity, the coding region of dsp.S only contains 22 exons, where the missing exons correspond
to exons 11 and 12 in dsp.L. Closer inspection of the individual domains revealed differences in
the SR56/ SH3 plakin subdomains. This region corresponds to the missing exons in dsp.S. Further,
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RNAseq data reveals that both homologs are differentially expressed in the embryonic stages as
well as adult tissues (Session et al., 2016). Dsp.S has relatively higher expression until the gastrula
stages (st. 10) and this pattern reverses at neurulation stages (st. 15). In adult tissues, both homologs
are expressed in the skin, eye and heart tissues, although at differing levels. The high degree of
similarity between the homologs suggests that the differential expression patterns might only
persist as an ancestral mechanism that was not subject to selection. However, the expression of
both Dsp homologs simultaneously suggests an overall higher gene dosage requireme nt.
Investigating the mechanism of transcriptional regulation of each homolog might provide insight
into differences in expression. Although not analyzed in this study, only one of the two Dsp
morpholinos was predicted to target both the Dsp.L and Dsp.S mRNA, while the other is predicted
to target only Dsp.L. This is based on the number of mismatches between the morpholino and the
homolog. Therefore, it might be expected that targeting both homologs might have a more
detrimental effect than if only one homolog was targeted. Both Dsp morphants present with the
same phenotypes with similar severities, suggesting that 1) Dsp.L is the major homolog expressed
with minimal contribution from Dsp.S or 2) both homologs are targeted by the morpholino even
though one is not predicted to be targeted. One way to confirm this is to perform a qRT-PCR of
the Dsp.S mRNA in both morphants. Alternatively, designing morpholinos that are can bind to
homolog-specific regions can tease apart the relative importance of each homolog.

Deficient desmoplakin in X. laevis results in defects in epidermis and the heart
The desmoplakin morphant and F0 mutant Xenopus embryos were able to progress through
gastrulation without any apparent defects, similar to the Dsp knockout mouse (Gallicano et al.,
2001). Also comparable to mouse embryos lacking desmoplakin, defects became apparent after
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this stage. This coincides with the increase in desmosome number, suggesting that desmoplakin
and desmosomes might have a more significant role post-gastrulation.
The most distinct phenotype in Xenopus Dsp morphants and mutants was the smaller size
of the embryos. Mouse embryos lacking Dsp are also smaller (Gallicano et al., 2001). There are
several possibilities to explain the small size observed here. Preliminary data reveals a reduction
in cell division in the Xenopus Dsp morphants. A similar reduction in cell proliferation is reported
in the Dsp knockout mouse embryos (Gallicano et al., 2001). Smaller size could also be caused by
an increase in cell death in the embryo. However, while it was not determined whether Xenopus
embryos deficient in Dsp have increased cell death, no significant increase in apoptotic cells is
observed in the Dsp knockout mouse (Gallicano et al., 2001). Epidermal cell surface areas in
Xenopus Dsp morphants were smaller which could also account for a smaller size of the embryo.
Convergent extension, which facilitates expansion of the surface area in the developing embryo
and elongation along the anterio-posterior axis is partially regulated by cell adhesion (Shimizu et
al., 2005; Solnica-Krezel et al., 1996; Walck-Shannon and Hardin, 2014). For example, when
desmosomal cadherins Desmocollin 1 and Desmoglein 2 are decreased in zebrafish, convergent
extension

movements

are defective,

resulting

in reduced anterio-posterior

axis length

(Goonesinghe et al., 2012). Therefore, perturbations in this process may also occur as a result of
reduced desmoplakin. Finally, a failure of all the above processes in combination might culminate
in smaller embryo size in Dsp morphants.
Xenopus Dsp morphants and mutants also exhibited epidermal blistering. Such blistering
is also documented in plakoglobin- and epidermis-specific Desmocollin 3-knockout mouse models
as well as patients with desmosomal diseases such as pemphigus (Bierkamp et al., 1996; Chen et
al., 2008; Mahoney et al., 1999; Payne et al., 2004). Blistering can occur as a result of loss of
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keratinocyte adhesion or acantholysis. Therefore, reduction of Dsp in Xenopus embryos exhibit
blisters probably due to impaired adhesion between cell layers.
The skin of Xenopus embryos lacking Dsp was more fragile to mechanical perturbations
such as impact and shear forces. Such fragility is also present in human patients with desmosomal
diseases such as ectodermal dysplasia and skin fragility syndrome, which is caused by Plakophilin1 mutations (Jonkman et al., 2005; McGrath et al., 1997; Whittock et al., 2002). Additiona lly,
mouse knockout models of plakoglobin, desmoglein 3, and desmocollin 1 exhibit epidermal
fragility (Allen et al., 1996; Bierkamp et al., 1996; Chidgey et al., 2001). Also, loss of desmoplakin
in mice can result in intercellular separation of epidermal layers and fragility to handling
(Gallicano et al., 2001; Vasioukhin et al., 2001). Therefore, this suggests that the sensitivity of the
Xenopus epidermis to mechanical forces might be a result of impaired desmosomal function which
also mimics mammalian models.
Cardiac defects were also present in Xenopus Dsp morphants and mutants. Such defects
are a prominent clinical feature of disorders of desmosomal proteins, including desmoplakin,
plakoglobin, plakophilin 2, desmoglein 2, and desmocollin 2 (Awad et al., 2006; Beffagna et al.,
2007; Gerull et al., 2004; McKoy et al., 2000; Norgett et al., 2000; Pilichou et al., 2006; van
Tintelen et al., 2006; Yu et al., 2008). The Dsp knockout mouse also has a collapsed heart with a
relatively low heart rate (Gallicano et al., 2001). Overall, the similarities in defects further validates
the applicability of the frog model for studies of the desmosome.
Besides the common phenotypes associated with desmosome disruption, such as epidermal
blistering or tearing and cardiac defects, other less common defects including hyperpigmentatio n,
neural tube and eye defects also occur in Xenopus Dsp morphants and mutants.
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Xenopus Dsp morphants and F0 mutants exhibited darkened patches of epidermis or
hyperpigmentation.

In animal models, melanin-containing

melanosomes

which influe nce

epidermal pigmentation are known to be translocated by actin cytoskeleton and intermed iate
filaments (Mayerson and Brumbaugh, 1981; Wasmeier et al., 2008; Wu et al., 1998). Actin and
microtubules are also involved in melanosome movement in Xenopus melanophores (Rogers and
Gelfand, 1998; Tuma et al., 1998). Here, keratin filaments appeared to be disrupted in Xenopus
Dsp morphants. A similar disruption of these filaments is observed in patients with epidermolys is
bullosa simplex with mottled hyperpigmentation caused by mutations in Keratin 5 (KRT5)
(OMIM:131960) (Bruckner-Tuderman et al., 1989; Uttam et al., 1996). Ultrastructural analysis of
hyperpigmented tissue in these patients reveals a perinuclear aggregation of melanosomes (Irvine
et al., 2001). While it was not determined whether melanosome aggregation occurs in Dsp
morphants, this suggests the possibility that disruption of the desmosome-keratin attachment or
changes in actin organization indirectly might affect distribution of melanosomes within cells.
Neural tube defects were observed in Xenopus Dsp morphants and mutants. In mice lacking
Dsp, neural tube defects were also reported (Gallicano et al., 2001). Notably, no human cases of
neural tube closure defects have been associated with defective desmosomes, although this might
be because of embryonic lethality.
Eye defects including abnormal RPE pigmentation were also present in Xenopus Dsp
morphants

and

mutants.

Dsp

was

detected

in

the

Xenopus larval

outer

corneal

epithelium. Similarly, in the bovine, Dsp is detected in the corneal epithelium (Messent et al.,
2000). Further, desmosomes persist at the corneal wound edge in vitro in rabbits (Kuwabara et al.,
1976). Pemphigus vulgaris patients with anti-Dsg3 antibodies also have severe blistering of eyelid

102

conjunctiva (Lifshitz et al., 2004). Together these results suggest that desmosomes are required in
the eye and that Dsp may play a role in the proper development of eye structures.

Xenopus Dsp morphants have reduction in desmosomes and changes in tissue architecture
A reduction in desmosomes per junction was observed in Xenopus embryos with deficie nt
Dsp. Further, 43% of junctions had no desmosomes. A similar reduction in size and number of
desmosomes is also reported in Dsp knockout mice (Gallicano et al., 1998). The intercellular gap
between cells in Xenopus Dsp morphants was also increased at junctions with few or no
desmosomes. In Dsp knockout mice also, there is a loss of adherence between cells (Gallicano et
al., 2001). Similarly, zebrafish Desmocollin 1 and Desmoglein 2 morphants have an increase in
intercellular gap when desmosomes are defective or absent (Goonesinghe et al., 2012). Therefore,
these results suggest that desmoplakin might be essential for desmosome assembly or stability.
However, an epidermis-specific Dsp knockout mouse displays no significant reduction in
desmosome number in suprabasal layers, although keratin filament attachment is still perturbed
(Vasioukhin et al., 2001). This might warrant further study to determine if desmoplakin acts as a
desmosome reinforcer further in development.

Xenopus embryos with deficient Dsp have defects in specialized cell types
Cell types such as multiciliated cells, small secretory cells, and ionocytes are specified and
intercalate into the outer epidermal layer in Xenopus larvae beginning sometime after gastrulatio n
(Dubaissi et al., 2014). These cells are thought to contribute to the protection of the larva against
bacterial infections (Stubbs et al., 2006). Xenopus embryos with deficient Dsp exhibited a decrease
in the number of cilia-positive multiciliated cells and PNA-positive small secretory cells. When
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cilia were present, they were shorter and fewer in number. The defective structures in these cell
types indicate that differentiation might be perturbed when Dsp is reduced. The development of
these cell types is controlled by many proteins. Forkhead transcription factors, Foxa1 and Foxj1
are involved in the differentiation of small secretory cells and multiciliated cells, respectively
(Dubaissi et al., 2014; Stubbs et al., 2008). Other transcriptional regulators such as multicilin and
its upstream regulator Gmnc are necessary for expression of ciliogenesis genes such as α-tubulin
(Stubbs et al., 2012; Zhou et al., 2015). Further, the planar cell polarity protein, Dishevelled, can
regulate the docking of basal bodies which is required prior to extension of cilia (Park et al., 2008).
However, there is no reported role for Dsp or desmosomes in multiciliated cell differentiatio n.
Instead, Dsp may indirectly regulate basal body docking and ciliogenesis. For instance, loss of the
basal body protein ninein results in impaired

primary cilia formation in U2OS human

osteosarcoma cells (Graser et al., 2007). Microtubule organization through ninein can, in turn, be
regulated by Dsp in epidermal keratinocytes (Lechler and Fuchs, 2007). Thus, although basal body
generation differs between monociliated cells (such as primary cilia) and multiciliated cells
(Brooks and Wallingford, 2014), Dsp may influence ciliogenesis in these cell types indirectly.
Together, these results suggest that Dsp may play a role in differentiation of these cell types by
regulating the development of specialized structures.

Desmosomes may play a novel role in radial intercalation
Here, multiciliated cells and small secretory cells were identified based on the expression
of a single marker for each cell type. Since a second marker was not used to confirm these results,
two main possibilities might explain these findings: 1) cells emerge but differentiation of these
cell types is perturbed, and 2) the emergence of cells from the inner layer is disrupted. The
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emergence of specialized cell types occurs through the process of radial intercalation (Deblandre
et al., 1999; Dubaissi and Papalopulu, 2011; Dubaissi et al., 2014). Therefore, a plausible
hypothesis is that radial intercalation is perturbed in embryos with deficient Dsp. Biotin labeling
assays confirmed that radial intercalation was slightly but significantly reduced in Xenopus Dsp
morphants.
Regulation of cell-cell and cell-extracellular matrix interactions can influence radial
intercalation (Walck-Shannon and Hardin, 2014). For example, cell-ECM interactions through
dystroglycan are required for radial intercalation to occur in the X. laevis epidermis (Sirour et al.,
2011). Inhibition of the Epidermal Growth Factor pathway leads to defects in E-cadherin turnover
and is correlated with reduced intercalation in the zebrafish blastoderm during epiboly (Morita and
Heisenberg, 2013; Song et al., 2013). There is also some evidence for proteins that regulate planar
cell polarity in this process. For instance, Par3 and Par6 are required for apical positioning of
CLAMP in intercalating cells of X. laevis epidermis. In turn, CLAMP promotes microtub ule
stabilization, which is thought to be required for intercalation (Werner et al., 2014). Loss of
function of another PCP protein, the Rab11 GTPase, results in defects in establishment of the
apical domain of multiciliated cells and, in turn, intercalation in X. laevis epidermis (Kim et al.,
2012). The results of this study suggest a possible role for desmoplakin in facilitating radial
intercalation.
Radial intercalation culminates when emerging cells “dock” in the outer layer. This is
followed by expansion of the apical surfaces of these cells. Xenopus embryos deficient in Dsp have
a significant reduction in apical surface area of intercalating cells. Occasionally, cilia-positive and
PNA-positive cells were detected in Xenopus Dsp morphants. However, these cells were situated
below the apical surface, appearing to be “stuck” between the two layers (data not shown).
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Together, these results suggest a problem with both apical emergence and expansion. The resulting
defective apical expansion could explain why cells have fewer cilia (in MCCs) or vesicles (in
SSCs). The decrease in apical surface area might prevent basal body or vesicle docking at the
apical membrane resulting in defective development of these structures.
Two of the three major cytoskeletal filaments, actin and microtubules, are implicated as
drivers of emergence and apical expansion in the Xenopus epidermis. These processes are partly
governed by cell-autonomous RhoA- and formin1-mediated actomyosin tractive forces through Ecadherin (Sedzinski et al., 2016, 2017). Further, CLAMP-mediated stabilization of microtub ules
at the apical region of intercalating cells is required for radial intercalation (Werner et al., 2014).
The current study reveals that keratin filaments are disorganized in Xenopus embryos with
deficient Dsp. Therefore, it is possible that intermediate filaments, which constitute the third major
cytoskeletal protein might also be involved in emergence and apical expansion of intercala ting
cells. However, further experiments will have to be performed to determine whether this is the
case.
In summary, there are two possible mechanisms through which radial intercalation is
regulated by the desmosomal complex. First, desmosomal adhesion might be necessary for traction
forces, which are found to be important for this process. Therefore, the loss of desmosomal
complex from cell contacts when desmoplakin is reduced possibly abrogates this tractive force
required for radial intercalation and expansion. Second, tractive forces through the keratin
filaments might also be crucial. Therefore, the disorganization of keratin filaments observed in
desmoplakin morphants might result in a reduction in transmission of these forces within the
intercalating cell (Fig. 1.20).
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C-Jun N-terminal Kinase (JNK) is a potential regulator of desmoplakin localization and
stability
Altering JNK signaling was correlated with changes in desmoplakin localization in
Xenopus embryos. JNK (c-jun N-terminal kinase), a MAPK protein, is activated by exposure of
cells to stressors including osmotic stress and radiation (Ip and Davis, 1998; Rosette and Karin,
1996). It regulates a wide variety of cellular processes including apoptosis, migration, and cell
division (Davis, 2000; Dong et al., 2001; Karin and Gallagher, 2005). JNK can also regulate
morphogenesis in the embryo, such as convergent extension movements (Kuhl, 2002); (Yamanaka
et al., 2002). JNK is also known to regulate cell junction proteins. Constitutively-active JNK1
disrupts E-cadherin organization at cell contacts in Xenopus embryos (Houssin et al., 2017).
Cytoplasmic puncta of E-cadherin are also observed in these embryos in conjunction with
membrane-localized clathrin, suggesting endocytosis in response to JNK activity. Additiona lly,
increased JNK activity is associated with disruption of adherens and tight junction proteins in
different epithelial cell types (Naydenov et al., 2009; Samak et al., 2011; You et al., 2013).
In the current study, several experiments reveal a correlation between JNK activity and
desmoplakin localization and adhesion. First, increased JNK activity was found to be correlated
with reduced membrane desmoplakin in Xenopus embryonic epidermis. Cytosolic clusters of
desmoplakin were also present in these embryos. Conversely, inhibiting JNK in the neurula ting
Xenopus embryo was associated with increased desmoplakin at cell contracts relative to controls.
Second, inhibition of JNK protected against cytosolic displacement of desmoplakin in the
presence of EGTA, a calcium chelator. The EGTA-induced desmoplakin dissociation assay is used
to demonstrate the occurrence of hyperadhesion or calcium-independent adhesion (Garrod et al.,
2005; Mattey and Garrod, 1986; Wallis et al., 2000). Following JNK inhibition, there is resistance
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to EGTA-mediated internalization of E-cadherin in Xenopus embryonic epidermis (Houssin et al.,
2017). Naydenov and colleagues (2009) also demonstrate an increase in phospho-JNK (active
JNK) following calcium depletion, further suggesting this increase in active JNK as a mechanis m
for EGTA-mediated loss of desmosome adhesion. Post-translational modification of desmosomal
proteins might influence stability or adhesion. For instance, phosphorylation of Dsp at specific
serine residues is associated with desmosome disassembly or loss of hyperadhesion (Dehner et al.,
2014; Kroger et al., 2013). This phenomenon is found to occur in a Protein Kinase C alpha (PKCα)dependent manner, although a direct interaction is yet to be demonstrated (Bass-Zubek et al., 2008;
Godsel et al., 2005; Hobbs and Green, 2012; Kroger et al., 2013; Sheu et al., 1989). Furthermore,
PKCα is an established regulator of desmosomal hyperadhesion in confluent cell culture and
wound edge epidermis (Garrod and Chidgey, 2008; Garrod et al., 2005; Wallis et al., 2000).
Similarly, JNK can also regulate cell adhesion and migration by phosphorylating cell junction
proteins including β-catenin and focal adhesion protein paxillin, respectively (Huang et al., 2003;
Lee et al., 2009). Therefore, JNK might regulate desmosomal hyperadhesion directly or indirectly
through phosphorylation of desmosomal proteins.
Third, the epidermis of Xenopus Dsp morphants displays increased resistance to
mechanical stress following JNK inhibition. Previous data reveals maintenance of adhesion against
EGTA-mediated calcium depletion in Xenopus embryos following treatment with a JNK inhib itor
(Houssin et al., 2017). E-cadherin is also not internalized in these embryos. Since the JNK pathway
is known to be involved in mechanotransduction, it is possible that JNK signaling might affect the
mechanical response of Xenopus Dsp morphants. For example, mechanical stretching can activate
JNK in multiple cell types in vitro (Ingram et al., 2000; Katsumi et al., 2005; Pereira et al., 2011).
Mechanically-activated JNK can further lead to cellular and morphological effects such as actin
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remodeling in endothelial cells and enhanced migration in human mesenchymal stem cells
(Mengistu et al., 2011; Yuan et al., 2012). Activation of JNK through mechanotransductive signals
can also induce osteoblast apoptosis (Matsui et al., 2014). However, the response of JNK to
mechanotransduction in these instances occurs over minutes or hours. The mechanical assays
performed here are virtually instantaneous, making it implausible that JNK-mediated increase in
adhesion is due to rapid modifications of desmosomal proteins. Instead, the inhibition of JNK
during the treatment phase might modify desmosomal adhesion. Dsp morphants still form some
desmosomes at cell-cell junctions. Preliminary data also reveals that E-cadherin is present at the
membrane in Dsp morphants but may be reduced. Therefore, JNK inhibition in Dsp morphants
might increase resistance to mechanical forces by strengthening adhesive contacts at existing
desmosomes and adherens junctions.
There are a number of plausible mechanisms through which JNK might be regulating
desmosome assembly or stability. First, JNK may directly interact with and phosphorylate
desmosomal or desmosome-associated

proteins,

leading

to conformational

changes and

disassembly. JNK phosphorylates the armadillo protein β-catenin leading to disruption of the
adherens junction (Lee et al., 2009; You et al., 2013). The adherens junctions and desmosomes are
analogous to each other since both junctions contain members of the cadherin and armadillo
protein families. For example, desmosomes contain plakoglobin, a member of the armadillo family
most closely related to β-catenin (Peifer et al., 1992). Further, plakoglobin has overlapping
functions with β-catenin, being able to interact with the same molecules (Zhurinsky et al., 2000).
Plakoglobin is also able to interact with Tcf/ Lef proteins, a β-catenin target in the canonical Wnt
signaling pathway (Kolly et al., 2007; Williamson et al., 2006). Therefore, plakoglobin might be
a hypothetical target for JNK phosphorylation in the desmosome. JNK phosphorylates β-catenin
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at the Ser37 and Thr41 residues (Lee et al., 2009; You et al., 2013). Both residues appear to be
conserved in plakoglobin as well, further suggesting that plakoglobin is a putative JNK target. JNK
also associates with the underlying intermediate filaments. JNK can phosphorylate keratin 8
leading to intermediate filament reorganization (He et al., 2002; Park et al., 2011). Thus, a
plausible hypothesis is that JNK phosphorylates plakoglobin or keratin (or both) leading to
desmosome disruption.
Second, JNK might regulate desmosome assembly through a transcriptional mechanis m.
In the current study, the JNK inhibition and activation paradigms were performed over many hours
or days. Therefore, it is possible that changes in desmoplakin localization observed are due to
JNK-mediated transcription. Inhibition of JNK in human epidermal keratinocytes over 48h leads
to over 2-fold transcriptional induction of desmosomal genes of suprabasal cells includ ing
Desmoglein 1 and Desmocollin 1 (Gazel et al., 2006). Also, JNK inhibition in HaCaT
keratinocytes alters expression of basal epidermal markers Keratin 5, Keratin 17, and Desmogle in
3 (Kitagawa et al., 2014). However, while changes to desmoplakin expression were not
investigated here, a microarray of JNK-inhibited Xenopus embryos did not reveal deregulation of
expression of any desmosomal genes. This suggests that JNK might differentially regulate
transcriptional control of desmosomal genes in different stages of development or differe nt
models.
Third, JNK activity might also regulate desmosome assembly indirectly through the
adherens junction. As mentioned above, inhibiting JNK activity leads to adherens junction
formation in many epithelial cell types (Naydenov et al., 2009; Samak et al., 2011; You et al.,
2013). There is also evidence to suggest that adherens junctions formation is a prerequisite to
desmosome formation. For instance, disruption of adherens junctions and classical cadherins delay
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desmosome assembly in keratinocytes and other epithelial cell types, although a detailed
mechanism is yet to be determined (Amagai et al., 1995a; Gumbiner et al., 1988). Therefore, JNK
activity might regulate desmosome formation indirectly through its effects on adherens junction
formation.
Fourth, JNK might regulate desmosome assembly though an endocytic mechanism. Upon
injection of constitutively-active JNK1 in Xenopus embryos, there is an increase in membranelocalized clathrin (Houssin et al., 2017). JNK might also remodel actin filaments near the
membrane through activation of the ezrin-radixin- moesin complex, which associates with
epithelial junctions (Ivanov et al., 2004b; Naydenov et al., 2009). Actin filament remodeling into
contractile F-actin rings is known to be required for endocytosis of epithelial junctions (Ivanov et
al., 2004a). While there are no direct JNK targets reported in this process, other MAPK proteins
have been shown to be involved in junction endocytosis. For instance, p38MAPK inhibitio n
prevents Pemphigus vulgaris IgG-mediated endocytosis of Dsg3 in keratinocytes (Jolly et al.,
2010). Moreover, this endocytosis is thought to occur through a caveolin-1-dependent mechanis m
(Delva et al., 2008). Therefore, JNK might regulate desmosome assembly dynamics through
control of the endocytic pathway.
In summary, there are many direct and indirect mechanisms through which JNK activity
might regulate desmosome assembly. Based on what is known about JNK-mediated assembly of
the tight and adherens junctions as well as interaction with keratin filaments, it is likely that the
JNK-mediated phosphorylation of desmosomal proteins, for example, plakoglobin, regulates
desmosome assembly (Fig. 1.21). On the other hand, JNK activity might also regulate desmosomal
gene expression based on evidence of this pathway occurring in mammalian tissues (Fig. 1.22).
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CONCLUSIONS AND FUTURE DIRECTIONS

The current study reveals roles for the desmosomal protein, desmoplakin, in the embryonic
epidermis using the Xenopus laevis model. In addition to phenotypes commonly observed with
desmosomal disruption, there are defects in neural tube closure and improper development of eye
structures. There is evidence for the presence of junctional desmosomes in these tissues. This
suggests that desmosomes are important for the morphogenesis of these tissues in the developing
embryo. Knowledge of fate maps in the Xenopus embryo makes it a convenient model to alter the
expression of desmoplakin (or other desmosomal proteins) in a tissue-specific manner. This
method is one way to determine the function of desmoplakin in specific tissues. Such experime nts
can verify whether some of the phenotypes observed in this study are a consequence of 1) loss of
desmoplakin function in the developing tissue itself or, 2) a non-specific effect due to disruptio n
of an earlier developmental process.
The results of the present study also reveal a relationship between desmosomes and radial
intercalation in the epidermis. Specifically, there are perturbations in both radial intercalation and
apical expansion when desmoplakin is reduced. Loss of desmosome from the cell contacts might
1) enhance the ability of cells to intercalate due to less resistance, or 2) hinder the process due to
less traction. The defective apical expansion might disrupt the final stages of differentiation and
development of specialized structures. Assembly of actin and microtubule cytoskeletal filame nts
are thought to partially regulate radial intercalation, implying that keratin filaments might also play
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a role (Sedzinski et al., 2016, 2017; Werner et al., 2014). Together, Dsp localization and Dspmediated linkage of keratin might act as mediators of radial intercalation (Fig. 1.20).
It is unknown whether Dsp and keratin attachment are required cell-autonomously or in the
neighboring cells to facilitate apical expansion. One way to test this is to perform donor transplants
of the outer epidermal layer prior to intercalation. This method involves removing the outer
epidermal layer of a desmoplakin morphant and replacing the outer epidermal layer of the “host”
control embryo or vice-versa. If desmoplakin or the desmoplakin- intermediate filament attachment
is required in the outer layer for intercalation, then donor transplants that have reduced
desmoplakin would exhibit reduced intercalation. If desmoplakin is required in the intercala ting
cell, then host embryos that have reduced desmoplakin would exhibit reduced intercalatio n.
Desmoplakin may also be required for proper organization of actin or microtubules which, in turn,
are known to be required for radial intercalation. Desmoplakin serves as a microtubule organizing
center in differentiated keratinocytes (Lechler and Fuchs, 2007). Desmoplakin loss is also
correlated with changes in actin cytoskeleton organization (Sumigray and Lechler, 2012;
Vasioukhin et al., 2001). In addition, disruption of the desmosomal complex in Dsp morphants
may lead to mislocalization of plakophilin 1, which is involved in actin cytoskeleton dynamics
(Hatzfeld et al., 2000). To determine whether actin or microtubule organization is affected,
immunofluorescence labelling of either filament can be performed.
Finally, data from this study highlights JNK as a possible regulator of desmosome
assembly and adhesion. Phosphorylation and other post-translational modifications of junctio na l
proteins is associated with control of junction assembly and adhesive strength. Alternatively, JNK
might regulate desmosome assembly through a transcriptional pathway. Junction remodeling is
crucial in tissues undergoing dynamic processes including morphogenesis, wound healing, and
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cell division (Garrod et al., 2005; Higashi et al., 2016; Thomason et al., 2012). Indeed, JNK activity
is high in the proliferating basal layer and relatively lower in differentiated suprabasal layers of
human neonatal foreskin epidermis (You et al., 2013). Collectively, there are at least two plausible
mechanisms through which JNK might regulate desmosome assembly and adhesion (Fig. 1.21,
1.22).
It is not yet known whether JNK interacts with desmosomal proteins as it does with proteins
in the adherens and tight junctions. Performing a Co-IP and mass spectrometry of proteins that
associate with JNK might give some insight into interactions. One caveat is the insoluble nature
of the desmosomal plaque. This characteristic makes it difficult to separate the desmosomal
proteins and therefore, study protein-protein interactions. However, new tools such as the biotin
ligase-based BioID can be utilized to screen for possible protein-protein interactions (Roux et al.,
2013). For example, a fusion protein of biotin ligase with JNK can be injected into embryos.
Performing a capture of biotinylated proteins in these embryos followed by mass spectrometry can
reveal if desmosomal proteins interact with JNK. If JNK-mediated phosphorylation of plakoglobin
leads to changes in desmosome assembly dynamics, a phospho-deficient mutant of plakoglobin
can be used. An expected result would be that overexpression of JNK would not affect desmosome
assembly. Alternatively, a JNK in vitro kinase assay can be performed with plakoglobin as a
substrate, which can then be analyzed for phosphorylation using mass spectrometry.
If JNK exerts direct transcriptional control, a ChIP-Seq can be performed following
treatment to determine whether cJun or the AP-1 complex are bound to promoter sequences. If
there are changes in the level of binding to desmosomal genes, it would suggest that JNK
transcriptionally regulates these loci. Alternatively, a bioinformatics analysis of promoter
sequences can be performed to identify consensus binding sites for cJun or the AP-1 complex.
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The assay to test for hyperadhesion also suggests that inhibiting JNK improves the
adhesiveness

of the desmosomal complex.

Specifically,

inhibiting

JNK might

lead to

conformational changes in the calcium-binding domain of the desmoglein or desmocollins (Fig.
1.23). One way to test this hypothesis is to image desmosomes using TEM to determine if there
are more desmosomes with a midline, which is thought to represent a hyperadhesive desmosome.
Since altering JNK activity has effects on desmosomal assembly and adhesion, it might
influence radial intercalation as well. For instance, one plausible hypothesis is that overexpressio n
of JNK leads to reduced intercalation due to reduction in desmoplakin at cell contacts.
The results of this study have possible applications in treating human desmosomal disease.
For example, inhibition p38MAPK alleviates some of the pathogenic effects of Pemphigus
Vulgaris IgG in tissue culture, such as endocytosis of Desmoglein 3 (Saito et al., 2012). A plausible
hypothesis is that inhibition of JNK might also prevent Desmoglein 3 internalization, similar to
the effects observed in Xenopus epidermis.
In conclusion, the present study validates the use of the frog as a tractable model for the
study of desmosomes. The study also demonstrates potential functions for desmoplakin and
desmosomes in regulating epidermal morphogenesis and radial intercalation in the embryo.
Finally, JNK is identified as a potential regulator of desmosome assembly and adhesion. This
implicates JNK as a new therapeutic target in desmosomal disease treatment. Further investiga tio n
into the mechanism of JNK-mediated regulation of the desmosome might reveal its efficacy in
treating human disease.
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Figure 1.20: Desmoplakin is a potential mediator of radial intercalation.
(A) Radial intercalation in a normal embryo occurs through a step-wise process of apical
emergence followed by apical expansion and development of specialized characteristics such as
cilia in a multiciliated cell. This probably occurs through enrichment of Dsp. (B) Radial
intercalation in embryos with deficient Dsp is faulty, possibly due to defective apical emergence
and expansion, leading to smaller apical surface and defective development of specialized
structures such as fewer and shorter cilia.
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Figure 1.21: Model for JNK-mediated regulation of desmosome assembly through posttranslational modification.
(A) A desmosomal complex at the cell-cell junction. (B, C) Increased JNK activity might lead to
direct or indirect phosphorylation of desmosomal proteins such as plakoglobin (Pg) and keratin
filaments. (D) Phosphorylation probably leads to keratin detachment and internalization of
desmosomal components.

118

Figure 1.22: Model for JNK-mediated regulation of desmosome assembly through
transcriptional changes.
(A) Increased JNK activity might lead to reduced expression of desmosomal genes such as
desmoglein (Dsg), desmocollin (Dsc), plakoglobin (Pg), and desmoplakin (Dsp). (B) These
changes in expression might reduce the number of desmosomes at cell contacts as the embryo
develops.

119

120

Figure 1.23: Model for JNK-mediated regulation of desmosome hyperadhesion.
(A) Exposure to EGTA triggers calcium chelation which results in loss of calcium-depende nt
binding. (B) Reducing JNK activity prior to EGTA-mediated calcium chelation protects the
desmosome from internalization by probably leading to a more organized structure and calciumindependence.
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CHAPTER 2:FAST AND EFFICIENT CRISPR/ CAS9 DESIGN FOR GENERATION OF
XENOPUS LAEVIS DESMOPLAKIN MUTANTS

INTRODUCTION

This protocol presents a method for the generation of desmoplakin (Dsp) mutants in Xenopus
laevis. First, a gene-specific single guide RNA (sgRNA) was designed and synthesized as a double
stranded DNA (dsDNA) template with an RNA polymerase binding site and loop sequence. This
template was then transcribed into an oligo containing the sgRNA target site and loop sequence.
Then, sgRNA along with Cas9 protein were injected into the embryo at an appropriate
developmental stage based on whether whole embryo or tissue-specific targeting is required. DNA
was then extracted from F0 mutants and analyzed with the T7 endonuclease I assay to determine
if mutations were present. This protocol also describes methods to sequence the sgRNA target site
to identify specific mutations.
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RELATED INFORMATION

Some methods described here are partially adapted from a protocol used for generating mutants in
zebrafish (Danio rerio) (Shah et al., 2016). Additional considerations for efficient sgRNA design
have been described elsewhere (Doench et al., 2016; Doench et al., 2014; Xu et al., 2015).
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MATERIALS

REAGENTS
Agarose gel (3% [w/v] in 1X TAE buffer)
Prepare as 1:1 ratio of regular agarose (1.5% [w/v]) and Super Fine Resolution agarose
(1.5% [w/v]). This mix is easier to dissolve and has high resolution.
Alkaline Lysis Buffer (1X)
Prepare fresh from 50X stock (25mM NaOH, 0.2mM Na 2+-EDTA).
Cas9 protein
Store at -80°C.
Ethanol (70% [w/v], prepared in nuclease-free water)
Lithium chloride precipitation solution
Store at -20°C.
MEGAscript T7 transcription kit
Store at -20°C.
Modified Barth’s Solution (MBS) (0.1X)
Na2+-EDTA (0.25M)
NEBuffer 2 (10X)
Neutralization buffer (1X)
Prepare fresh from 50X stock (40mM Tris-HCl).
Nuclease-free water
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PCR product purification kit
Phusion PCR Master Mix
Store at -20°C.

Scaffold Oligo (PAGE purified)
5’GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTA
ACTTGCTATTTCTAGCTCTAAAAC-3’

T7 endonuclease I (M0302, NEB) Store at -20°C.
This is used to detect heteroduplex DNA resulting from CRISPR/ Cas9-mediated
mutagenesis.

Xenopus laevis embryos, stage of interest
Embryo jelly coat must be removed completely prior to microinjection. See Dejellying
Xenopus laevis Embryos (Sive et al., 2007) for more details.

EQUIPMENT
Dissecting or stereoscopic microscope
Equipment for injecting Xenopus embryos
see Microinjection of Xenopus Embryos (Sive et al., 2010).
Forceps
Freezer, -20°C and -80°C
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Gloves, powder-free
Incubator, 15-23°C
Microcentrifuge
Micropipettors, 2-, 20-, and 100-µl, with corresponding tips
Microwave oven
PCR tubes, 0.2ml, as needed
Petri dishes, polystyrene
Pipette pump
Alternatively, a transfer pipette can be used.
Spectrophotometer
Thermal cycler, with Ramp function
Tissue grinder or pestle (optional; see Step 22)
Vortex mixer
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METHOD

A. DESIGN OF GENE- AND HOMOLOG-SPECIFIC sgRNA TEMPLATE

1. Obtain coding sequence in the Xenopus laevis genome on Xenbase (xenbase.org).

2. Determine if Dsp is present on the Long (L) and Short (S) chromosomes.

X. laevis is an allotetraploid, therefore, there are subgenome homologs of Dsp on both the L and
S chromosomes (Graf and Kobel, 1991; Session et al., 2016). This step helps in identifying
conserved sequence motifs between both subgenome homologs.

3. Ensure that exons in the coding region of all homologs are present.

Creating mutations in exons can result in successful loss of function. Exons are also preferable
because many X. laevis genes have incompletely sequenced introns (except when proximal to exon
boundaries) making them unreliable targets.

4. Use individual exons as targets in a prediction software and run the program to obtain the most
efficient sgRNA(s) against a target region.
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The

CHOPCHOP

tool

was

used

to

predict

sgRNA

targets

in

Xenopus

laevis (http://chopchop.cbu.uib.no/).The sgRNA sequence generated was a 23 bp oligonucleotide
which includes a 3 bp NGG protospacer-adjacent motif (PAM) at the 3’ end. The target region
was chosen as close to the N-terminus or within well-characterized functional domains (Shi et al.,
2015a). In order of preference, the first two nucleotides of this sequence should be
GG>GA=GT>GC for efficient transcription by T7 RNA polymerase (Milligan and Uhlenbeck,
1989; Shah et al., 2015). Multiple sgRNAs each targeting different exonic regions were chosen.
This ensures specificity of phenotypes (Shah et al., 2016).

To target one subgenome homolog:
i. Choose an sgRNA with >3nt mismatches between homologs, preferably within 8-12 base pairs
proximal to the PAM site.

Alternatively, choose a region not conserved between subgenome homologs. Greater than 5
mismatches can increase off-target mutagenesis (Fu et al., 2013). Therefore, it is always important
to determine off-target site binding (for example, by performing a BLAST search).

To target both subgenome homologs:
ii. Choose an sgRNA with <3nt mismatch between homologs.

IMPORTANT: Mismatches should not lie within the PAM sequence or 8-12 base pairs proximal
to the PAM site when targeting both homologs.
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Alternatively, choose a perfectly matched sgRNA for each homolog which will be injected together.
In some cases, type and position of mismatch may either reduce or have no effect on efficiency
(Doench et al., 2016). Here, sgRNAs were designed to target two different exons in X. laevis Dsp
(Chapter 1, Table 1.3).

B. SYNTHESIS OF sgRNA

As stated above in Section I, the software generates a 5’-(N)20 -NGG-3’ sequence, where NGG is
the PAM sequence. This PAM sequence is required for targeted binding and cleavage by Cas9
(Jinek et al., 2012; Sternberg et al., 2014). However, only the 5’-(N)20 -3’ sequence is incorporated
into the guide oligo.

5. To the desired sgRNA sequence (without PAM), add AATTAATACGACTCACTATA to the
5’ side and GTTTTAGAGCTAGAAATAGC to the 3’ side. This will result in an oligo that is 60
bp long (5’-AATTAATACGACTCACTATA-(N)20 -GTTTTAGAGCTAGAAATAGC-3’).

The 5’-AATTAATACGACTCACTATA-3’ oligo on the 5’ side contains the T7 RNA polymerase
minimal promoter sequence to facilitate transcription. The 5’-GTTTTAGAGCTAGAAATAGC-3’
oligo on the 3’ side is an overlap with the loop-sequence oligo.

6. Order the 60 bp oligo above and the 80 bp scaffold oligo.
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Since both oligos are long, PAGE purification was performed to remove smaller oligos that are a
byproduct of synthesis. The scaffold oligo partially overlaps with the 60 bp oligo in Step 5 and
contains the loop sequence for Cas9 interaction (Hsu et al., 2014; Jinek et al., 2012).

7. Prepare both oligos as 100μM (stock concentration) and 10μM (working concentration) aliquots
in nuclease-free water.

Primers can be stored at -20°C. Stocks can even be stored at -80°C with minimal freeze-thaw
cycles for longer shelf life.

8. Synthesize the dsDNA template for transcription using the following Reaction mix and Protocol.

Reaction mix:

Reagents

Volume

2X Phusion Master Mix

12.5μl

60 bp oligo (10μM)

5μl

80 bp scaffold oligo (10μM)

5μl

Nuclease-free water

2.5μl

Total

25μl
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Protocol:

i. 98°C for 30s.
ii. (98°C for 10s, 61°C for 10s, 72°C for 15s) X 45 cycles.
iii. 72°C for 5 min.
iv. 4°C hold.

This reaction yields a 120 bp dsDNA PCR product. Optional: Run 1μl on a gel to ensure the
product is synthesized and of appropriate size.

9. Clean the PCR product using DNA concentrator columns, eluting and dissolving in the smallest
volume of nuclease-free water.

Measure concentration with a spectrophotometer. Ideally, a concentration of 200‐300 ng/μl
should be achieved.

10. Use the clean PCR product as the template for the RNA in vitro transcription (IVT) kit
(MEGAscript T7) using ~100ng of the PCR product per reaction. Set up 2 reactions and pool
together before next step.

Follow manufacturer’s protocol for IVT.

11. Stop the reaction by adding 1μl DNase and incubating at 37°C for 15 minutes.
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12. Add 60μl Lithium chloride and 60μl nuclease-free water and incubate at -20°C overnight.

13. Centrifuge at maximum speed at 4°C for 30 minutes.

14. Remove supernatant.

Pellet should be visible. If not, amount may be insufficient. Scale up IVT reaction as required.

15. Add 1ml of freshly-prepared 70% ethanol and centrifuge at maximum speed at 4°C for 10
minutes.

16. Discard ethanol and spin for 10s at maximum speed to remove residual ethanol.

17. Air dry and elute in 7-10μl nuclease-free water.

Optional: Quantify a diluted sample. Store RNA at ‐80°C.

C. MICROINJECTION OF XENOPUS EMBRYOS

We performed titrations of sgRNA and Cas9 protein to rule out toxicity effects in addition to using
multiple sgRNAs. The concentrations of sgRNA mentioned here were found to be appropriate for
mutagenesis of Dsp. It is also recommended to first perform positive or negative controls
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(preferably both) when determining the function of a gene not tested in Xenopus before. A positive
control targets a gene that is thought to be involved in the same process as the gene of interest and
allows setting a threshold for phenotypic screening. A negative control targets a gene not involved
in that process and provides a measure of natural variability for that phenotype. It can also give
information about toxicity or stress effects of the reagents or the injection itself (Shah et al., 2016).

18. Prepare 830ng/μl aliquots of sgRNA (in nuclease-free water) and 2μg/μl aliquots of Cas9
protein.

Store sgRNA and Cas9 protein at ‐80°C, avoiding repeated freeze-thaw cycles.

19. On the day of injection, mix Cas9 and sgRNA(s) to final concentration of 750ng/μl (Cas9) and
500ng/μl (sgRNA).

20. Inject ~2nl per embryo at 1-cell stage (1.5ng Cas9 and 1ng sgRNA/ embryo). Perform
microinjections as described in Microinjection of Xenopus Embryos (Sive et al., 2010).

The amount of sgRNA and Cas9 can depend on factors such as functional redundancy, and
whether the protein function is cell-autonomous or can be rescued by wild-type cells. For best
results, inject and culture embryos in 15°C 0.1X MBS to delay the first mitotic division.
For mosaic embryos, perform injections at 4-cell stage. Alternatively, since fate maps are wellcharacterized in X. laevis, perform injections at 16- to 32-cell stage to target only a specific subset
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of cells or tissues (Dale and Slack, 1987; Moody, 1987; Moody and Kline, 1990). Adjust
concentrations and injection volumes accordingly.

D. DNA EXTRACTION FROM F0 MUTANT EMBRYOS

A quick diagnostic test of successful mutation by CRISPR/ Cas9 is the presence of phenotypic
changes. Dsp F0 mutants mimicked phenotypes observed in Dsp morphants but at lower
prevalence (Chapter 1, Fig. 1.9-1.10). The tyrosinase genes, tyra and tyrb, were also targeted to
determine the effect on morphology of F0 mutants (Wang et al., 2015). Embryos injected with
sgRNAs targeting both tyra and tyrb developed normally except for defects in pigmentation
patterns (Fig. 2.1B-D). Similar to reports in (Wang et al., 2015), there was phenotypic variability
in the amount of pigmentation lost.
However, absence of phenotypes suggests a number of explanations. As mentioned above, these
may include low mutagenesis rate coupled with rescue by wild-type cells, and unknown
functionally-redundant genes. Alternatively, the gene of interest may not be mutated at all. In most
cases, DNA will have to be extracted to determine presence of mutations in the genome.

21. Place one embryo per PCR tube on ice. Remove any medium with a pipette.

Here, we use embryos at stage 30-31 (35-38hpf) but use any stage after stage 20 (22hpf) to obtain
sufficient quantities of DNA.

22. Add 35µl 1X Alkaline Lysis Buffer and heat at 95°C for 40 minutes.
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Alkaline Lysis Buffer should be freshly prepared from 50X stock. Optional: Macerate embryos
with a pestle to increase yield.

23. Cool to 4°C.

24. Add 35μl of 1X Neutralization Buffer.

Neutralization Buffer should be freshly prepared from 50X stock.

25. Vortex lightly and store at -20°C. Spin with centrifuge every time before usage.

E. DETECTING MUTATIONS IN THE TARGET SEQUENCE
To confirm that mutations have occurred in the target region, there are a number of methods such
as high resolution melting (HRM) analysis and nuclease digest (Restriction Fragment Length
Polymorphism). Here, we provide a modified T7 endonuclease I assay from New England Biolabs,
Inc. (NEB) for fast and effective mutation analysis. This method relies on the random nature of
different indels and heteroduplex formation (Mashal et al., 1995).

26. Amplify the target region with specific primers using the following reaction mix and protocol.
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Reaction mix:
Reagents

Volume

2X Phusion Master Mix

15μl

Sample DNA

Variable (100ng)

Primers (10μM)

3μl each

Nuclease-free water

To 30μl

Total

30μl

Protocol:

i. 98°C for 30s.
ii. (98°C for 5s, 61°C for 10s, 72°C for 20s) X 35 cycles.
iii. 72°C for 120s.
iv. 4°C hold.

Primers should be designed to create products 200bp-1kb in size. Primers should be designed in
such a way that the target site is off-center within the amplicon so that digestion produces easily
resolvable DNA fragments.
IMPORTANT: At least one primer in the primer pair should be sufficiently different to be able to
distinguish between L and S homologs. Additionally, design primers such that amplicons from L
and S homologs are also distinctly different sizes to avoid ambiguity. Primer design for an sgRNA
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targeting both desmoplakin homologs is provided in Table 1.4. Primer design for an sgRNA
targeting both tyrosinase homologs is provided in Table 2.1.

27. Clean the PCR product using DNA concentrator columns, eluting and dissolving in nuclease free water.

28. Measure the concentration using a spectrophotometer.

29. Analyze the purified PCR product for mutations.

Reaction mix:

Reagents

Volume

Purified PCR product

Variable (200ng)

10X NEBuffer 2

2μl

Nuclease-free water

To 19μl

Total

19μl
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Protocol:

i. 95°C for 5 min.
ii. 95°C-85°C @ -2°C/s.
iii. 85°C-25°C @ -0.1°C/s.
iv. 4°C hold.

30. Add 1μl of T7 endonuclease I and incubate at 37°C for 15 min.

31. Stop reaction by adding 1.5μl of 0.25 Na2+-EDTA.

32. Run samples on an agarose gel to identify if mutations are present.

If mutations are not present, only one band of expected size will be observed. If mutations are
present, three bands are observed. The largest band is the expected amplicon size of the original
target. The remaining two bands are the products of cleavage of unmatched heteroduplexes. Their
combined size roughly equals the original size. An example for mutation analysis in the
desmoplakin homologs is shown in Fig. 1.6.
The T7 endonuclease I method is fast and requires no special equipment but does not provide
information about the specific nature of the mutation(s). As an alternative, we have also sequenced
the total PCR product to determine if mutations are present in the dsp.L homolog. However,
sequencing a heterogeneous mix of templates results in ambiguous base calling (Fig. 2.2).
Performing colony sequencing or Next Generation Sequencing of the PCR product mix can
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provide the specific nature of the different mutations. The colony sequencing method still only
provides a semi-quantitative measure of the mutation frequency. The NGS method is highly
quantitative but is also expensive (Shah et al., 2016).
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Figure 2.1: CRISPR/ Cas9 targeting of tyrosinase genes resulted in pigmentation defects.
(A) Wild-type embryo with normal pigmentation in head and trunk melanocytes and Retinal
Pigmented Epithelium of the eye. (B) tyra+tyrb CRISPR F0 mutants with severe loss of
pigmentation in head and trunk melanocytes and RPE. (C) tyra+tyrb CRISPR F0 mutants with
partial loss of pigmentation in head and trunk melanocytes and RPE. (D) tyra+tyrb CRISPR F0
mutants with relatively normal pigmentation in head and trunk melanocytes and RPE.
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Figure 2.2: CRISPR/ Cas9 induced mutations in target region of desmoplakin gene.
(A) Chromatogram of wild-type dsp.L homolog within target region of DspCRISPR1 sgRNA.
Target sequence is denoted by black double-headed arrow. (B-D) Chromatogram of DspCRISPR1
F0 mutant dsp.L homolog within target region of DspCRISPR1 sgRNA in Embryo 1 (B), Embryo
2 (C) and Embryo 3 (D). Red line indicates start position of sgRNA target in all samples. Bases
are color-coded as follows: Guanine=Black; Adenine=Green; Cytosine=Blue; Thymine=Red.
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Table 2.1: CRISPR gRNA sequences against tyrosinase homologs.
gRNA

gRNA sequence + PAM
(5’ –> 3’)

Tyra

GGGTCGATGATAGAGAGGAC TGG

Tyrb

GGCCCGTAGCAGAGCTGGTGAGG
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DISCUSSION

Xenopus laevis is an excellent and highly tractable model for the study of developmenta l
processes. Some advantages include large egg size for microinjections, large brood size, and gene
conservation. Still, constraints such as allotetraploidy, incompletely annotated genome, and time
to reach sexual maturity had presented challenges for the generation of genetic mutants. However,
recent developments have helped overcome some of these issues. For instance, open reading
frames in the X. laevis (and related X. tropicalis) genomes are rapidly being annotated on the
Xenopus genome database, Xenbase. This is tied with the identification of homologs on the Long
(L) and Short (S) chromosomes of X. laevis in addition to information about expression patterns
(Session et al., 2016). These milestones have made it possible to generate mutants and establish
mutant lines in Xenopus (Shi et al., 2015b).
The CRISPR/ Cas9 genome modification system was developed from an RNA-mediated
adaptive defense system naturally present in bacteria and archaea (Jinek et al., 2012; Wiedenheft
et al., 2012). Over the last five years, it has been employed for the creation of transgenic tissues
and whole organisms (Cong et al., 2013). In comparison to other recent genome-editing techniques
such as Zinc-finger nucleases (ZFN) and transcription activator-like effectors nucleases (TALEN),
this system has proven to be fast, scalable, and relatively easy to engineer in most laboratories
(Christian et al., 2010; Doudna and Charpentier, 2014; Miller et al., 2007; Miller et al., 2011;
Porteus and Baltimore, 2003; Wood et al., 2011). It has already been widely used in cells, mice,
Drosophila, C. elegans and zebrafish (Bassett et al., 2014; Friedland et al., 2013; Hisano et al.,
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2015; Yang et al., 2014). Until recently, morpholinos and TALENs were utilized for loss-offunction studies and transgenics in zebrafish and Xenopus (Christian et al., 2010; Heasman, 2002;
Nasevicius and Ekker, 2000). However, the CRISPR/ Cas9 system has been successfully used to
generate F0 mutants in X. tropicalis and X. laevis (Banach et al., 2017; Bhattacharya et al., 2015;
Nakayama et al., 2013; Wang et al., 2015). Additionally, other protocols exist for generation of
germline mutants in Xenopus sp. (Aslan et al., 2017).
In this protocol, we use an established PCR-based system of synthesizing a dsDNA
template that is transcribed into the sgRNA with appropriate CRISPR-targeting sequences
(Bhattacharya et al., 2015; Shah et al., 2016). This RNA is simply injected along with Cas9 protein
into the embryo or oocyte. In comparison to using a plasmid-based delivery system for sgRNA or
Cas9 mRNA, this method results in a relatively rapid rate of mutagenesis. Furthermore, the Cas9
protein has reportedly less toxicity than the mRNA (Bhattacharya et al., 2015). Only the 20nt guide
RNA will have to be custom-designed for the intended target.
Here, we have targeted the desmosomal structural protein, desmoplakin. A higher
concentration of sgRNA was necessary to see phenotypes when targeting dsp relative to
tyrosinase. Similarly, other groups also use lower amounts of sgRNA when targeting tyrosinase
(Bhattacharya et al., 2015; Wang et al., 2015). This is likely because of the cell-autono mo us
requirement for tyrosinase in melanophores (Cichorek et al., 2013; Iozumi et al., 1993). For
instance, there is variability in pigmentation loss in Xenopus tyrosinase mutants. Desmoplakin is
a structural cell junction protein and therefore desmoplakin loss may be necessary in a large
contiguous patch of tissue for phenotypes to be visible. Thus, higher levels of sgRNA could be
required due to rescue by neighboring wild-type cells in embryos with low dsp mutagene s is
efficiency.
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We provide a protocol for targeting both subgenome homologs and suggest methods to
only target one of the two homologs if desired. Also, steps to design homolog-specific primers for
mutation analysis are detailed here. Since the X. laevis is allotetraploid, many loci are present as
four copies within two ancestral subgenomes (Matsuda et al., 2015; Uno et al., 2013). This may
result in lack of phenotypes if both subgenome homologs are not targeted due to potential
redundancy. This may not necessarily be the case for genes that have variable expression between
subgenomes. An RNAseq transcriptome analysis details this variability between loci (Session et
al., 2016). Additionally, some genes exist only as a diploid state on either the ‘L’ or ‘S’
chromosome (estimated to be 17-40% of genes) (Hellsten et al., 2007; Session et al., 2016; Uno et
al., 2013). Therefore, taking into account these considerations while targeting a specific gene will
facilitate efficient mutagenesis.
Xenopus has historically been used extensively as a model to understand vertebrate
development. Knowledge about fate maps also makes it suitable for targeted mutagenesis. This
protocol can also be potentially used for other CRISPR/ Cas9 applications. For instance, CRISPR/
Cas9 can be used to generate knock-ins in Xenopus, which can be used to study the effects of
polymorphisms associated with human disease (Aslan et al., 2017). Expressing fusion reporters in
Xenopus has already been used to study Rho GTPase activity, cell shape changes, and other
dynamic processes (Davidson et al., 2008; Stephenson and Miller, 2017). Combining CRISPR/
Cas9 with fusion reporter-knock-in has the potential benefit of stable expression over a longer
period of development, although this remains to be tested. Applying transgenic approaches to
Xenopus can further add to the multitude of advantages already present in this model.
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APPENDIX

A.1. MULTIPLE SEQUENCE ALIGNMENT OF DESMOPLAKIN PROTEIN
REVEALED HIGHLY SIMILAR FUNCTIONAL DOMAINS
Pairwise alignments of whole desmoplakin protein homologs against X. laevis Dsp.L
revealed high sequence similarity. Multiple sequence alignments were performed using Clustal
Omega against X. laevis Dsp.L to visualize the extent of similarity between the homologs (Fig.
A.1). Overall, the sequences shared large regions of similarity within local stretches. These large
motifs correspond to important desmoplakin functional domains. This indicates that the X. laevis
Dsp.L homolog is largely conserved at the domain level with mammalian counterparts suggesting
a shared function.
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Figure A.1: Multiple sequence alignment of desmoplakin protein across species revealed
conserved sequence. Multiple sequence alignment of desmoplakin protein sequences in X. laevis
Dsp.L, human and mouse was performed with Clustal Omega (EMBL-EBI) using the HHalign
algorithm. The threshold for shading was set to 50% using the BOXSHADE tool (EMBL-EBI) in
the Clustal Omega generated sequence alignment. Start and End amino acid coordinates are
marked for all Dsp functional domains, including, Plakin domain, Rod domain, and C-terminal tail
domains (A,B,C) using arrowheads. Black shading denotes residues identical to X. laevis Dsp.L.
Gray shading denotes residues similar to X. laevis Dsp.L.
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A.2. SEQUENCE ALIGNMENT OF XENOPUS DESMOPLAKIN HOMOLOGS
REVEALED DIFFERENCES IN EXON NUMBER
While the X. laevis S subgenome has experienced more deletions, genes retained on both
subgenomes sometimes display differences in gene expression. Such homologous pairs are also
predicted to differ in coding sequence length (Session et al., 2016). The X. laevis Dsp.S homolog
had 96.5% of the length of the Dsp.L homolog. Therefore, alignments of the gene coding regions
of X. laevis Dsp.L and Dsp.S were performed to determine where the deletions occurred in the
coding region. Results revealed that while infrequent mismatches occurred in some regions, a very
large gap was present only in Dsp.S (Fig. A.2). This gap coincided with exons 11 and 12 of X.
laevis Dsp.L (Fig. A.3). This gap that is observed only in the X. laevis S homolog but not the L
homolog suggests that ancestral deletions occurred in Dsp.S.
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Figure A.2: Multiple sequence alignment of Xenopus desmoplakin protein revealed gap in
Dsp.S. Multiple sequence alignment of desmoplakin protein sequences of X. laevis Dsp.L and X.
laevis Dsp.S was performed with Clustal Omega (EMBL-EBI) using the HHalign algorithm. The
threshold for shading was set to 50% using the BOXSHADE tool (EMBL-EBI) in the Clustal
Omega generated sequence alignment. Black arrowheads denote exon 11 (X. laevis Dsp.L). White
arrowheads denote exon 12 (X. laevis Dsp.L). Black shading denotes residues identical to each
other. Gray shading denotes residues similar to each other.
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Figure A.3: Multiple sequence alignment of Xenopus desmoplakin coding regions revealed
gap in Dsp.S. Multiple sequence alignment of desmoplakin coding DNA sequences of X. laevis
Dsp.L and X. laevis Dsp.S was performed with Clustal Omega (EMBL-EBI) using the HHalign
algorithm. Black arrowheads denote exon 11 (X. laevis Dsp.L). White arrowheads denote exon 12
(X. laevis Dsp.L). Asterisk denotes identical residues.
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A.3. COMPARATIVE ANALYSIS OF PLAKIN SUBDOMAINS REVEALED
SIMILARITY ACROSS SPECIES
The results above revealed a high degree of similarity in plakin, rod and C-terminal
domains across species. The plakin domain consists of six spectrin repeats and an Src homology
3 domain (Fig. A.4). Therefore, performed pairwise alignments were performed between X. laevis
Dsp.L and mammalian Dsp homologs to determine the homology of these regions. Results
revealed that the SR34 domain of H. sapiens and M. musculus homologs each shared 88%
similarity with the corresponding domain in X. laevis Dsp.L (Table A.1). The SR56 domain of H.
sapiens and M. musculus homologs each shared 91% similarity with the corresponding domain in
X. laevis Dsp.L. The SR78 domain of H. sapiens and M. musculus homologs each shared 70%
similarity with the corresponding domain in X. laevis Dsp.L. The SR8-CT linker domain of H.
sapiens and M. musculus homologs each shared 77% similarity with the corresponding domain in
X. laevis Dsp.L. Comparative analysis of plakin subdomains between Dsp.L and Dsp.S also
revealed a high level of similarity. An exception was the SR56 subdomain, which only shared 60%
similarity. The predicted SH3 domain which lies within was truncated in Dsp.S (Fig. A.4).
Together, these results indicate that the plakin subdomains share a high degree of similar ity
between X. laevis Dsp.L and mammalian homologs. The Dsp.L and Dsp.S homologs shared
overall high similarity except in one domain. This region is where the deletion in Dsp.S lies and
very likely explains the relatively low homology.
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Figure A.4: Comparative bioinformatics analysis of the plakin domain in the desmoplakin
protein. (A) Comparative analysis of plakin subdomains in the desmoplakin protein between
vertebrate species and the X. laevis dsp.L homolog. Numbers below boxes depict amino acid
coordinates for each subdomain. SR=Spectrin Repeat; SH3=Src homology 3; CT=C-Termina l
region.
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Table A.1: Desmoplakin plakin subdomains comparative analysis against X. laevis Dsp.L.
Organism

X. laevis
(Dsp.L)
H. sapiens
M. musculus
X. laevis
(Dsp.S)

SR34
%Identity/
Similarity

SR56
%Identity/
Similarity

SH3
%Identity/
Similarity

SR78
%Identity/
Similarity

SR8-CT
%Identity/
Similarity

100

100

100

100

100

75.9/88.2

79.1/90.9

79.5/92.3

45.4/70.5

61.8/77.5

75.4/87.7

78.3/90.9

79.5/92.3

45.4/70.0

62.2/77.5

94.4/98.5

58.3/59.8

-

94.7/97.8

94.0/96.8

155

REFERENCES

Adams, M.J., Reichel, M.B., King, I.A., Marsden, M.D., Greenwood, M.D., Thirlwell, H.,
Arnemann, J., Buxton, R.S., Ali, R.R., 1998. Characterization of the regulatory regions in the
human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Biochem J 329 ( Pt 1), 165-174.
Aebi, U., Häner, M., Troncoso, J., Eichner, R., Engel, A., 1988. Unifying principles in intermed iate
filament (IF) structure and assembly. Protoplasma 145, 73-81.
Al-Jassar, C., Bernadomicron, P., Chidgey, M., Overduin, M., 2013. Hinged plakin domains
provide specialized degrees of articulation in envoplakin, periplakin and desmoplakin. PLoS One
8, e69767.
Al-Jassar, C., Knowles, T., Jeeves, M., Kami, K., Behr, E., Bikker, H., Overduin, M., Chidgey,
M., 2011. The nonlinear structure of the desmoplakin plakin domain and the effects of
cardiomyopathy- linked mutations. J Mol Biol 411, 1049-1061.
Alberts, B.B., D.; Lewis, J.; Raff, M.; Roberts, K.; Watson, J.D., 1994. Cell junctions, Molecular
Biology of the Cell (3rd edn.). Garland Publishing, New York (1994), pp. 950-963.
Allen, E., Yu, Q.C., Fuchs, E., 1996. Mice expressing a mutant desmosomal cadherin exhibit
abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 133, 13671382.
Amagai, M., Fujimori, T., Masunaga, T., Shimizu, H., Nishikawa, T., Shimizu, N., Takeichi, M.,
Hashimoto, T., 1995a. Delayed assembly of desmosomes in keratinocytes with disrupted classic cadherin-mediated cell adhesion by a dominant negative mutant. J Invest Dermatol 104, 27-32.
Amagai, M., Ishii, K., Hashimoto, T., Gamou, S., Shimizu, N., Nishikawa, T., 1995b.
Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and
glycosylation independent. J Invest Dermatol 105, 243-247.
Amagai, M., Klaus-Kovtun, V., Stanley, J.R., 1991. Autoantibodies against a novel epithelia l
cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67, 869-877.
Armstrong, D.K., McKenna, K.E., Purkis, P.E., Green, K.J., Eady, R.A., Leigh, I.M., Hughes,
A.E., 1999. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar
keratoderma. Hum Mol Genet 8, 143-148.
Aslan, Y., Tadjuidje, E., Zorn, A.M., Cha, S.W., 2017. High-efficiency non-mosaic CRISPRmediated knock-in and indel mutation in F0 Xenopus. Development 144, 2852-2858.
156

Awad, M.M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., Tucker, A., Russell,
S.D., Bluemke, D.A., Dietz, H.C., Calkins, H., Judge, D.P., 2006. DSG2 mutations contribute to
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet 79, 136-142.
Bagowski, C.P., Xiong, W., Ferrell, J.E., Jr., 2001. c-Jun N-terminal kinase activation in Xenopus
laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway. J Biol Chem
276, 1459-1465.
Banach, M., Edholm, E.S., Robert, J., 2017. Exploring the functions of nonclassical MHC class Ib
genes in Xenopus laevis by the CRISPR/Cas9 system. Dev Biol 426, 261-269.
Bass-Zubek, A.E., Hobbs, R.P., Amargo, E.V., Garcia, N.J., Hsieh, S.N., Chen, X., Wahl, J.K.,
3rd, Denning, M.F., Green, K.J., 2008. Plakophilin 2: a critical scaffold for PKC alpha that
regulates intercellular junction assembly. J Cell Biol 181, 605-613.
Bassett, A.R., Tibbit, C., Ponting, C.P., Liu, J.L., 2014. Mutagenesis and homologo us
recombination in Drosophila cell lines using CRISPR/Cas9. Biol Open 3, 42-49.
Bazzi, H., Demehri, S., Potter, C.S., Barber, A.G., Awgulewitsch, A., Kopan, R., Christiano, A.M.,
2009. Desmoglein 4 is regulated by transcription factors implicated in hair shaft differentiatio n.
Differentiation 78, 292-300.
Beffagna, G., De Bortoli, M., Nava, A., Salamon, M., Lorenzon, A., Zaccolo, M., Mancuso, L.,
Sigalotti, L., Bauce, B., Occhi, G., Basso, C., Lanfranchi, G., Towbin, J.A., Thiene, G., Danieli,
G.A., Rampazzo, A., 2007. Missense mutations in desmocollin-2 N-terminus, associated with
arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin2 in vitro. BMC Med Genet 8, 65.
Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C.,
Motiwala, A., Pierce, S., Satoh, Y., 2001. SP600125, an anthrapyrazolone inhibitor of Jun N terminal kinase. Proceedings of the National Academy of Sciences 98, 13681-13686.
Berika, M., Garrod, D., 2014. Desmosomal adhesion in vivo. Cell Commun Adhes 21, 65-75.
Bhattacharya, D., Marfo, C.A., Li, D., Lane, M., Khokha, M.K., 2015. CRISPR/Cas9: An
inexpensive, efficient loss of function tool to screen human disease genes in Xenopus. Dev Biol
408, 196-204.
Bierkamp, C., McLaughlin, K.J., Schwarz, H., Huber, O., Kemler, R., 1996. Embryonic heart and
skin defects in mice lacking plakoglobin. Dev Biol 180, 780-785.
Billett, F.S., Gould, R.P., 1971. Fine structural changes in the differentiating epidermis of Xenopus
laevis embryos. J Anat 108, 465-480.
Blank, J.L., Gerwins, P., Elliott, E.M., Sather, S., Johnson, G.L., 1996. Molecular cloning of
mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequentia l
phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J Biol
Chem 271, 5361-5368.

157

Blum, M., De Robertis, E.M., Wallingford, J.B., Niehrs, C., 2015. Morpholinos: Antisense and
Sensibility. Dev Cell 35, 145-149.
Bogoyevitch, M.A., Kobe, B., 2006. Uses for JNK: the many and varied substrates of the c-Jun Nterminal kinases. Microbiol Mol Biol Rev 70, 1061-1095.
Bonne, S., van Hengel, J., Nollet, F., Kools, P., van Roy, F., 1999. Plakophilin-3, a novel
armadillo- like protein present in nuclei and desmosomes of epithelial cells. J Cell Sci 112 ( Pt 14),
2265-2276.
Bornslaeger, E.A., Corcoran, C.M., Stappenbeck, T.S., Green, K.J., 1996. Breaking the
connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces
disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J
Cell Biol 134, 985-1001.
Borysenko, J.Z., Revel, J.P., 1973. Experimental manipulation of desmosome structure. Am J Anat
137, 403-421.
Bray, S.J., 2006. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7,
678-689.
Breathnach, A.S., Wyllie, L.M., 1965. Fine structure of cells forming the surface layer of the
epidermis in human fetuses at fourteen and twelve weeks. J Invest Dermatol 45, 179-189.
Brooke, M.A., Nitoiu, D., Kelsell, D.P., 2012. Cell-cell connectivity: desmosomes and disease. J
Pathol 226, 158-171.
Brooks, E.R., Wallingford, J.B., 2014. Multiciliated cells. Curr Biol 24, R973-982.
Broussard, J.A., Yang, R., Huang, C., Nathamgari, S.S.P., Beese, A.M., Godsel, L.M., Lee, S.,
Zhou, F., Sniadecki, N.J., Green, K.J., Espinosa, H.D., 2017. The desmoplakin/intermed iate
filament linkage regulates cell mechanics. Mol Biol Cell.
Bruckner-Tuderman, L., Vogel, A., Ruegger, S., Odermatt, B., Tonz, O., Schnyder, U.W., 1989.
Epidermolysis bullosa simplex with mottled pigmentation. J Am Acad Dermatol 21, 425-432.
Butz, S., Stappert, J., Weissig, H., Kemler, R., 1992. Plakoglobin and beta-catenin: distinct but
closely related. Science 257, 1142-1144.
Calkins, C.C., Setzer, S.V., Jennings, J.M., Summers, S., Tsunoda, K., Amagai, M., Kowalczyk,
A.P., 2006. Desmoglein endocytosis and desmosome disassembly are coordinated responses to
pemphigus autoantibodies. J Biol Chem 281, 7623-7634.
Carvajal-Huerta, L., 1998. Epidermolytic palmoplantar keratoderma with woolly hair and dilated
cardiomyopathy. J Am Acad Dermatol 39, 418-421.
Celentano, A., Cirillo, N., 2017. Desmosomes in disease: a guide for clinicians. Oral Dis 23, 157167.
Chain, F.J., Evans, B.J., 2006. Multiple mechanisms promote the retained expression of gene
duplicates in the tetraploid frog Xenopus laevis. PLoS Genet 2, e56.
158

Chalmers, A.D., Strauss, B., Papalopulu, N., 2003. Oriented cell divisions asymmetrica lly
segregate aPKC and generate cell fate diversity in the early Xenopus embryo. Development 130,
2657-2668.
Chan, Y., Anton-Lamprecht, I., Yu, Q.C., Jackel, A., Zabel, B., Ernst, J.P., Fuchs, E., 1994. A
human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex
and a function for an intermediate filament protein. Genes Dev 8, 2574-2587.
Chen, J., Den, Z., Koch, P.J., 2008. Loss of desmocollin 3 in mice leads to epidermal blistering. J
Cell Sci 121, 2844-2849.
Chen, S.N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J.T., Marian, A.J., 2014. The hippo
pathway is activated and is a causal mechanism for adipogenesis in arrhythmoge nic
cardiomyopathy. Circ Res 114, 454-468.
Chen, Z., Yang, A., Xu, C., Xing, Y., Gong, W., Li, J., 2011. c-Jun N-terminal kinase is involved
in the regulation of proliferation and apoptosis by integrin- linked kinase in human retinoblas to ma
cells. Graefes Arch Clin Exp Ophthalmol 249, 1399-1407.
Chidgey, M., Brakebusch, C., Gustafsson, E., Cruchley, A., Hail, C., Kirk, S., Merritt, A., North,
A., Tselepis, C., Hewitt, J., Byrne, C., Fassler, R., Garrod, D., 2001. Mice lacking desmocollin 1
show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol
155, 821-832.
Chidgey, M., Dawson, C., 2007. Desmosomes: a role in cancer? Br J Cancer 96, 1783-1787.
Chitaev, N.A., Troyanovsky, S.M., 1997. Direct Ca2+-dependent heterophilic interaction between
desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol
138, 193-201.
Choi, H.J., Park-Snyder, S., Pascoe, L.T., Green, K.J., Weis, W.I., 2002. Structures of two
intermediate filament-binding fragments of desmoplakin reveal a unique repeat motif structure.
Nat Struct Biol 9, 612-620.
Christian, M., Cermak, T., Doyle, E.L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A.J.,
Voytas, D.F., 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics
186, 757-761.
Chun, M.G., Hanahan, D., 2010. Genetic deletion of the desmosomal component desmoplakin
promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogene s is.
PLoS Genet 6, e1001120.
Chung, M.I., Kwon, T., Tu, F., Brooks, E.R., Gupta, R., Meyer, M., Baker, J.C., Marcotte, E.M.,
Wallingford, J.B., 2014. Coordinated genomic control of ciliogenesis and cell movement by
RFX2. Elife 3, e01439.
Chung, M.I., Peyrot, S.M., LeBoeuf, S., Park, T.J., McGary, K.L., Marcotte, E.M., Wallingford,
J.B., 2012. RFX2 is broadly required for ciliogenesis during vertebrate development. Dev Biol
363, 155-165.
159

Cibois, M., Scerbo, P., Thomé, V., Pasini, A., Kodjabachian, L., 2014. Induction and
differentiation of the Xenopus ciliated embryonic epidermis. Xenopus Development, 112-129.
Cichorek, M., Wachulska, M., Stasiewicz, A., Tyminska, A., 2013. Skin melanocytes: biology and
development. Postepy Dermatol Alergol 30, 30-41.
Cirillo, N., Lanza, A., Prime, S.S., 2010. Induction of hyper-adhesion attenuates autoimmuneinduced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanis ms
that involve PKC. Exp Cell Res 316, 580-592.
Clark, I.B., Muha, V., Klingseisen, A., Leptin, M., Muller, H.A., 2011. Fibroblast growth factor
signalling controls successive cell behaviours during mesoderm layer formation in Drosophila.
Development 138, 2705-2715.
Collins, J.E., Garrod, D., 1994. Molecular biology of desmosomes and hemidesmosomes. RG
Landes Company.
Collins, J.E., Legan, P.K., Kenny, T.P., MacGarvie, J., Holton, J.L., Garrod, D.R., 1991. Cloning
and sequence analysis of desmosomal glycoproteins 2 and 3 (desmocollins): cadherin- like
desmosomal adhesion molecules with heterogeneous cytoplasmic domains. J Cell Biol 113, 381391.
Conacci-Sorrell, M.E., Ben-Yedidia, T., Shtutman, M., Feinstein, E., Einat, P., Ben-Ze'ev, A.,
2002. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer
and its expression enhances motility and confers tumorigenesis. Genes Dev 16, 2058-2072.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W.,
Marraffini, L.A., Zhang, F., 2013. Multiplex genome engineering using CRISPR/Cas systems.
Science 339, 819-823.
Constant, S.L., Dong, C., Yang, D.D., Wysk, M., Davis, R.J., Flavell, R.A., 2000. JNK1 is required
for T cell-mediated immunity against Leishmania major infection. J Immunol 165, 2671-2676.
Conway, J.F., Parry, D.A., 1988. Intermediate filament structure: 3. Analysis of sequence
homologies. International Journal of Biological Macromolecules 10, 79-98.
Cowin, P., Kapprell, H.P., Franke, W.W., Tamkun, J., Hynes, R.O., 1986. Plakoglobin: a protein
common to different kinds of intercellular adhering junctions. Cell 46, 1063-1073.
Dale, B.A., Holbrook, K.A., Kimball, J.R., Hoff, M., Sun, T.T., 1985. Expression of epidermal
keratins and filaggrin during human fetal skin development. J Cell Biol 101, 1257-1269.
Dale, L., Slack, J.M., 1987. Fate map for the 32-cell stage of Xenopus laevis. Development 99,
527-551.
Davidson, L.A., Dzamba, B.D., Keller, R., Desimone, D.W., 2008. Live imaging of cell protrusive
activity, and extracellular matrix assembly and remodeling during morphogenesis in the frog,
Xenopus laevis. Dev Dyn 237, 2684-2692.
Davis, R.J., 2000. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
160

Deacon, K., Blank, J.L., 1997. Characterization of the mitogen-activated protein kinase kinase 4
(MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and
3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J Biol Chem
272, 14489-14496.
Deblandre, G.A., Wettstein, D.A., Koyano-Nakagawa, N., Kintner, C., 1999. A two-step
mechanism generates the spacing pattern of the ciliated cells in the skin of Xenopus embryos.
Development 126, 4715-4728.
Dehner, C., Rotzer, V., Waschke, J., Spindler, V., 2014. A desmoplakin point mutation with
enhanced keratin association ameliorates pemphigus vulgaris autoantibody- mediated loss of cell
cohesion. Am J Pathol 184, 2528-2536.
Delgehyr, N., Sillibourne, J., Bornens, M., 2005. Microtubule nucleation and anchoring at the
centrosome are independent processes linked by ninein function. J Cell Sci 118, 1565-1575.
Delmar, M., McKenna, W.J., 2010. The cardiac desmosome
cardiomyopathies: from gene to disease. Circ Res 107, 700-714.

and

arrhythmoge nic

Delva, E., Jennings, J.M., Calkins, C.C., Kottke, M.D., Faundez, V., Kowalczyk, A.P., 2008.
Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are
mediated by a clathrin- and dynamin- independent mechanism. J Biol Chem 283, 18303-18313.
Delva, E., Tucker, D.K., Kowalczyk, A.P., 2009. The desmosome. Cold Spring Harb Perspect Biol
1, a002543.
DeMarais, A.A., Moon, R.T., 1992. The armadillo homologs beta-catenin and plakoglobin are
differentially expressed during early development of Xenopus laevis. Dev Biol 153, 337-346.
Den, Z., Cheng, X., Merched-Sauvage, M., Koch, P.J., 2006. Desmocollin 3 is required for preimplantation development of the mouse embryo. J Cell Sci 119, 482-489.
Derijard, B., Raingeaud, J., Barrett, T., Wu, I.H., Han, J., Ulevitch, R.J., Davis, R.J., 1995.
Independent human MAP-kinase signal transduction pathways defined by MEK and MKK
isoforms. Science 267, 682-685.
Dickinson, A.J., 2016. Using frogs faces to dissect the mechanisms underlying human orofacial
defects. Semin Cell Dev Biol 51, 54-63.
Dickinson, A.J., Sive, H.L., 2009. The Wnt antagonists Frzb-1 and Crescent locally regulate
basement membrane dissolution in the developing primary mouth. Development 136, 1071-1081.
Ding, X., Aoki, V., Mascaro, J.M., Jr., Lopez-Swiderski, A., Diaz, L.A., Fairley, J.A., 1997.
Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody
profiles. J Invest Dermatol 109, 592-596.
Doench, J.G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E.W., Donovan, K.F., Smith, I.,
Tothova, Z., Wilen, C., Orchard, R., Virgin, H.W., Listgarten, J., Root, D.E., 2016. Optimized
sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat
Biotechnol 34, 184-191.
161

Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I., Sullender, M.,
Ebert, B.L., Xavier, R.J., Root, D.E., 2014. Rational design of highly active sgRNAs for CRISPRCas9-mediated gene inactivation. Nat Biotechnol 32, 1262-1267.
Dong, C., Davis, R.J., Flavell, R.A., 2001. Signaling by the JNK group of MAP kinases. c-jun Nterminal Kinase. J Clin Immunol 21, 253-257.
Dong, C., Yang, D.D., Tournier, C., Whitmarsh, A.J., Xu, J., Davis, R.J., Flavell, R.A., 2000. JNK
is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94.
Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., Flavell, R.A., 1998. Defective T
cell differentiation in the absence of Jnk1. Science 282, 2092-2095.
Donovan, N., Becker, E.B., Konishi, Y., Bonni, A., 2002. JNK phosphorylation and activation of
BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277,
40944-40949.
Doudna, J.A., Charpentier, E., 2014. Genome editing. The new frontier of genome engineer ing
with CRISPR-Cas9. Science 346, 1258096.
Dragatsis, I., Efstratiadis, A., Zeitlin, S., 1998. Mouse mutant embryos lacking huntingtin are
rescued from lethality by wild-type extraembryonic tissues. Development 125, 1529-1539.
Drysdale, T.A., Elinson, R.P., 1992. Cell Migration and Induction in the Development of the
Surface Ectodermal Pattern of the Xenopus laevis Tadpole. Development, Growth &
Differentiation 34, 51-59.
Dubaissi, E., Papalopulu, N., 2011. Embryonic frog epidermis: a model for the study of cell- cell
interactions in the development of mucociliary disease. Dis Model Mech 4, 179-192.
Dubaissi, E., Rousseau, K., Lea, R., Soto, X., Nardeosingh, S., Schweickert, A., Amaya, E.,
Thornton, D.J., Papalopulu, N., 2014. A secretory cell type develops alongside multiciliated cells,
ionocytes and goblet cells, and provides a protective, anti-infective function in the frog embryonic
mucociliary epidermis. Development 141, 1514-1525.
Ducibella, T., Albertini, D.F., Anderson, E., Biggers, J.D., 1975. The preimplantation mamma lia n
embryo: characterization of intercellular junctions and their appearance during development. Dev
Biol 45, 231-250.
Duellman, W.E., Trueb, L., 1994. Biology of amphibians. Johns Hopkins University Press,
Baltimore.
Eisen, J.S., Smith, J.C., 2008. Controlling morpholino experiments: don't stop making antisense.
Development 135, 1735-1743.
Ellinger-Ziegelbauer, H., Brown, K., Kelly, K., Siebenlist, U., 1997. Direct activation of the stressactivated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways
by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J Biol
Chem 272, 2668-2674.

162

Eshkind, L., Tian, Q., Schmidt, A., Franke, W.W., Windoffer, R., Leube, R.E., 2002. Loss of
desmoglein 2 suggests essential functions for early embryonic development and proliferation of
embryonal stem cells. Eur J Cell Biol 81, 592-598.
Evans, B.J., 2008. Genome evolution and speciation genetics of clawed frogs (Xenopus and
Silurana). Front Biosci 13, 4687-4706.
Evans, B.J., Kelley, D.B., Tinsley, R.C., Melnick, D.J., Cannatella, D.C., 2004. A mitochondr ia l
DNA phylogeny of African clawed frogs: phylogeography and implications for polyploid
evolution. Mol Phylogenet Evol 33, 197-213.
Farquhar, M.G., Palade, G.E., 1963. Junctional complexes in various epithelia. J Cell Biol 17, 375412.
Farquhar, M.G., Palade, G.E., 1965. Cell junctions in amphibian skin. J Cell Biol 26, 263-291.
Fawcett, S.R., Klymkowsky, M.W., 2004. Embryonic expression of Xenopus laevis SOX7. Gene
Expr Patterns 4, 29-33.
Ferreira, D.M., Castro, R.E., Machado, M.V., Evangelista, T., Silvestre, A., Costa, A., Coutinho,
J., Carepa, F., Cortez-Pinto, H., Rodrigues, C.M., 2011. Apoptosis and insulin resistance in liver
and peripheral tissues of morbidly obese patients is associated with different stages of nonalcoholic fatty liver disease. Diabetologia 54, 1788-1798.
Ferrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., Avila, J., 2005. Current
advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's
disease and tauopathies. Curr Alzheimer Res 2, 3-18.
Fleming, T.P., Garrod, D.R., Elsmore, A.J., 1991. Desmosome biogenesis in the mouse
preimplantation embryo. Development 112, 527-539.
Fontao, L., Favre, B., Riou, S., Geerts, D., Jaunin, F., Saurat, J.H., Green, K.J., Sonnenberg, A.,
Borradori, L., 2003. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin
with intermediate filaments is mediated by distinct sequences within their COOH terminus. Mol
Biol Cell 14, 1978-1992.
Fox, H., 1986. Epidermis, Biology of the Integument. Springer, pp. 78-110.
Friedland, A.E., Tzur, Y.B., Esvelt, K.M., Colaiacovo, M.P., Church, G.M., Calarco, J.A., 2013.
Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10, 741-743.
Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K., Sander, J.D., 2013. Highfrequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat
Biotechnol 31, 822-826.
Fuchs, E., Green, H., 1980. Changes in keratin gene expression during terminal differentiation of
the keratinocyte. Cell 19, 1033-1042.

163

Fujita, M., Furukawa, F., Fujii, K., Horiguchi, Y., Takeichi, M., Imamura, S., 1992. Expression of
cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis,
hair follicles and eccrine sweat ducts. Arch Dermatol Res 284, 159-166.
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A.,
Tsukita, S., 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier:
a lesson from claudin-1-deficient mice. J Cell Biol 156, 1099-1111.
Gallicano, G.I., Bauer, C., Fuchs, E., 2001. Rescuing desmoplakin function in extra-embryonic
ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and
vasculature. Development 128, 929-941.
Gallicano, G.I., Kouklis, P., Bauer, C., Yin, M., Vasioukhin, V., Degenstein, L., Fuchs, E., 1998.
Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal
linkage. J Cell Biol 143, 2009-2022.
Gantress, J., Maniero, G.D., Cohen, N., Robert, J., 2003. Development and characterization of a
model system to study amphibian immune responses to iridoviruses. Virology 311, 254-262.
Garriock, R.J., D'Agostino, S.L., Pilcher, K.C., Krieg, P.A., 2005. Wnt11-R, a protein closely
related to mammalian Wnt11, is required for heart morphogenesis in Xenopus. Dev Biol 279, 179192.
Garrod, D., 2010. Desmosomes in vivo. Dermatol Res Pract 2010, 212439.
Garrod, D., Chidgey, M., 2008. Desmosome structure, composition and function. Biochim
Biophys Acta 1778, 572-587.
Garrod, D., Kimura, T.E., 2008. Hyper-adhesion: a new concept in cell-cell adhesion. Biochem
Soc Trans 36, 195-201.
Garrod, D.R., 1993. Desmosomes and hemidesmosomes. Curr Opin Cell Biol 5, 30-40.
Garrod, D.R., Berika, M.Y., Bardsley, W.F., Holmes, D., Tabernero, L., 2005. Hyper-adhesion in
desmosomes: its regulation in wound healing and possible relationship to cadherin crystal
structure. J Cell Sci 118, 5743-5754.
Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R.D., Bairoch, A., 2003. ExPASy: The
proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31, 3784-3788.
Gazel, A., Banno, T., Walsh, R., Blumenberg, M., 2006. Inhibition of JNK promotes
differentiation of epidermal keratinocytes. J Biol Chem 281, 20530-20541.
Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C.T., McDermott, D.A., Lerman, B.B.,
Markowitz, S.M., Ellinor, P.T., MacRae, C.A., Peters, S., Grossmann, K.S., Drenckhahn, J.,
Michely, B., Sasse-Klaassen, S., Birchmeier, W., Dietz, R., Breithardt, G., Schulze-Bahr, E.,
Thierfelder, L., 2004. Mutations in the desmosomal protein plakophilin-2 are common in
arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36, 1162-1164.

164

Gerwins, P., Blank, J.L., Johnson, G.L., 1997. Cloning of a novel mitogen-activated protein kinase
kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J Biol
Chem 272, 8288-8295.
Glise, B., Noselli, S., 1997. Coupling of Jun amino-terminal kinase and Decapentaplegic signaling
pathways in Drosophila morphogenesis. Genes Dev 11, 1738-1747.
Godsel, L.M., Hsieh, S.N., Amargo, E.V., Bass, A.E., Pascoe-McGillicuddy, L.T., Huen, A.C.,
Thorne, M.E., Gaudry, C.A., Park, J.K., Myung, K., Goldman, R.D., Chew, T.L., Green, K.J.,
2005. Desmoplakin assembly dynamics in four dimensions: multiple phases differentia lly
regulated by intermediate filaments and actin. J Cell Biol 171, 1045-1059.
Goldie, K.N., Wedig, T., Mitra, A.K., Aebi, U., Herrmann, H., Hoenger, A., 2007. Dissecting the
3-D structure of vimentin intermediate filaments by cryo-electron tomography. J Struct Biol 158,
378-385.
Gonzalez-Mariscal, L., Dominguez-Calderon, A., Raya-Sandino, A., Ortega-Olvera, J.M., VargasSierra, O., Martinez-Revollar, G., 2014. Tight junctions and the regulation of gene expression.
Semin Cell Dev Biol 36, 213-223.
Goonesinghe, A., Luan, X.M., Hurlstone, A., Garrod, D., 2012. Desmosomal cadherins in
zebrafish epiboly and gastrulation. BMC Dev Biol 12, 1.
Gottardi, C.J., Wong, E., Gumbiner, B.M., 2001. E-cadherin suppresses cellular transformation by
inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153, 1049-1060.
Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., Lopez, R., 2010. A new
bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 38, W695-699.
Graf, J.D., Kobel, H.R., 1991. Genetics of Xenopus laevis. Methods Cell Biol 36, 19-34.
Graser, S., Stierhof, Y.D., Lavoie, S.B., Gassner, O.S., Lamla, S., Le Clech, M., Nigg, E.A., 2007.
Cep164, a novel centriole appendage protein required for primary cilium formation. J Cell Biol
179, 321-330.
Green, K.J., Guy, S.G., Cserhalmi-Friedman, P.B., McLean, W.H., Christiano, A.M., Wagner,
R.M., 1999. Analysis of the desmoplakin gene reveals striking conservation with other members
of the plakin family of cytolinkers. Exp Dermatol 8, 462-470.
Green, K.J., Kowalczyk, A.P., Bornslaeger, E.A., Palka, H.L., Norvell, S.M., 1998. Desmosomes :
integrators of mechanical integrity in tissues. Biol Bull 194, 374-376; discussion 376-377.
Green, K.J., Parry, D.A., Steinert, P.M., Virata, M.L., Wagner, R.M., Angst, B.D., Nilles, L.A.,
1990. Structure of the human desmoplakins. Implications for function in the desmosomal plaque.
J Biol Chem 265, 11406-11407.
Green, K.J., Simpson, C.L., 2007. Desmosomes: new perspectives on a classic. J Invest Dermatol
127, 2499-2515.

165

Green, K.J., Stappenbeck, T.S., Parry, D.A., Virata, M.L., 1992. Structure of desmoplakin and its
association with intermediate filaments. J Dermatol 19, 765-769.
Gulmann, C., Sheehan, K.M., Conroy, R.M., Wulfkuhle, J.D., Espina, V., Mullarkey, M.J., Kay,
E.W., Liotta, L.A., Petricoin, E.F., 3rd, 2009. Quantitative cell signalling analysis reveals downregulation of MAPK pathway activation in colorectal cancer. J Pathol 218, 514-519.
Gumbiner, B., Stevenson, B., Grimaldi, A., 1988. The role of the cell adhesion molecule
uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107,
1575-1587.
Gupta, S., Barrett, T., Whitmarsh, A.J., Cavanagh, J., Sluss, H.K., Derijard, B., Davis, R.J., 1996.
Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15, 27602770.
Hadj-Rabia, S., Baala, L., Vabres, P., Hamel-Teillac, D., Jacquemin, E., Fabre, M., Lyonnet, S.,
De Prost, Y., Munnich, A., Hadchouel, M., Smahi, A., 2004. Claudin-1 gene mutations in neonatal
sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology 127,
1386-1390.
Hanakawa, Y., Schechter, N.M., Lin, C., Garza, L., Li, H., Yamaguchi, T., Fudaba, Y., Nishifuji,
K., Sugai, M., Amagai, M., Stanley, J.R., 2002. Molecular mechanisms of blister formation in
bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 110, 53-60.
Hanakawa, Y., Selwood, T., Woo, D., Lin, C., Schechter, N.M., Stanley, J.R., 2003. Calciumdependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J Invest
Dermatol 121, 383-389.
Harland, R.M., Grainger, R.M., 2011. Xenopus research: metamorphosed by genetics and
genomics. Trends Genet 27, 507-515.
Haslam, I.S., Roubos, E.W., Mangoni, M.L., Yoshizato, K., Vaudry, H., Kloepper, J.E., Pattwell,
D.M., Maderson, P.F., Paus, R., 2014. From frog integument to human skin: dermatologica l
perspectives from frog skin biology. Biol Rev Camb Philos Soc 89, 618-655.
Hatzfeld, M., 2007. Plakophilins: Multifunctional proteins or just regulators of desmosomal
adhesion? Biochim Biophys Acta 1773, 69-77.
Hatzfeld, M., Haffner, C., Schulze, K., Vinzens, U., 2000. The function of plakophilin 1 in
desmosome assembly and actin filament organization. J Cell Biol 149, 209-222.
Hatzfeld, M., Kristjansson, G.I., Plessmann, U., Weber, K., 1994. Band 6 protein, a major
constituent of desmosomes from stratified epithelia, is a novel member of the armadillo multige ne
family. J Cell Sci 107 ( Pt 8), 2259-2270.
Hatzfeld, M., Weber, K., 1990. The coiled coil of in vitro assembled keratin filaments is a
heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein
expression. J Cell Biol 110, 1199-1210.

166

Hayes, J.M., Kim, S.K., Abitua, P.B., Park, T.J., Herrington, E.R., Kitayama, A., Grow, M.W.,
Ueno, N., Wallingford, J.B., 2007. Identification of novel ciliogenesis factors using a new in vivo
model for mucociliary epithelial development. Dev Biol 312, 115-130.
He, T., Stepulak, A., Holmstrom, T.H., Omary, M.B., Eriksson, J.E., 2002. The intermed iate
filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J Biol
Chem 277, 10767-10774.
Heasman, J., 2002. Morpholino oligos: making sense of antisense? Dev Biol 243, 209-214.
Hellsten, U., Khokha, M.K., Grammer, T.C., Harland, R.M., Richardson, P., Rokhsar, D.S., 2007.
Accelerated gene evolution and subfunctionalization in the pseudotetraploid frog Xenopus laevis.
BMC Biol 5, 31.
Hentula, M., Peltonen, J., Peltonen, S., 2001. Expression profiles of cell-cell and cell-matr ix
junction proteins in developing human epidermis. Arch Dermatol Res 293, 259-267.
Herrmann, H., Aebi, U., 1998. Structure, assembly, and dynamics of intermediate filame nts.
Subcell Biochem 31, 319-362.
Herrmann, H., Strelkov, S.V., Burkhard, P., Aebi, U., 2009. Intermediate filaments: primary
determinants of cell architecture and plasticity. J Clin Invest 119, 1772-1783.
Higashi, T., Arnold, T.R., Stephenson, R.E., Dinshaw, K.M., Miller, A.L., 2016. Maintenance of
the Epithelial Barrier and Remodeling of Cell-Cell Junctions during Cytokinesis. Curr Biol 26,
1829-1842.
Hirai, S., Katoh, M., Terada, M., Kyriakis, J.M., Zon, L.I., Rana, A., Avruch, J., Ohno, S., 1997.
MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates
SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem 272,
15167-15173.
Hirsch, N., Zimmerman, L.B., Grainger, R.M., 2002. Xenopus, the next generation: X. tropicalis
genetics and genomics. Dev Dyn 225, 422-433.
Hisano, Y., Sakuma, T., Nakade, S., Ohga, R., Ota, S., Okamoto, H., Yamamoto, T., Kawahara,
A., 2015. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in
zebrafish. Sci Rep 5, 8841.
Hobbs, R.P., Green, K.J., 2012. Desmoplakin regulates desmosome hyperadhesion. The Journal
of investigative dermatology 132, 482-485.
Holbrook, K.A., 1983. The biology of human fetal skin at ages related to prenatal diagnosis.
Pediatr Dermatol 1, 97-111.
Holbrook, K.A., Odland, G.F., 1975. The fine structure of developing human epidermis: light,
scanning, and transmission electron microscopy of the periderm. J Invest Dermatol 65, 16-38.

167

Holbrook, K.A., Odland, G.F., 1980. Regional development of the human epidermis in the first
trimester embryo and the second trimester fetus (ages related to the timing of amniocentesis and
fetal biopsy). J Invest Dermatol 74, 161-168.
Hou, X.S., Goldstein, E.S., Perrimon, N., 1997. Drosophila Jun relays the Jun amino-termina l
kinase signal transduction pathway to the Decapentaplegic signal transduction pathway in
regulating epithelial cell sheet movement. Genes Dev 11, 1728-1737.
Houssin, N.S., Bharathan, N.K., Turner, S.D., Dickinson, A.J., 2017. Role of JNK during
buccopharyngeal membrane perforation, the last step of embryonic mouth formation. Dev Dyn
246, 100-115.
Hsu, P.D., Lander, E.S., Zhang, F., 2014. Development and applications of CRISPR-Cas9 for
genome engineering. Cell 157, 1262-1278.
Hu, W., Haamedi, N., Lee, J., Kinoshita, T., Ohnuma, S., 2013. The structure and development of
Xenopus laevis cornea. Exp Eye Res 116, 109-128.
Huang, C., Rajfur, Z., Borchers, C., Schaller, M.D., Jacobson, K., 2003. JNK phosphorylates
paxillin and regulates cell migration. Nature 424, 219-223.
Huen, A.C., Park, J.K., Godsel, L.M., Chen, X., Bannon, L.J., Amargo, E.V., Hudson, T.Y.,
Mongiu, A.K., Leigh, I.M., Kelsell, D.P., Gumbiner, B.M., Green, K.J., 2002. Intermed iate
filament- membrane attachments function synergistically with actin-dependent contacts to regulate
intercellular adhesive strength. J Cell Biol 159, 1005-1017.
Hughes, M.K., Hughes, A.L., 1993. Evolution of duplicate genes in a tetraploid animal, Xenopus
laevis. Mol Biol Evol 10, 1360-1369.
Hunt, D.M., Rickman, L., Whittock, N.V., Eady, R.A., Simrak, D., Dopping-Hepenstal, P.J.,
Stevens, H.P., Armstrong, D.K., Hennies, H.C., Kuster, W., Hughes, A.E., Arnemann, J., Leigh,
I.M., McGrath, J.A., Kelsell, D.P., Buxton, R.S., 2001. Spectrum of dominant mutations in the
desmosomal cadherin desmoglein 1, causing the skin disease striate palmoplantar keratoderma.
Eur J Hum Genet 9, 197-203.
Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto,
K., Miyazono, K., Gotoh, Y., 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK
that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
Ingram, A.J., James, L., Ly, H., Thai, K., Scholey, J.W., 2000. Stretch activation of jun N-terminal
kinase/stress-activated protein kinase in mesangial cells. Kidney Int 58, 1431-1439.
Iozumi, K., Hoganson, G.E., Pennella, R., Everett, M.A., Fuller, B.B., 1993. Role of tyrosinase as
the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol 100, 806-811.
Ip, Y.T., Davis, R.J., 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)--from
inflammation to development. Curr Opin Cell Biol 10, 205-219.

168

Irvine, A.D., Rugg, E.L., Lane, E.B., Hoare, S., Peret, C., Hughes, A.E., Heagerty, A.H., 2001.
Molecular confirmation of the unique phenotype of epidermolysis bullosa simplex with mottled
pigmentation. Br J Dermatol 144, 40-45.
Ishibashi, S., Love, N.R., Amaya, E., 2012. A simple method of transgenesis using I-SceI
meganuclease in Xenopus. Methods Mol Biol 917, 205-218.
Ishii, K., Amagai, M., Hall, R.P., Hashimoto, T., Takayanagi, A., Gamou, S., Shimizu, N.,
Nishikawa, T., 1997. Characterization of autoantibodies in pemphigus using antigen-spec if ic
enzyme- linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J
Immunol 159, 2010-2017.
Itoh, K., Yamashita, A., Kubota, H.Y., 1988. The expression of epidermal antigens in Xenopus
laevis. Development 104, 1-14.
Ivanov, A.I., McCall, I.C., Parkos, C.A., Nusrat, A., 2004a. Role for actin filament turnover and a
myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex.
Mol Biol Cell 15, 2639-2651.
Ivanov, A.I., Nusrat, A., Parkos, C.A., 2004b. Endocytosis of epithelial apical junctional proteins
by a clathrin- mediated pathway into a unique storage compartment. Mol Biol Cell 15, 176-188.
Jackson, B.W., Grund, C., Winter, S., Franke, W.W., Illmensee, K., 1981. Formation of
cytoskeletal elements during mouse embryogenesis. II. Epithelial differentiation and intermedia te sized filaments in early postimplantation embryos. Differentiation 20, 203-216.
Jefferson, J.J., Leung, C.L., Liem, R.K., 2004. Plakins: goliaths that link cell junctions and the
cytoskeleton. Nat Rev Mol Cell Biol 5, 542-553.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., 2012. A
programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337,
816-821.
Johnson, J.L., Najor, N.A., Green, K.J., 2014. Desmosomes: regulators of cellular signaling and
adhesion in epidermal health and disease. Cold Spring Harb Perspect Med 4, a015297.
Jolly, P.S., Berkowitz, P., Bektas, M., Lee, H.E., Chua, M., Diaz, L.A., Rubenstein, D.S., 2010.
p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus
acantholysis. J Biol Chem 285, 8936-8941.
Jonas, E., Sargent, T.D., Dawid, I.B., 1985. Epidermal keratin gene expressed in embryos of
Xenopus laevis. Proc Natl Acad Sci U S A 82, 5413-5417.
Jonkman, M.F., Pasmooij, A.M., Pasmans, S.G., van den Berg, M.P., Ter Horst, H.J., Timmer, A.,
Pas, H.H., 2005. Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am J
Hum Genet 77, 653-660.
Jorgensen, K., Davidson, B., Florenes, V.A., 2006. Activation of c-jun N-terminal kinase is
associated with cell proliferation and shorter relapse-free period in superficial spreading maligna nt
melanoma. Mod Pathol 19, 1446-1455.
169

Joung, J.K., Sander, J.D., 2013. TALENs: a widely applicable technology for targeted genome
editing. Nat Rev Mol Cell Biol 14, 49-55.
Kane, D.A., McFarland, K.N., Warga, R.M., 2005. Mutations in half baked/E-cadherin block cell
behaviors that are necessary for teleost epiboly. Development 132, 1105-1116.
Kapprell, H.P., Owaribe, K., Franke, W.W., 1988. Identification of a basic protein of Mr 75,000
as an accessory desmosomal plaque protein in stratified and complex epithelia. J Cell Biol 106,
1679-1691.
Karin, M., Gallagher, E., 2005. From JNK to pay dirt: jun kinases, their biochemistry, physiolo gy
and clinical importance. IUBMB Life 57, 283-295.
Karnovsky, A., Klymkowsky, M.W., 1995. Anterior axis duplication in Xenopus induced by the
over-expression of the cadherin-binding protein plakoglobin. Proc Natl Acad Sci U S A 92, 45224526.
Kartenbeck, J., Schmelz, M., Franke, W.W., Geiger, B., 1991. Endocytosis of junctional cadherins
in bovine kidney epithelial (MDBK) cells cultured in low Ca2+ ion medium. J Cell Biol 113, 881892.
Katsumi, A., Naoe, T., Matsushita, T., Kaibuchi, K., Schwartz, M.A., 2005. Integrin activatio n
and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 280, 1654616549.
Kennedy, A.E., Dickinson, A.J., 2012. Median facial clefts in Xenopus laevis: roles of retinoic
acid signaling and homeobox genes. Dev Biol 365, 229-240.
Kharbanda, S., Saxena, S., Yoshida, K., Pandey, P., Kaneki, M., Wang, Q., Cheng, K., Chen, Y.N.,
Campbell, A., Sudha, T., Yuan, Z.M., Narula, J., Weichselbaum, R., Nalin, C., Kufe, D., 2000.
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA
damage. J Biol Chem 275, 322-327.
Kim, K., Lake, B.B., Haremaki, T., Weinstein, D.C., Sokol, S.Y., 2012. Rab11 regulates planar
polarity and migratory behavior of multiciliated cells in Xenopus embryonic epidermis. Dev Dyn
241, 1385-1395.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
embryonic development of the zebrafish. Dev Dyn 203, 253-310.
Kimura, T.E., Merritt, A.J., Garrod, D.R., 2007. Calcium-independent
keratinocytes are hyper-adhesive. J Invest Dermatol 127, 775-781.

desmosomes of

Kimura, T.E., Merritt, A.J., Lock, F.R., Eckert, J.J., Fleming, T.P., Garrod, D.R., 2012.
Desmosomal adhesiveness is developmentally regulated in the mouse embryo and modulated
during trophectoderm migration. Dev Biol 369, 286-297.
Kitagawa, N., Inai, Y., Higuchi, Y., Iida, H., Inai, T., 2014. Inhibition of JNK in HaCaT cells
induced tight junction formation with decreased expression of cytokeratin 5, cytokeratin 17 and
desmoglein 3. Histochem Cell Biol 142, 389-399.
170

Klessner, J.L., Desai, B.V., Amargo, E.V., Getsios, S., Green, K.J., 2009. EGFR and ADAMs
cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein
2. Mol Biol Cell 20, 328-337.
Kljuic, A., Bazzi, H., Sundberg, J.P., Martinez-Mir, A., O'Shaughnessy, R., Mahoney, M.G., Levy,
M., Montagutelli, X., Ahmad, W., Aita, V.M., Gordon, D., Uitto, J., Whiting, D., Ott, J., Fischer,
S., Gilliam, T.C., Jahoda, C.A., Morris, R.J., Panteleyev, A.A., Nguyen, V.T., Christiano, A.M.,
2003a. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from
inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113, 249-260.
Kljuic, A., Gilead, L., Martinez-Mir, A., Frank, J., Christiano, A.M., Zlotogorski, A., 2003b. A
nonsense mutation in the desmoglein 1 gene underlies striate keratoderma. Exp Dermatol 12, 523527.
Koch, P.J., Mahoney, M.G., Ishikawa, H., Pulkkinen, L., Uitto, J., Shultz, L., Murphy, G.F.,
Whitaker-Menezes, D., Stanley, J.R., 1997. Targeted disruption of the pemphigus vulgaris antigen
(desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to
pemphigus vulgaris. J Cell Biol 137, 1091-1102.
Kockel, L., Zeitlinger, J., Staszewski, L.M., Mlodzik, M., Bohmann, D., 1997. Jun in Drosophila
development: redundant and nonredundant functions and regulation by two MAPK signal
transduction pathways. Genes Dev 11, 1748-1758.
Kofron, M., Heasman, J., Lang, S.A., Wylie, C.C., 2002. Plakoglobin is required for maintena nce
of the cortical actin skeleton in early Xenopus embryos and for cdc42-mediated wound healing. J
Cell Biol 158, 695-708.
Kofron, M., Spagnuolo, A., Klymkowsky, M., Wylie, C., Heasman, J., 1997. The roles of maternal
alpha-catenin and plakoglobin in the early Xenopus embryo. Development 124, 1553-1560.
Kok, F.O., Shin, M., Ni, C.W., Gupta, A., Grosse, A.S., van Impel, A., Kirchmaier, B.C., PetersonMaduro, J., Kourkoulis, G., Male, I., DeSantis, D.F., Sheppard-Tindell, S., Ebarasi, L., Betsholtz,
C., Schulte-Merker, S., Wolfe, S.A., Lawson, N.D., 2015. Reverse genetic screening reveals poor
correlation between morpholino- induced and mutant phenotypes in zebrafish. Dev Cell 32, 97108.
Kolly, C., Zakher, A., Strauss, C., Suter, M.M., Muller, E.J., 2007. Keratinocyte transcriptio na l
regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from
neoplastic cells. FEBS Lett 581, 1969-1976.
Koster, M.I., Roop, D.R., 2007. Mechanisms regulating epithelial stratification. Annu Rev Cell
Dev Biol 23, 93-113.
Kowalczyk, A.P., Bornslaeger, E.A., Borgwardt, J.E., Palka, H.L., Dhaliwal, A.S., Corcoran,
C.M., Denning, M.F., Green, K.J., 1997. The amino-terminal domain of desmoplakin binds to
plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J Cell Biol 139, 773-784.
Kowalczyk, A.P., Hatzfeld, M., Bornslaeger, E.A., Kopp, D.S., Borgwardt, J.E., Corcoran, C.M.,
Settler, A., Green, K.J., 1999. The head domain of plakophilin-1 binds to desmoplakin and
171

enhances its recruitment to desmosomes. Implications for cutaneous disease. J Biol Chem 274,
18145-18148.
Kowalczyk, A.P., Stappenbeck, T.S., Parry, D.A., Palka, H.L., Virata, M.L., Bornslaeger, E.A.,
Nilles, L.A., Green, K.J., 1994. Structure and function of desmosomal transmembrane core and
plaque molecules. Biophys Chem 50, 97-112.
Kroger, C., Loschke, F., Schwarz, N., Windoffer, R., Leube, R.E., Magin, T.M., 2013. Keratins
control intercellular adhesion involving PKC-alpha-mediated desmoplakin phosphorylation. J Cell
Biol 201, 681-692.
Krylov, V., Kubickova, S., Rubes, J., Macha, J., Tlapakova, T., Seifertova, E., Sebkova, N., 2010.
Preparation of Xenopus tropicalis whole chromosome painting probes using laser microdissec tio n
and reconstruction of X. laevis tetraploid karyotype by Zoo-FISH. Chromosome Res 18, 431-439.
Kuan, C.Y., Yang, D.D., Samanta Roy, D.R., Davis, R.J., Rakic, P., Flavell, R.A., 1999. The Jnk1
and Jnk2 protein kinases are required for regional specific apoptosis during early brain
development. Neuron 22, 667-676.
Kuhl, M., 2002. Non-canonical Wnt signaling in Xenopus: regulatio n of axis formation and
gastrulation. Semin Cell Dev Biol 13, 243-249.
Kukekov, N.V., Xu, Z., Greene, L.A., 2006. Direct interaction of the molecular scaffolds POSH
and JIP is required for apoptotic activation of JNKs. J Biol Chem 281, 15517-15524.
Kupriyanov, S., Baribault, H., 1998. Genetic control of extraembryonic cell lineages studied with
tetraploid<-->diploid chimeric concepti. Biochem Cell Biol 76, 1017-1027.
Kuwabara, T., Perkins, D.G., Cogan, D.G., 1976. Sliding of the epithelium in experimental corneal
wounds. Invest Ophthalmol 15, 4-14.
Larre, I., Ponce, A., Franco, M., Cereijido, M., 2014. The emergence of the concept of tight
junctions and physiological regulation by ouabain. Semin Cell Dev Biol 36, 149-156.
Lechler, T., Fuchs, E., 2005. Asymmetric cell divisions promote stratification and differentia tio n
of mammalian skin. Nature 437, 275-280.
Lechler, T., Fuchs, E., 2007. Desmoplakin: an unexpected regulator of microtubule organiza tio n
in the epidermis. J Cell Biol 176, 147-154.
Lee, M.H., Koria, P., Qu, J., Andreadis, S.T., 2009. JNK phosphorylates beta-catenin and regulates
adherens junctions. FASEB J 23, 3874-3883.
Lei, K., Davis, R.J., 2003. JNK phosphorylation of Bim-related members of the Bcl2 family
induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 100, 2432-2437.
Lei, K., Nimnual, A., Zong, W.X., Kennedy, N.J., Flavell, R.A., Thompson, C.B., Bar-Sagi, D.,
Davis, R.J., 2002. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal
transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22, 4929-4942.

172

Lei, Y., Guo, X., Liu, Y., Cao, Y., Deng, Y., Chen, X., Cheng, C.H., Dawid, I.B., Chen, Y., Zhao,
H., 2012. Efficient targeted gene disruption in Xenopus embryos using engineered transcriptio n
activator-like effector nucleases (TALENs). Proc Natl Acad Sci U S A 109, 17484-17489.
Leung, C.L., Green, K.J., Liem, R.K., 2002. Plakins: a family of versatile cytolinker proteins.
Trends Cell Biol 12, 37-45.
Li, W., Cowley, A., Uludag, M., Gur, T., McWilliam, H., Squizzato, S., Park, Y.M., Buso, N.,
Lopez, R., 2015. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic
Acids Res 43, W580-584.
Liao, G., Tao, Q., Kofron, M., Chen, J.S., Schloemer, A., Davis, R.J., Hsieh, J.C., Wylie, C.,
Heasman, J., Kuan, C.Y., 2006. Jun NH2-terminal kinase (JNK) prevents nuclear beta-catenin
accumulation and regulates axis formation in Xenopus embryos. Proc Natl Acad Sci U S A 103,
16313-16318.
Lifshitz, T., Levy, J., Cagnano, E., Halevy, S., 2004. Severe conjunctival and eyelid involve me nt
in pemphigus vulgaris. Int Ophthalmol 25, 73-74.
Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L.,
Karin, M., 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38Mpk2. Science 268, 286-290.
Liu, S., Zhang, H., Duan, E., 2013. Epidermal development in mammals: key regulators, signals
from beneath, and stem cells. Int J Mol Sci 14, 10869-10895.
Lohr, J.L., Yost, H.J., 2000. Vertebrate model systems in the study of early heart development:
Xenopus and zebrafish. Am J Med Genet 97, 248-257.
Lourenco, S.V., Kamibeppu, L., Fernandes, J.D., Sotto, M.N., Nico, M.M., 2008. Relationship of
adhesion molecules expression with epithelial differentiation markers during fetal skin
development. J Cutan Pathol 35, 731-737.
Magnuson, T., Demsey, A., Stackpole, C.W., 1977. Characterization of intercellular junctions in
the preimplantation mouse embryo by freeze-fracture and thin-section electron microscopy. Dev
Biol 61, 252-261.
Mahoney, M.G., Wang, Z., Rothenberger, K., Koch, P.J., Amagai, M., Stanley, J.R., 1999.
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and
vulgaris. J Clin Invest 103, 461-468.
Marcozzi, C., Burdett, I.D., Buxton, R.S., Magee, A.I., 1998. Coexpression of both types of
desmosomal cadherin and plakoglobin confers strong intercellular adhesion. J Cell Sci 111 ( Pt 4),
495-509.
Marsden, M.D., Collins, J.E., Greenwood, M.D., Adams, M.J., Fleming, T.P., Magee, A.I.,
Buxton, R.S., 1997. Cloning and transcriptional analysis of the promoter of the human type 2
desmocollin gene (DSC2). Gene 186, 237-247.

173

Mashal, R.D., Koontz, J., Sklar, J., 1995. Detection of mutations by cleavage of DNA
heteroduplexes with bacteriophage resolvases. Nat Genet 9, 177-183.
Mathur, M., Goodwin, L., Cowin, P., 1994. Interactions of the cytoplasmic domain of the
desmosomal cadherin Dsg1 with plakoglobin. J Biol Chem 269, 14075-14080.
Matsuda, Y., Uno, Y., Kondo, M., Gilchrist, M.J., Zorn, A.M., Rokhsar, D.S., Schmid, M., Taira,
M., 2015. A New Nomenclature of Xenopus laevis Chromosomes Based on the Phylogene tic
Relationship to Silurana/Xenopus tropicalis. Cytogenet Genome Res 145, 187-191.
Matsui, H., Fukuno, N., Kanda, Y., Kantoh, Y., Chida, T., Nagaura, Y., Suzuki, O., Nishitoh, H.,
Takeda, K., Ichijo, H., Sawada, Y., Sasaki, K., Kobayashi, T., Tamura, S., 2014. The expression
of Fn14 via mechanical stress-activated JNK contributes to apoptosis induction in osteoblasts. J
Biol Chem 289, 6438-6450.
Mattey, D.L., Garrod, D.R., 1986. Splitting and internalization of the desmosomes of cultured
kidney epithelial cells by reduction in calcium concentration. J Cell Sci 85, 113-124.
Mayerson, P.L., Brumbaugh, J.A., 1981. Lavender, a chick melanocyte mutant with defective
melanosome translocation: a possible role for 10 nm filaments and microfilaments but not
microtubules. J Cell Sci 51, 25-51.
McCrea, P.D., Turck, C.W., Gumbiner, B., 1991. A homolog of the armadillo protein in
Drosophila (plakoglobin) associated with E-cadherin. Science 254, 1359-1361.
McGrath, J.A., 2005. Inherited disorders of desmosomes. Australas J Dermatol 46, 221-229.
McGrath, J.A., McMillan, J.R., Shemanko, C.S., Runswick, S.K., Leigh, I.M., Lane, E.B., Garrod,
D.R., Eady, R.A., 1997. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/sk in
fragility syndrome. Nat Genet 17, 240-244.
McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A.,
Norman, M., Baboonian, C., Jeffery, S., McKenna, W.J., 2000. Identification of a deletion in
plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma
and woolly hair (Naxos disease). Lancet 355, 2119-2124.
McMahon, A., Reeves, G.T., Supatto, W., Stathopoulos, A., 2010. Mesoderm migration in
Drosophila is a multi-step process requiring FGF signaling and integrin activity. Developme nt
137, 2167-2175.
McMahon, A., Supatto, W., Fraser, S.E., Stathopoulos, A., 2008. Dynamic analyses of Drosophila
gastrulation provide insights into collective cell migration. Science 322, 1546-1550.
McWilliam, H., Li, W., Uludag, M., Squizzato, S., Park, Y.M., Buso, N., Cowley, A.P., Lopez,
R., 2013. Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids Res 41, W597-600.
Melish, M.E., Glasgow, L.A., 1970. The staphylococcal scalded-skin syndrome. N Engl J Med
282, 1114-1119.

174

Mengistu, M., Brotzman, H., Ghadiali, S., Lowe-Krentz, L., 2011. Fluid shear stress-induced JNK
activity leads to actin remodeling for cell alignment. J Cell Physiol 226, 110-121.
Mertens, C., Kuhn, C., Franke, W.W., 1996. Plakophilins 2a and 2b: constitutive proteins of dual
location in the karyoplasm and the desmosomal plaque. J Cell Biol 135, 1009-1025.
Mertens, C., Kuhn, C., Moll, R., Schwetlick, I., Franke, W.W., 1999. Desmosomal plakophilin 2
as a differentiation marker in normal and malignant tissues. Differentiation 64, 277-290.
Messent, A.J., Blissett, M.J., Smith, G.L., North, A.J., Magee, A., Foreman, D., Garrod, D.R.,
Boulton, M., 2000. Expression of a single pair of desmosomal glycoproteins renders the corneal
epithelium unique amongst stratified epithelia. Invest Ophthalmol Vis Sci 41, 8-15.
Miller, J.C., Holmes, M.C., Wang, J., Guschin, D.Y., Lee, Y.L., Rupniewski, I., Beausejour, C.M.,
Waite, A.J., Wang, N.S., Kim, K.A., Gregory, P.D., Pabo, C.O., Rebar, E.J., 2007. An improved
zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25, 778-785.
Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, D.E., Leung,
E., Hinkley, S.J., Dulay, G.P., Hua, K.L., Ankoudinova, I., Cost, G.J., Urnov, F.D., Zhang, H.S.,
Holmes, M.C., Zhang, L., Gregory, P.D., Rebar, E.J., 2011. A TALE nuclease architecture for
efficient genome editing. Nat Biotechnol 29, 143-148.
Milligan, J.F., Uhlenbeck, O.C., 1989. Synthesis of small RNAs using T7 RNA polymerase.
Methods Enzymol 180, 51-62.
Miravet, S., Piedra, J., Castano, J., Raurell, I., Franci, C., Dunach, M., Garcia de Herreros, A.,
2003. Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with
desmosomes and adherens junction components and modulates beta-catenin-mediated
transcription. Mol Cell Biol 23, 7391-7402.
Miravet, S., Piedra, J., Miro, F., Itarte, E., Garcia de Herreros, A., Dunach, M., 2002. The
transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol
Chem 277, 1884-1891.
Mitsuyama, K., Suzuki, A., Tomiyasu, N., Tsuruta, O., Kitazaki, S., Takeda, T., Satoh, Y., Bennett,
B.L., Toyonaga, A., Sata, M., 2006. Pro-inflammatory signaling by Jun-N-terminal kinase in
inflammatory bowel disease. Int J Mol Med 17, 449-455.
Mogensen, M.M., Malik, A., Piel, M., Bouckson-Castaing, V., Bornens, M., 2000. Microtubule
minus-end anchorage at centrosomal and non-centrosomal sites: the role of ninein. J Cell Sci 113
( Pt 17), 3013-3023.
Moll, R., Moll, I., Wiest, W., 1982. Changes in the pattern of cytokeratin polypeptides in epidermis
and hair follicles during skin development in human fetuses. Differentiation 23, 170-178.
Moody, S.A., 1987. Fates of the blastomeres of the 32-cell-stage Xenopus embryo. Dev Biol 122,
300-319.
Moody, S.A., Kline, M.J., 1990. Segregation of fate during cleavage of frog (Xenopus laevis)
blastomeres. Anat Embryol (Berl) 182, 347-362.
175

Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y., Nishida, E., 1997. A novel
SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J 16, 7045-7053.
Morita, H., Heisenberg, C.P., 2013. Holding on and letting go: cadherin turnover in cell
intercalation. Dev Cell 24, 567-569.
Mueller, C.A., Seymour, R.S., 2011. The importance of perivitelline fluid convection to oxygen
uptake of Pseudophryne bibronii eggs. Physiol Biochem Zool 84, 299-305.
Muhmer, M., Ditthardt, D., Jakel, J., Wischmann, V., Moll, R., Schmidt, A., 2014. An alternative
promoter of the human plakophilin-3 gene controls the expression of the new isoform PKP3b. Cell
Tissue Res 355, 143-162.
Mun, S.H., Kim, J.W., Nah, S.S., Ko, N.Y., Lee, J.H., Kim, J.D., Kim, D.K., Kim, H.S., Choi,
J.D., Kim, S.H., Lee, C.K., Park, S.H., Kim, B.K., Kim, H.S., Kim, Y.M., Choi, W.S., 2009. Tumor
necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase
Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 60, 678-685.
Nakayama, T., Fish, M.B., Fisher, M., Oomen-Hajagos, J., Thomsen, G.H., Grainger, R.M., 2013.
Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis
51, 835-843.
Nasevicius, A., Ekker, S.C., 2000. Effective targeted gene 'knockdown' in zebrafish. Nat Genet
26, 216-220.
Naydenov, N.G., Hopkins, A.M., Ivanov, A.I., 2009. c-Jun N-terminal kinase mediates
disassembly of apical junctions in model intestinal epithelia. Cell Cycle 8, 2110-2121.
Niessen, C.M., 2007. Tight junctions/adherens junctions: basic structure and function. J Invest
Dermatol 127, 2525-2532.
Niessen, C.M., Gottardi, C.J., 2008. Molecular components of the adherens junction. Biochim
Biophys Acta 1778, 562-571.
Nieuwkoop, P., Faber, J., 1967. Normal table of Xenopus laevis (Daudin): a systematic and
chronological survey of the development from the fertilized egg till the end of metamorpho s is.
North-Holland.
Nishifuji, K., Sugai, M., Amagai, M., 2008. Staphylococcal exfoliative toxins: "molecular
scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 49, 2131.
Norgett, E.E., Hatsell, S.J., Carvajal-Huerta, L., Cabezas, J.C., Common, J., Purkis, P.E.,
Whittock, N., Leigh, I.M., Stevens, H.P., Kelsell, D.P., 2000. Recessive mutation in desmoplakin
disrupts desmoplakin- intermediate filament interactions and causes dilated cardiomyopathy,
woolly hair and keratoderma. Hum Mol Genet 9, 2761-2766.
Odegaard, E., Staff, A.C., Abeler, V.M., Kopolovic, J., Onsrud, M., Lazarovici, P., Davidson, B.,
2007. The activated nerve growth factor receptor p-TrkA is selectively expressed in advancedstage ovarian carcinoma. Hum Pathol 38, 140-146.
176

Ohga, R., Shida, M., Shida, H., 2004. Isolation of desmosomes from the epidermis of Xenopus
laevis and immunochemical characterization of the Xenopus desmosomal cadherins. Cell Struct
Funct 29, 17-26.
Oliver, J., 1944. New directions in renal morphology: A method, its results and its future. Harvey
Lectures 40, 102-155.
Park, M.K., Lee, H.J., Shin, J., Noh, M., Kim, S.Y., Lee, C.H., 2011. Novel participation of
transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine induced keratin reorganization of PANC-1 cells. Biochim Biophys Acta 1811, 1021-1029.
Park, T.J., Mitchell, B.J., Abitua, P.B., Kintner, C., Wallingford, J.B., 2008. Dishevelled controls
apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 40,
871-879.
Parker, A.E., Wheeler, G.N., Arnemann, J., Pidsley, S.C., Ataliotis, P., Thomas, C.L., Rees, D.A.,
Magee, A.I., Buxton, R.S., 1991. Desmosomal glycoproteins II and III. Cadherin-like junctio na l
molecules generated by alternative splicing. J Biol Chem 266, 10438-10445.
Payne, A.S., Hanakawa, Y., Amagai, M., Stanley, J.R., 2004. Desmosomes and disease:
pemphigus and bullous impetigo. Curr Opin Cell Biol 16, 536-543.
Pearl, E.J., Grainger, R.M., Guille, M., Horb, M.E., 2012. Development of Xenopus resource
centers: the National Xenopus Resource and the European Xenopus Resource Center. Genesis 50,
155-163.
Peifer, M., Berg, S., Reynolds, A.B., 1994. A repeating amino acid motif shared by proteins with
diverse cellular roles. Cell 76, 789-791.
Peifer, M., McCrea, P.D., Green, K.J., Wieschaus, E., Gumbiner, B.M., 1992. The vertebrate
adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene
armadillo form a multigene family with similar properties. J Cell Biol 118, 681-691.
Pereira, A.M., Tudor, C., Kanger, J.S., Subramaniam, V., Martin-Blanco, E., 2011. Integrindependent activation of the JNK signaling pathway by mechanical stress. PLoS One 6, e26182.
Perrais, M., Chen, X., Perez-Moreno, M., Gumbiner, B.M., 2007. E-cadherin homophilic ligatio n
inhibits cell growth and epidermal growth factor receptor signaling independently of other cell
interactions. Mol Biol Cell 18, 2013-2025.
Pilichou, K., Nava, A., Basso, C., Beffagna, G., Bauce, B., Lorenzon, A., Frigo, G., Vettori, A.,
Valente, M., Towbin, J., Thiene, G., Danieli, G.A., Rampazzo, A., 2006. Mutations in desmogle in2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113,
1171-1179.
Pokutta, S., Weis, W.I., 2007. Structure and mechanism of cadherins and catenins in cell- cell
contacts. Annu Rev Cell Dev Biol 23, 237-261.
Porteus, M.H., Baltimore, D., 2003. Chimeric nucleases stimulate gene targeting in human cells.
Science 300, 763.
177

Potter, E., Braun, S., Lehmann, U., Brabant, G., 2001. Molecular cloning of a functional promoter
of the human plakoglobin gene. Eur J Endocrinol 145, 625-633.
Pulverer, B.J., Kyriakis, J.M., Avruch, J., Nikolakaki, E., Woodgett, J.R., 1991. Phosphoryla tio n
of c-jun mediated by MAP kinases. Nature 353, 670-674.
Pummi, K., Malminen, M., Aho, H., Karvonen, S.L., Peltonen, J., Peltonen, S., 2001. Epidermal
tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in
vitro differentiating keratinocytes. J Invest Dermatol 117, 1050-1058.
Quigley, I.K., Stubbs, J.L., Kintner, C., 2011. Specification of ion transport cells in the Xenopus
larval skin. Development 138, 705-714.
Rice, P., Longden, I., Bleasby, A., 2000. EMBOSS: the European Molecular Biology Open
Software Suite. Trends Genet 16, 276-277.
Riesgo-Escovar, J.R., Hafen, E., 1997. Drosophila Jun kinase regulates expression of
decapentaplegic via the ETS-domain protein Aop and the AP-1 transcription factor DJun during
dorsal closure. Genes Dev 11, 1717-1727.
Rogers, S.L., Gelfand, V.I., 1998. Myosin cooperates with microtubule motors during organelle
transport in melanophores. Curr Biol 8, 161-164.
Roh, J.Y., Stanley, J.R., 1995. Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen)
in keratinocytes requires the cadherin-like intracytoplasmic segment. J Invest Dermatol 104, 720724.
Roop, D.R., Huitfeldt, H., Kilkenny, A., Yuspa, S.H., 1987. Regulated expression of
differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies
to unique peptides of mouse epidermal keratins. Differentiation 35, 143-150.
Roper, K., Gregory, S.L., Brown, N.H., 2002. The 'spectraplakins': cytoskeletal giants with
characteristics of both spectrin and plakin families. J Cell Sci 115, 4215-4225.
Rosette, C., Karin, M., 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade
through multiple growth factor and cytokine receptors. Science 274, 1194-1197.
Rotzer, V., Hartlieb, E., Vielmuth, F., Gliem, M., Spindler, V., Waschke, J., 2015. E-cadherin and
Src associate with extradesmosomal Dsg3 and modulate desmosome assembly and adhesion. Cell
Mol Life Sci 72, 4885-4897.
Roux, K.J., Kim, D.I., Burke, B., 2013. BioID: a screen for protein-protein interactions. Curr
Protoc Protein Sci 74, Unit 19 23.
Russell, D., Andrews, P.D., James, J., Lane, E.B., 2004. Mechanical stress induces profound
remodelling of keratin filaments and cell junctions in epidermolysis bullosa simplex keratinocytes.
J Cell Sci 117, 5233-5243.

178

Sabapathy, K., Hochedlinger, K., Nam, S.Y., Bauer, A., Karin, M., Wagner, E.F., 2004. Distinct
roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol
Cell 15, 713-725.
Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M., Wagner, E.F., 1999.
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2.
Mech Dev 89, 115-124.
Saito, M., Stahley, S.N., Caughman, C.Y., Mao, X., Tucker, D.K., Payne, A.S., Amagai, M.,
Kowalczyk, A.P., 2012. Signaling dependent and independent mechanisms in pemphigus vulgar is
blister formation. PLoS One 7, e50696.
Samak, G., Narayanan, D., Jaggar, J.H., Rao, R., 2011. CaV1.3 channels and intracellular calcium
mediate osmotic stress-induced N-terminal c-Jun kinase activation and disruption of tight junctions
in Caco-2 CELL MONOLAYERS. J Biol Chem 286, 30232-30243.
Sater, A.K., Moody, S.A., 2017. Using Xenopus to understand human disease and developmenta l
disorders. Genesis 55.
Schempp, C., Emde, M., Wolfle, U., 2009. Dermatology in the Darwin anniversary. Part 1:
Evolution of the integument. J Dtsch Dermatol Ges 7, 750-757.
Schett, G., Tohidast-Akrad, M., Smolen, J.S., Schmid, B.J., Steiner, C.W., Bitzan, P., Zenz, P.,
Redlich, K., Xu, Q., Steiner, G., 2000. Activation, differential localization, and regulation of the
stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase,
and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Arthritis Rheum 43, 2501-2512.
Schmelz, M., Franke, W.W., 1993. Complexus adhaerentes, a new group of desmoplakincontaining junctions in endothelial cells: the syndesmos connecting retothelial cells of lymph
nodes. Eur J Cell Biol 61, 274-289.
Schmelz, M., Moll, R., Kuhn, C., Franke, W.W., 1994. Complexus adhaerentes, a new group of
desmoplakin-containing junctions in endothelial cells: II. Different types of lymphatic vessels.
Differentiation 57, 97-117.
Schmidt, A., Langbein, L., Rode, M., Pratzel, S., Zimbelmann, R., Franke, W.W., 1997.
Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as
desmosomal plaque components. Cell Tissue Res 290, 481-499.
Schmitt, S.M., Gull, M., Brandli, A.W., 2014. Engineering Xenopus embryos for phenotypic drug
discovery screening. Adv Drug Deliv Rev 69-70, 225-246.
Sedzinski, J., Hannezo, E., Tu, F., Biro, M., Wallingford, J.B., 2016. Emergence of an Apical
Epithelial Cell Surface In Vivo. Dev Cell 36, 24-35.
Sedzinski, J., Hannezo, E., Tu, F., Biro, M., Wallingford, J.B., 2017. RhoA regulates actin network
dynamics during apical surface emergence in multiciliated epithelial cells. J Cell Sci 130, 420428.
179

Session, A.M., Uno, Y., Kwon, T., Chapman, J.A., Toyoda, A., Takahashi, S., Fukui, A.,
Hikosaka, A., Suzuki, A., Kondo, M., van Heeringen, S.J., Quigley, I., Heinz, S., Ogino, H., Ochi,
H., Hellsten, U., Lyons, J.B., Simakov, O., Putnam, N., Stites, J., Kuroki, Y., Tanaka, T., Michiue,
T., Watanabe, M., Bogdanovic, O., Lister, R., Georgiou, G., Paranjpe, S.S., van Kruijsbergen, I.,
Shu, S., Carlson, J., Kinoshita, T., Ohta, Y., Mawaribuchi, S., Jenkins, J., Grimwood, J., Schmutz,
J., Mitros, T., Mozaffari, S.V., Suzuki, Y., Haramoto, Y., Yamamoto, T.S., Takagi, C., Heald, R.,
Miller, K., Haudenschild, C., Kitzman, J., Nakayama, T., Izutsu, Y., Robert, J., Fortriede, J., Burns,
K., Lotay, V., Karimi, K., Yasuoka, Y., Dichmann, D.S., Flajnik, M.F., Houston, D.W., Shendure,
J., DuPasquier, L., Vize, P.D., Zorn, A.M., Ito, M., Marcotte, E.M., Wallingford, J.B., Ito, Y.,
Asashima, M., Ueno, N., Matsuda, Y., Veenstra, G.J., Fujiyama, A., Harland, R.M., Taira, M.,
Rokhsar, D.S., 2016. Genome evolution in the allotetraploid frog Xenopus laevis. Nature 538, 336343.
Shah, A.N., Davey, C.F., Whitebirch, A.C., Miller, A.C., Moens, C.B., 2015. Rapid reverse genetic
screening using CRISPR in zebrafish. Nat Methods 12, 535-540.
Shah, A.N., Moens, C.B., Miller, A.C., 2016. Targeted candidate gene screens using CRISPR/Cas9
technology. Methods Cell Biol 135, 89-106.
Sheu, H.M., Kitajima, Y., Yaoita, H., 1989. Involvement of protein kinase C in translocation of
desmoplakins from cytosol to plasma membrane during desmosome formation in human
squamous cell carcinoma cells grown in low to normal calcium concentration. Exp Cell Res 185,
176-190.
Shi, J., Wang, E., Milazzo, J.P., Wang, Z., Kinney, J.B., Vakoc, C.R., 2015a. Discovery of cancer
drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol 33, 661-667.
Shi, Z., Wang, F., Cui, Y., Liu, Z., Guo, X., Zhang, Y., Deng, Y., Zhao, H., Chen, Y., 2015b.
Heritable CRISPR/Cas9-mediated targeted integration in Xenopus tropicalis. FASEB J 29, 49144923.
Shimizu, T., Yabe, T., Muraoka, O., Yonemura, S., Aramaki, S., Hatta, K., Bae, Y.K., Nojima, H.,
Hibi, M., 2005. E-cadherin is required for gastrulation cell movements in zebrafish. Mech Dev
122, 747-763.
Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C.F., Ono,
S., Okazawa, H., 2000. JNK activation is associated with intracellular beta-amyloid accumulatio n.
Brain Res Mol Brain Res 85, 221-233.
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H.,
Remmert, M., Soding, J., Thompson, J.D., Higgins, D.G., 2011. Fast, scalable generation of highquality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 539.
Simcha, I., Shtutman, M., Salomon, D., Zhurinsky, J., Sadot, E., Geiger, B., Ben-Ze'ev, A., 1998.
Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J
Cell Biol 141, 1433-1448.

180

Sirour, C., Hidalgo, M., Bello, V., Buisson, N., Darribere, T., Moreau, N., 2011. Dystroglycan is
involved in skin morphogenesis downstream of the Notch signaling pathway. Mol Biol Cell 22,
2957-2969.
Sive, H.L., Grainger, R.M., Harland, R.M., 2000. Early development of Xenopus laevis: a
laboratory manual.
Slanchev, K., Carney, T.J., Stemmler, M.P., Koschorz, B., Amsterdam, A., Schwarz, H.,
Hammerschmidt, M., 2009. The epithelial cell adhesion molecule EpCAM is required for
epithelial morphogenesis and integrity during zebrafish epiboly and skin development. PLoS
Genet 5, e1000563.
Sluss, H.K., Davis, R.J., 1997. Embryonic morphogenesis signaling pathway mediated by JNK
targets the transcription factor JUN and the TGF-beta homologue decapentaplegic. J Cell Biochem
67, 1-12.
Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M., Karin, M., 1991. Oncogenic and transcriptio na l
cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494496.
Solnica-Krezel, L., Stemple, D.L., Mountcastle-Shah, E., Rangini, Z., Neuhauss, S.C., Malicki, J.,
Schier, A.F., Stainier, D.Y., Zwartkruis, F., Abdelilah, S., Driever, W., 1996. Mutations affecting
cell fates and cellular rearrangements during gastrulation in zebrafish. Development 123, 67-80.
Song, S., Eckerle, S., Onichtchouk, D., Marrs, J.A., Nitschke, R., Driever, W., 2013. Pou5f1dependent EGF expression controls E-cadherin endocytosis, cell adhesion, and zebrafish epiboly
movements. Dev Cell 24, 486-501.
Spindler, V., Dehner, C., Hubner, S., Waschke, J., 2014. Plakoglobin but not desmoplakin
regulates keratinocyte cohesion via modulation of p38MAPK signaling. J Invest Dermatol 134,
1655-1664.
Staehelin, L.A., Hull, B.E., 1978. Junctions between living cells. Sci Am 238, 140-152.
Stahley, S.N., Kowalczyk, A.P., 2015. Desmosomes in acquired disease. Cell Tissue Res 360, 439456.
Stahley, S.N., Saito, M., Faundez, V., Koval, M., Mattheyses, A.L., Kowalczyk, A.P., 2014.
Desmosome assembly and disassembly are membrane raft-dependent. PLoS One 9, e87809.
Stappenbeck, T.S., Bornslaeger, E.A., Corcoran, C.M., Luu, H.H., Virata, M.L., Green, K.J., 1993.
Functional analysis of desmoplakin domains: specification of the interaction with keratin vers us
vimentin intermediate filament networks. J Cell Biol 123, 691-705.
Steinert, P.M., Marekov, L.N., Fraser, R.D., Parry, D.A., 1993. Keratin intermediate fila me nt
structure. Crosslinking studies yield quantitative information on molecular dimensions and
mechanism of assembly. J Mol Biol 230, 436-452.
Stephenson, R.E., Miller, A.L., 2017. Tools for live imaging of active Rho GTPases in Xenopus.
Genesis 55.
181

Sternberg, S.H., Redding, S., Jinek, M., Greene, E.C., Doudna, J.A., 2014. DNA interrogation by
the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62-67.
Stubbs, J.L., Davidson, L., Keller, R., Kintner, C., 2006. Radial intercalation of ciliated cells
during Xenopus skin development. Development 133, 2507-2515.
Stubbs, J.L., Oishi, I., Izpisua Belmonte, J.C., Kintner, C., 2008. The forkhead protein Foxj1
specifies node-like cilia in Xenopus and zebrafish embryos. Nat Genet 40, 1454-1460.
Stubbs, J.L., Vladar, E.K., Axelrod, J.D., Kintner, C., 2012. Multicilin promotes centriole
assembly and ciliogenesis during multiciliate cell differentiation. Nat Cell Biol 14, 140-147.
Sumigray, K.D., Lechler, T., 2012. Desmoplakin controls microvilli length but not cell adhesion
or keratin organization in the intestinal epithelium. Mol Biol Cell 23, 792-799.
Syed, S.E., Trinnaman, B., Martin, S., Major, S., Hutchinson, J., Magee, A.I., 2002. Molecular
interactions between desmosomal cadherins. Biochem J 362, 317-327.
Takahashi, H., Ibe, M., Nakamura, S., Ishida-Yamamoto, A., Hashimoto, Y., Iizuka, H., 2002.
Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved
epidermis. J Dermatol Sci 30, 94-99.
Takekawa, M., Posas, F., Saito, H., 1997. A human homolog of the yeast Ssk2/Ssk22 MAP kinase
kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO
J 16, 4973-4982.
Tandon, P., Conlon, F., Furlow, J.D., Horb, M.E., 2017. Expanding the genetic toolkit in Xenopus:
Approaches and opportunities for human disease modeling. Dev Biol 426, 325-335.
Thakur, A., Wang, X., Siedlak, S.L., Perry, G., Smith, M.A., Zhu, X., 2007. c-Jun phosphoryla tio n
in Alzheimer disease. J Neurosci Res 85, 1668-1673.
Thomason, H.A., Cooper, N.H., Ansell, D.M., Chiu, M., Merrit, A.J., Hardman, M.J., Garrod,
D.R., 2012. Direct evidence that PKCalpha positively regulates wound re-epithelializatio n:
correlation with changes in desmosomal adhesiveness. J Pathol 227, 346-356.
Thomason, H.A., Scothern, A., McHarg, S., Garrod, D.R., 2010. Desmosomes: adhesive strength
and signalling in health and disease. Biochem J 429, 419-433.
Tournier, C., Dong, C., Turner, T.K., Jones, S.N., Flavell, R.A., Davis, R.J., 2001. MKK7 is an
essential component of the JNK signal transduction pathway activated by proinflammator y
cytokines. Genes Dev 15, 1419-1426.
Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N.,
Flavell, R.A., Davis, R.J., 2000. Requirement of JNK for stress-induced activation of the
cytochrome c-mediated death pathway. Science 288, 870-874.
Tournier, C., Whitmarsh, A.J., Cavanagh, J., Barrett, T., Davis, R.J., 1997. Mitogen-activated
protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc Natl Acad Sci U S
A 94, 7337-7342.
182

Trinkaus, J.P., Lentz, T.L., 1967. Surface specializatio ns of Fundulus cells and their relation to
cell movements during gastrulation. J Cell Biol 32, 139-153.
Troyanovsky, S.M., Troyanovsky, R.B., Eshkind, L.G., Leube, R.E., Franke, W.W., 1994.
Identification of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein, that are
required for plakoglobin binding and plaque formation. Proc Natl Acad Sci U S A 91, 1079010794.
Tselepis, C., Chidgey, M., North, A., Garrod, D., 1998. Desmosomal adhesion inhibits invasive
behavior. Proc Natl Acad Sci U S A 95, 8064-8069.
Tsunoda, K., Ota, T., Aoki, M., Yamada, T., Nagai, T., Nakagawa, T., Koyasu, S., Nishikawa, T.,
Amagai, M., 2003. Induction of pemphigus phenotype by a mouse monoclonal antibody against
the amino-terminal adhesive interface of desmoglein 3. J Immunol 170, 2170-2178.
Tucker, D.K., Stahley, S.N., Kowalczyk, A.P., 2014. Plakophilin-1 Protects Keratinocytes from
Pemphigus Vulgaris IgG by Forming Calcium-Independent Desmosomes. Journal of Investiga tive
Dermatology 134, 1033-1043.
Tuma, M.C., Zill, A., Le Bot, N., Vernos, I., Gelfand, V., 1998. Heterotrimeric kinesin II is the
microtubule motor protein responsible for pigment dispersion in Xenopus melanophores. J Cell
Biol 143, 1547-1558.
Tymowska, J., Kobel, H.R., 1972. Karyotype analysis of Xenopus muelleri (Peters) and Xenopus
laevis (Daudin), Pipidae. Cytogenetics 11, 270-278.
Uno, Y., Nishida, C., Takagi, C., Ueno, N., Matsuda, Y., 2013. Homoeologous chromosomes of
Xenopus laevis are highly conserved after whole-genome duplication. Heredity (Edinb) 111, 430436.
Uttam, J., Hutton, E., Coulombe, P.A., Anton-Lamprecht, I., Yu, Q.C., Gedde-Dahl, T., Jr., Fine,
J.D., Fuchs, E., 1996. The genetic basis of epidermolysis bullosa simplex with mottled
pigmentation. Proc Natl Acad Sci U S A 93, 9079-9084.
van Tintelen, J.P., Entius, M.M., Bhuiyan, Z.A., Jongbloed, R., Wiesfeld, A.C., Wilde, A.A., van
der Smagt, J., Boven, L.G., Mannens, M.M., van Langen, I.M., Hofstra, R.M., Otterspoor, L.C.,
Doevendans, P.A., Rodriguez, L.M., van Gelder, I.C., Hauer, R.N., 2006. Plakophilin-2 mutatio ns
are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Circulation 113, 1650-1658.
Vasioukhin, V., Bowers, E., Bauer, C., Degenstein, L., Fuchs, E., 2001. Desmoplakin is essential
in epidermal sheet formation. Nat Cell Biol 3, 1076-1085.
Virata, M.L., Wagner, R.M., Parry, D.A., Green, K.J., 1992. Molecular structure of the human
desmoplakin I and II amino terminus. Proc Natl Acad Sci U S A 89, 544-548.
Walck-Shannon, E., Hardin, J., 2014. Cell intercalation from top to bottom. Nat Rev Mol Cell Biol
15, 34-48.

183

Wall, S.M., 2005. Recent advances in our understanding of intercalated cells. Curr Opin Nephrol
Hypertens 14, 480-484.
Wallis, S., Lloyd, S., Wise, I., Ireland, G., Fleming, T.P., Garrod, D., 2000. The alpha isoform of
protein kinase C is involved in signaling the response of desmosomes to wounding in cultured
epithelial cells. Mol Biol Cell 11, 1077-1092.
Wan, H., South, A.P., Hart, I.R., 2007. Increased keratinocyte proliferation initiated through
downregulation of desmoplakin by RNA interference. Exp Cell Res 313, 2336-2344.
Wang, F., Shi, Z., Cui, Y., Guo, X., Shi, Y.B., Chen, Y., 2015. Targeted gene disruption in
Xenopus laevis using CRISPR/Cas9. Cell Biosci 5, 15.
Wang, Q., Margolis, B., 2007. Apical junctional complexes and cell polarity. Kidney Int 72, 14481458.
Wang, X., Chao, L., Li, X., Ma, G., Chen, L., Zang, Y., Zhou, G., 2010. Elevated expression of
phosphorylated c-Jun NH2-terminal kinase in basal-like and "triple-negative" breast cancers. Hum
Pathol 41, 401-406.
Wang, X.S., Diener, K., Jannuzzi, D., Trollinger, D., Tan, T.H., Lichenstein, H., Zukowski, M.,
Yao, Z., 1996. Molecular cloning and characterization of a novel protein kinase with a catalytic
domain homologous to mitogen-activated protein kinase kinase kinase. J Biol Chem 271, 3160731611.
Warkman, A.S., Krieg, P.A., 2007. Xenopus as a model system for vertebrate heart development.
Semin Cell Dev Biol 18, 46-53.
Wasmeier, C., Hume, A.N., Bolasco, G., Seabra, M.C., 2008. Melanosomes at a glance. J Cell Sci
121, 3995-3999.
Watt, F.M., Mattey, D.L., Garrod, D.R., 1984. Calcium- induced reorganization of desmosomal
components in cultured human keratinocytes. J Cell Biol 99, 2211-2215.
Wei, S.Y., Escudero, L.M., Yu, F., Chang, L.H., Chen, L.Y., Ho, Y.H., Lin, C.M., Chou, C.S.,
Chia, W., Modolell, J., Hsu, J.C., 2005. Echinoid is a component of adherens junctions that
cooperates with DE-Cadherin to mediate cell adhesion. Dev Cell 8, 493-504.
Werner, M.E., Mitchell, J.W., Putzbach, W., Bacon, E., Kim, S.K., Mitchell, B.J., 2014. Radial
intercalation is regulated by the Par complex and the microtubule-stabilizing protein
CLAMP/Spef1. J Cell Biol 206, 367-376.
Weston, C.R., Wong, A., Hall, J.P., Goad, M.E., Flavell, R.A., Davis, R.J., 2004. The c-Jun NH2terminal kinase is essential for epidermal growth factor expression during epidermal
morphogenesis. Proc Natl Acad Sci U S A 101, 14114-14119.
Whittock, N.V., Ashton, G.H., Dopping-Hepenstal, P.J., Gratian, M.J., Keane, F.M., Eady, R.A.,
McGrath, J.A., 1999. Striate palmoplantar keratoderma resulting from desmoplakin
haploinsufficiency. J Invest Dermatol 113, 940-946.

184

Whittock, N.V., Wan, H., Morley, S.M., Garzon, M.C., Kristal, L., Hyde, P., McLean, W.H.,
Pulkkinen, L., Uitto, J., Christiano, A.M., Eady, R.A., McGrath, J.A., 2002. Compound
heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin
fragility/woolly hair syndrome. J Invest Dermatol 118, 232-238.
Wiedenheft, B., Sternberg, S.H., Doudna, J.A., 2012. RNA-guided genetic silencing systems in
bacteria and archaea. Nature 482, 331-338.
Williamson, L., Raess, N.A., Caldelari, R., Zakher, A., de Bruin, A., Posthaus, H., Bolli, R.,
Hunziker, T., Suter, M.M., Muller, E.J., 2006. Pemphigus vulgaris identifies plakoglobin as key
suppressor of c-Myc in the skin. EMBO J 25, 3298-3309.
Wilson, P., Keller, R., 1991. Cell rearrangement during gastrulation of Xenopus: direct observation
of cultured explants. Development 112, 289-300.
Wilson, P.A., Hemmati-Brivanlou, A., 1995. Induction of epidermis and inhibition of neural fate
by Bmp-4. Nature 376, 331-333.
Wood, A.J., Lo, T.W., Zeitler, B., Pickle, C.S., Ralston, E.J., Lee, A.H., Amora, R., Miller, J.C.,
Leung, E., Meng, X., Zhang, L., Rebar, E.J., Gregory, P.D., Urnov, F.D., Meyer, B.J., 2011.
Targeted genome editing across species using ZFNs and TALENs. Science 333, 307.
Wu, X., Bowers, B., Rao, K., Wei, Q., Hammer, J.A., 3rd, 1998. Visualization of melanoso me
dynamics within wild-type and dilute melanocytes suggests a paradigm for myosin V function In
vivo. J Cell Biol 143, 1899-1918.
Xu, H., Xiao, T., Chen, C.H., Li, W., Meyer, C.A., Wu, Q., Wu, D., Cong, L., Zhang, F., Liu, J.S.,
Brown, M., Liu, X.S., 2015. Sequence determinants of improved CRISPR sgRNA design. Genome
Res 25, 1147-1157.
Xu, Z., Kukekov, N.V., Greene, L.A., 2005. Regulation of apoptotic c-Jun N-terminal kinase
signaling by a stabilization-based feed-forward loop. Mol Cell Biol 25, 9949-9959.
Yamamoto, K., Ichijo, H., Korsmeyer, S.J., 1999. BCL-2 is phosphorylated and inactivated by an
ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19,
8469-8478.
Yamanaka, H., Moriguchi, T., Masuyama, N., Kusakabe, M., Hanafusa, H., Takada, R., Takada,
S., Nishida, E., 2002. JNK functions in the non-canonical Wnt pathway to regulate convergent
extension movements in vertebrates. EMBO Rep 3, 69-75.
Yan, M., Dai, T., Deak, J.C., Kyriakis, J.M., Zon, L.I., Woodgett, J.R., Templeton, D.J., 1994.
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1.
Nature 372, 798-800.
Yang, L., Chen, Y., Cui, T., Knosel, T., Zhang, Q., Albring, K.F., Huber, O., Petersen, I., 2012.
Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway
in human lung cancer. Carcinogenesis 33, 1863-1870.

185

Yang, L., Yang, J.L., Byrne, S., Pan, J., Church, G.M., 2014. CRISPR/Cas9-Directed Genome
Editing of Cultured Cells. Curr Protoc Mol Biol 107, 31 31 31-17.
Yin, T., Getsios, S., Caldelari, R., Godsel, L.M., Kowalczyk, A.P., Muller, E.J., Green, K.J., 2005.
Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and
regulation by epidermal growth factor receptor. J Biol Chem 280, 40355-40363.
You, H., Padmashali, R.M., Ranganathan, A., Lei, P., Girnius, N., Davis, R.J., Andreadis, S.T.,
2013. JNK regulates compliance- induced adherens junctions formation in epithelial cells and
tissues. J Cell Sci 126, 2718-2729.
Yu, C.C., Yu, C.H., Hsueh, C.H., Yang, C.T., Juang, J.M., Hwang, J.J., Lin, J.L., Lai, L.P., 2008.
Arrhythmogenic right ventricular dysplasia: clinical characteristics and identification of novel
desmosome gene mutations. J Formos Med Assoc 107, 548-558.
Yuan, L., Sakamoto, N., Song, G., Sato, M., 2012. Migration of human mesenchymal stem cells
under low shear stress mediated by mitogen-activated protein kinase signaling. Stem Cells Dev
21, 2520-2530.
Zhou, F., Narasimhan, V., Shboul, M., Chong, Y.L., Reversade, B., Roy, S., 2015. Gmnc Is a
Master Regulator of the Multiciliated Cell Differentiation Program. Curr Biol 25, 3267-3273.
Zhu, X., Raina, A.K., Rottkamp, C.A., Aliev, G., Perry, G., Boux, H., Smith, M.A., 2001.
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in
degenerating neurons in Alzheimer's disease. J Neurochem 76, 435-441.
Zhurinsky, J., Shtutman, M., Ben-Ze'ev, A., 2000. Plakoglobin and beta-catenin: protein
interactions, regulation and biological roles. J Cell Sci 113 ( Pt 18), 3127-3139.
Zihni, C., Balda, M.S., Matter, K., 2014. Signalling at tight junctions during epithelia l
differentiation and microbial pathogenesis. J Cell Sci 127, 3401-3413.

186

VITA

Navaneetha Krishnan Bharathan was born on January 12, 1990, in Doha, Qatar, and is an Indian
citizen. He graduated from St. John’s English School and Junior College, Chennai, India in 2007.
He received his Bachelor of Technology in Genetic Engineering from SRM University, Chennai,
India in 2011, where he was awarded the Gold Medal for his academic achievements. He was
awarded the Roscoe D. Hughes Fellowship in 2016 and the Alpha Epsilon Lambda Award in 2017.

187

